data_1cok_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cok _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.435 ' CD2' HD12 ' A' ' 34' ' ' LEU . 1.9 tm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.829 0.347 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.85 -50.87 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.166 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -25.01 65.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.116 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -50.9 6.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.029 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.406 ' CD2' HD13 ' A' ' 28' ' ' LEU . 2.2 tm? -48.9 -53.03 21.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.015 0.436 . . . . 0.0 110.859 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 55.8 m -74.69 -46.88 34.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.46 -29.82 17.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.286 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 2.8 tp -62.38 -15.05 46.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.642 0.258 . . . . 0.0 111.277 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.59 12.78 8.48 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.419 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.1 m -116.12 67.21 3.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.684 0.278 . . . . 0.0 111.057 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 59.5 Cg_endo -72.55 -17.5 26.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.526 2.151 . . . . 0.0 112.521 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -130.04 21.36 5.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.028 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -28.07 8.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 tt -52.2 -34.76 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.817 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.96 -44.05 86.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.667 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -71.98 -33.57 68.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.482 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' CE1' HD22 ' A' ' 45' ' ' LEU . 10.2 m-85 -73.76 -45.19 53.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.58 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -55.73 -32.08 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.79 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -49.52 -25.92 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.996 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -99.9 -48.07 4.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.44 47.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.469 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.461 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.24 39.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.126 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -30.24 12.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.039 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.52 110.47 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.075 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.447 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -46.44 -27.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.004 0.431 . . . . 0.0 111.279 -178.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -21.82 49.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.63 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -21.52 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.214 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.3 19.25 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -28.61 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.329 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.75 -20.44 10.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.513 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.433 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -44.94 148.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.633 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.39 178.63 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.121 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.463 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 9.6 tp -59.65 -33.33 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.48 0.657 . . . . 0.0 109.23 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.18 -50.94 71.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.04 -24.27 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.9 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.509 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.63 -6.9 60.09 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.734 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.38 -43.63 32.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.964 0.412 . . . . 0.0 110.432 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.445 HD22 ' CE1' ' A' ' 23' ' ' PHE . 9.3 mp -47.35 -29.11 2.35 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.174 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER 82.44 21.37 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.439 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 4.5 mt -81.35 138.0 48.52 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.305 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.439 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.0 Cg_exo -39.66 136.76 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.527 2.151 . . . . 0.0 112.294 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -78.73 55.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.399 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.53 -43.16 13.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -140.36 30.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -50.71 -59.31 4.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.9 ptm -59.37 -44.49 92.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 m -51.7 -50.19 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.456 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.437 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 17.6 mt -59.74 -46.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.523 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 13.2 t90 -57.64 -61.65 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.56 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.8 ptm180 -51.78 -31.16 25.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -74.7 -36.58 47.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.714 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 2.6 tp -67.46 -42.08 83.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.253 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.523 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 37.3 mt-30 -61.02 -27.69 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.279 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.292 178.916 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.403 HD11 ' HA ' ' A' ' 29' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.836 0.351 . . . . 0.0 110.72 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.1 -33.84 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.02 64.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -85.7 -47.5 9.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.93 -48.45 67.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.363 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.7 m -81.06 -40.83 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.097 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.25 -30.83 11.56 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.195 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -20.46 25.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.94 19.06 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.185 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 78.85 35.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.638 0.256 . . . . 0.0 110.974 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.74 13.85 2.64 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.656 2.237 . . . . 0.0 112.93 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -143.0 25.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 111.022 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.18 -34.34 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.294 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -46.95 -28.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -59.8 -46.6 88.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.095 0.474 . . . . 0.0 110.625 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -78.72 -28.65 45.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -77.46 -43.85 30.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.841 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -67.49 -28.74 68.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.754 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m -54.12 -22.42 11.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.968 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -99.78 -56.72 2.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.33 43.51 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.213 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.461 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.2 40.78 1.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.833 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.403 ' HA ' HD11 ' A' ' 7' ' ' LEU . 7.5 pt20 -99.46 -27.53 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.09 109.95 18.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.116 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.432 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -46.48 -27.52 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 111.095 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -58.04 -22.22 49.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -84.18 -19.19 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.03 4.45 15.7 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.83 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -53.31 -36.48 61.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.724 0.297 . . . . 0.0 111.186 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -112.81 19.41 17.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.464 ' CD2' ' CD2' ' A' ' 42' ' ' LEU . 12.8 tp -84.79 155.98 21.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.27 177.38 7.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.478 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 9.5 tp -58.29 -34.16 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.419 0.628 . . . . 0.0 109.42 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.89 -47.33 77.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.715 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' CB ' HD12 ' A' ' 37' ' ' LEU . 21.0 m-20 -80.93 -31.0 35.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.551 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.464 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -51.3 -51.39 54.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.28 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.09 -20.33 77.87 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.324 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.04 -44.17 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.14 0.495 . . . . 0.0 110.202 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 8.1 mp -48.52 -29.46 4.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.318 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttpt 86.63 19.43 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.315 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 3.8 mt -83.98 138.62 39.96 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.242 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 61.7 Cg_exo -36.81 151.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.703 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -91.65 22.47 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 33.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -62.16 -51.14 69.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.376 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.3 ttp -66.22 -32.32 73.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.121 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.2 m -59.63 -50.36 74.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.1 mt -62.7 -41.42 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.805 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.512 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 9.4 t90 -57.19 -51.52 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.101 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -50.8 -46.85 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.441 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.95 93.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.585 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -61.61 -36.47 80.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 178.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.512 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 56.5 mt-30 -66.53 -28.6 68.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.203 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.585 179.169 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.755 0.312 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 t -59.01 -45.05 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.433 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -59.38 -30.5 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -88.11 -51.87 5.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.336 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -45.66 -53.21 9.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 111.151 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.433 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 51.3 m -74.36 -47.69 32.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.37 -24.35 22.62 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.478 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tp -61.38 -18.17 57.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.742 0.306 . . . . 0.0 111.327 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.98 18.68 5.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.299 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -134.33 74.6 66.48 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.858 0.361 . . . . 0.0 110.759 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.433 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 71.6 Cg_endo -84.63 10.06 3.88 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.809 2.34 . . . . 0.0 112.821 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.3 16.04 2.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 111.221 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -115.28 -22.24 9.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 tt -50.18 -36.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 110.974 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 12.2 pt-20 -57.63 -43.84 85.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.479 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 64.3 m-85 -70.71 -32.63 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 22.3 m-85 -73.91 -52.81 11.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.536 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.3 p -50.67 -29.18 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.57 -27.64 7.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.231 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.17 -42.43 6.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.87 45.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.182 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.44 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -99.5 40.01 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -99.22 -27.58 13.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.992 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.48 107.44 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.025 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.435 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -45.75 -27.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.059 0.457 . . . . 0.0 111.348 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -21.01 34.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 -22.35 29.04 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -107.01 18.78 21.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 0.0 111.508 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -19.23 64.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.258 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -125.39 -8.69 6.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -61.14 153.88 24.63 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.828 0.347 . . . . 0.0 110.984 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.439 ' CG2' ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -140.15 178.31 7.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.063 0.459 . . . . 0.0 111.478 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.482 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 7.4 tp -60.42 -34.0 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.52 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.5 OUTLIER -57.91 -39.87 78.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.416 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.05 -34.69 20.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.642 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.443 ' CD1' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -48.38 -59.01 3.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.879 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.48 -19.12 32.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.388 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.02 71.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.444 ' CB ' HG13 ' A' ' 47' ' ' ILE . 6.4 mp -62.85 -17.52 61.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.488 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 74.19 17.45 3.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 111.369 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.444 HG13 ' CB ' ' A' ' 45' ' ' LEU . 7.4 mt -80.95 137.82 49.94 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.678 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 59.6 Cg_exo -37.66 112.81 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.83 2.354 . . . . 0.0 112.787 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -68.15 63.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.112 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -85.11 -50.33 7.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.558 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.06 28.64 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.433 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -30.54 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.283 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -50.03 48.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.2 m -54.62 -40.0 68.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.369 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 6.8 mm -61.7 -55.65 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.895 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.516 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 6.5 t90 -52.05 -45.58 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.243 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -51.24 -53.77 32.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.611 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.2 -41.78 54.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mp -65.37 -28.18 69.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 110.355 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.516 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 47.6 mt-30 -75.07 -28.49 60.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.478 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.573 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.418 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.8 tm? . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.809 0.338 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' A' ' 11' ' ' LEU . 42.3 t -53.78 -59.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.056 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.1 -6.75 30.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.769 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.43 -59.61 1.97 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.48 ' CD1' ' N ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.04 -26.35 68.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.507 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.48 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 33.1 m -81.11 -50.43 9.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.282 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.23 -25.7 60.47 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.418 ' CD2' ' HA3' ' A' ' 58' ' ' GLY . 5.1 tp -49.63 -24.78 2.38 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.025 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.65 10.45 4.91 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.282 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 73.52 72.82 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 116.958 0.379 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 3.1 Cg_exo -77.67 4.03 6.38 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.897 2.398 . . . . 0.0 112.901 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -132.43 19.67 4.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.638 0.256 . . . . 0.0 111.264 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -114.01 -24.23 9.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.046 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.437 ' CD1' ' HG ' ' A' ' 11' ' ' LEU . 8.5 tp -49.89 -36.65 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.74 -40.67 92.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.548 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.1 m-30 -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.458 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.526 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 6.9 m-85 -80.89 -42.44 21.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 20' ' ' ILE . 11.9 p -52.88 -29.64 29.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -27.12 3.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.259 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -99.94 -58.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.957 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.44 46.86 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.446 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.477 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.4 39.89 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -99.66 -28.95 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.105 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -116.21 115.57 26.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.166 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -47.85 -26.74 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 111.049 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -59.91 -19.39 51.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -85.33 -30.22 23.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.864 0.364 . . . . 0.0 110.55 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -98.67 23.52 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.492 . . . . 0.0 110.757 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -68.1 -37.91 81.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.607 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.54 -18.17 12.47 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.661 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -44.78 148.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.303 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 173.71 11.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.108 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.484 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 6.9 tp -57.14 -33.77 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.392 0.615 . . . . 0.0 109.384 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.79 -45.35 78.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.332 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.62 -31.66 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.448 ' CD1' ' HB ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -54.49 -45.57 73.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.418 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -67.66 -10.27 57.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.58 -27.76 45.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.116 0.484 . . . . 0.0 110.403 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.526 ' CD2' ' CD2' ' A' ' 23' ' ' PHE . 8.1 mp -62.39 -11.74 17.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.146 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt 77.09 20.18 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.425 HG12 ' CB ' ' A' ' 45' ' ' LEU . 7.1 mm -82.35 131.74 54.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.66 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.7 176.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.667 2.245 . . . . 0.0 112.396 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.59 40.65 1.04 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.96 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -51.97 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.811 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -140.24 25.64 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.289 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.425 ' NE ' ' HA2' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -51.83 -57.72 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.7 mmm -59.98 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.915 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.0 m -50.36 -48.16 55.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.654 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 8.3 mt -55.53 -56.96 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.755 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.525 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 7.5 t90 -51.47 -52.44 46.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.855 0.359 . . . . 0.0 110.456 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -47.01 -59.6 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.018 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.418 ' HA3' ' CD2' ' A' ' 14' ' ' LEU . . . -51.67 -34.05 35.33 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.704 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 34' ' ' LEU . 1.8 mp -69.81 -31.25 69.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.427 . . . . 0.0 110.102 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.525 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 56.2 mt-30 -68.48 -28.9 67.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.941 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.375 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.427 HD21 ' CA ' ' A' ' 31' ' ' ILE . 1.7 tm? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.924 0.392 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.96 -42.35 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.042 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -24.94 37.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.53 -44.72 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.403 ' CD2' ' HB ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -46.01 -54.18 8.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.97 0.414 . . . . 0.0 111.138 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -76.89 -49.79 14.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.91 -24.87 8.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.192 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.46 -18.8 31.55 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.779 0.323 . . . . 0.0 111.113 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.4 19.49 7.05 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.069 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' SG ' ' CD1' ' A' ' 51' ' ' TYR . 3.7 m -134.23 77.69 60.17 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 111.113 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.47 19.43 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.892 2.394 . . . . 0.0 112.833 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.47 20.34 1.87 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.472 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 p -120.36 -30.98 4.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.69 0.281 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 24' ' ' THR . 12.2 tt -46.75 -30.8 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.567 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.46 -44.19 88.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 110.349 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -75.15 -29.0 60.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.818 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.481 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 25.3 m-85 -78.17 -30.36 49.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.94 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 20' ' ' ILE . 7.1 p -69.39 -32.94 72.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -24.56 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.95 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -99.89 -49.25 4.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.18 51.38 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.328 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.69 39.28 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.0 110.948 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -99.39 -28.55 13.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.128 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.98 112.9 23.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.022 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.456 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -45.37 -28.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.975 0.416 . . . . 0.0 111.116 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 m-85 -57.15 -21.01 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.753 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 -31.2 25.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.961 0.41 . . . . 0.0 110.613 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.475 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.94 25.35 8.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.875 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.401 ' HG3' ' HA ' ' A' ' 32' ' ' TYR . 3.7 mm-40 -67.76 -42.99 80.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.612 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.61 -21.33 13.75 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.503 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -46.31 144.91 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.119 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.415 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -135.02 178.67 6.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.131 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.487 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 9.2 tp -59.25 -32.99 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.363 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.07 -48.05 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.704 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.34 -25.97 38.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD21 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -55.62 -49.21 73.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.83 -9.16 58.87 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.775 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.54 -43.69 38.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.058 0.456 . . . . 0.0 110.433 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.481 ' CD2' ' CD1' ' A' ' 23' ' ' PHE . 10.0 mp -46.15 -27.57 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.9 ttmm 86.17 19.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.237 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.432 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 4.9 mm -78.13 138.42 60.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.692 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 81.4 Cg_exo -41.05 149.42 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.515 2.143 . . . . 0.0 112.389 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -89.01 47.21 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.19 -53.71 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.448 ' CD1' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -136.77 31.88 2.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.065 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -54.89 -48.28 73.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -45.21 94.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.7 m -51.95 -45.93 64.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 17.9 mt -61.16 -42.97 95.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.766 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 11.3 t90 -59.73 -50.29 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -47.13 -56.69 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.734 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.52 -42.29 65.7 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.661 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mp -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.518 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 39.6 mt-30 -71.53 -17.25 62.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.604 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.848 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 30' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.814 0.34 . . . . 0.0 111.147 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 m -43.95 -37.05 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.714 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -30.48 70.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.98 -47.28 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.36 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -48.69 -54.45 14.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.0 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -79.17 -44.25 22.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.261 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 -28.46 12.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.248 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.403 ' CD2' ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -55.09 -22.02 14.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.015 0.436 . . . . 0.0 110.844 178.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 20.95 5.75 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.086 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.7 p -134.96 83.6 39.8 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -87.28 21.48 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.785 2.323 . . . . 0.0 113.02 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -138.17 17.61 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.385 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.9 p -115.72 -26.73 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.2 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.85 -42.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.83 -42.29 75.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -74.16 -30.52 62.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.652 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 33.2 m-85 -76.83 -51.59 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.752 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 53.3 p -50.43 -27.61 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.153 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.3 t -53.23 -24.12 10.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -103.89 -38.72 6.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.058 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.68 47.08 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.9 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -99.19 44.62 1.02 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.309 0.576 . . . . 0.0 110.647 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -107.39 -13.98 14.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.314 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.43 ' N ' HD11 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -127.16 103.68 7.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.43 ' HA ' ' CG ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -43.04 -29.12 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 111.761 -177.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -56.76 -22.61 36.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -85.23 -11.47 54.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.496 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -122.37 14.81 10.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.404 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -24.28 62.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.21 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -115.38 -18.37 11.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.486 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.88 143.24 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.31 176.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.25 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.478 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 3.7 tp -55.84 -33.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.437 0.637 . . . . 0.0 109.46 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.02 -43.41 81.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.681 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.81 -28.62 26.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.762 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -52.45 -46.35 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.43 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.32 62.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.775 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.67 -44.94 18.0 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 9.4 mp -49.02 -28.14 3.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.249 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.6 tptt 83.34 21.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.317 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.445 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 6.1 mt -83.68 137.93 41.13 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.479 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 69.7 Cg_exo -38.07 153.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.783 2.322 . . . . 0.0 112.596 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.3 pm0 -91.84 21.18 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.403 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -58.58 -44.27 89.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.809 0.338 . . . . 0.0 110.828 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.476 ' CD2' ' HB3' ' A' ' 16' ' ' CYS . 12.4 m-85 -140.69 31.96 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.359 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.19 -61.15 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.381 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtm -56.54 -42.97 79.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.777 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.9 m -51.01 -50.47 58.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.43 HD13 ' CE2' ' A' ' 23' ' ' PHE . 6.6 mt -62.66 -37.66 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.478 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 11.0 t90 -61.63 -54.58 40.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.404 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -54.67 -36.75 64.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.853 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 14' ' ' LEU . . . -74.35 -31.58 59.0 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.114 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 3.6 tp -73.91 -36.34 64.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.801 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -69.1 -26.91 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.243 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.412 HD21 ' CD1' ' A' ' 31' ' ' ILE . 1.2 tm? . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.943 0.402 . . . . 0.0 110.636 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.403 HG13 HD12 ' A' ' 20' ' ' ILE . 39.0 t -68.82 -39.11 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.129 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 p -59.41 -34.35 72.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.87 -43.73 12.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -48.24 -52.8 19.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 55.4 m -75.68 -50.44 15.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.2 -23.61 12.96 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.328 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -58.59 -18.49 30.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 0.0 111.18 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.59 12.14 6.85 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.588 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.4 m -132.16 77.85 70.15 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.437 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 90.6 Cg_endo -79.97 4.7 6.52 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.7 2.267 . . . . 0.0 112.939 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.21 20.49 3.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.687 0.28 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 m -114.19 -28.25 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.976 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.403 HD12 HG13 ' A' ' 8' ' ' VAL . 1.7 tt -47.7 -44.15 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.07 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -49.97 -44.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.802 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.63 -32.79 62.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.556 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.515 ' CD1' ' CD1' ' A' ' 47' ' ' ILE . 4.0 m-85 -69.29 -51.08 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.4 p -58.16 -28.02 64.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.7 t -47.29 -27.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.239 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -101.61 -56.28 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.753 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.14 46.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.092 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 0.5 OUTLIER -99.4 38.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 111.14 -179.152 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.08 -27.83 13.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.785 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 108.04 17.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.852 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.434 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -43.23 -33.71 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.988 0.423 . . . . 0.0 111.548 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -55.92 -20.63 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.985 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.81 -15.77 47.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.675 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -113.28 9.84 18.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -36.38 65.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -99.88 -22.3 15.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 5.0 tp -47.79 135.2 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.42 ' CG2' ' NE1' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -132.67 178.55 6.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.009 0.433 . . . . 0.0 111.304 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.483 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 5.5 tp -58.97 -32.44 47.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.552 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -57.11 -45.37 83.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.833 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 2.4 m-20 -85.01 -27.11 26.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.441 ' CD2' ' HG ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -49.26 -53.31 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.855 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.428 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . -68.15 -8.83 55.77 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.733 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.13 -42.37 56.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 110.426 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 9.5 mp -47.87 -28.01 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.45 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.2 tttm 87.17 17.22 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.586 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.515 ' CD1' ' CD1' ' A' ' 23' ' ' PHE . 4.0 mt -85.91 138.49 35.13 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.595 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 2.7 Cg_endo -40.46 146.35 0.3 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.965 2.444 . . . . 0.0 112.108 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -90.21 42.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.76 -43.67 71.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.762 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -140.26 30.4 1.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.665 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 9.6 ttp180 -48.36 -50.75 29.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.9 mtt -61.2 -54.1 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.263 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -47.41 -48.93 26.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 0.0 111.034 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.6 mt -59.06 -41.51 83.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.743 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.483 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 7.9 t90 -62.43 -46.67 87.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.261 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.07 -60.03 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.43 -30.62 61.97 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.67 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -70.99 -25.96 62.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -69.24 -12.62 61.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 8' ' ' VAL . 1.2 tm? . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 9' ' ' SER . 34.9 m -57.21 -35.8 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.418 ' N ' HG22 ' A' ' 8' ' ' VAL . 83.6 p -64.38 -24.29 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.76 -48.74 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -48.26 -53.22 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.133 0.492 . . . . 0.0 110.876 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.432 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 93.0 m -70.67 -49.59 45.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.37 -32.7 22.93 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 tp -60.17 -17.14 38.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.81 11.23 6.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.611 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' CD1' ' A' ' 55' ' ' ILE . 1.3 m -114.91 72.41 2.86 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-O 120.739 0.304 . . . . 0.0 111.146 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 85.2 Cg_endo -80.64 -13.1 12.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.256 . . . . 0.0 112.943 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.87 22.08 4.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.112 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.6 m -114.83 -28.21 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.072 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 tt -48.52 -32.83 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.95 -44.82 96.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.69 -27.95 50.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.463 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE1' HD22 ' A' ' 45' ' ' LEU . 20.1 m-85 -76.54 -46.36 26.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.9 p -56.34 -30.75 63.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 p -55.79 -23.64 31.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.262 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.84 -34.98 9.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.75 41.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.304 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.79 39.53 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.024 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.22 -29.6 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.914 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.59 109.38 19.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.83 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -44.43 -28.34 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 111.526 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -58.64 -22.46 56.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.677 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -84.23 -19.9 33.16 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.468 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.56 13.38 22.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.679 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -17.46 64.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.408 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -128.36 17.86 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 0.1 OUTLIER -84.88 147.41 26.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.29 . . . . 0.0 110.654 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.438 ' HB ' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -131.02 172.72 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.012 0.434 . . . . 0.0 111.523 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.434 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 7.5 tp -56.98 -34.3 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.676 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.438 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -59.09 -38.85 80.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -85.47 -26.81 26.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.591 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -54.77 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.662 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -55.15 -20.44 20.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.369 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.83 85.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 0.0 110.358 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.457 HD22 ' CE1' ' A' ' 23' ' ' PHE . 6.8 mp -61.26 -15.41 34.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.485 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 74.81 19.3 2.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.93 0.395 . . . . 0.0 111.073 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.433 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 7.4 mm -79.23 138.17 56.21 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.513 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 87.7 Cg_exo -43.05 157.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.407 2.072 . . . . 0.0 112.136 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -85.56 -46.14 11.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -140.31 21.81 2.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.412 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -51.01 -57.34 8.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -41.86 94.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.628 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -54.4 -47.59 72.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.604 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.439 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 6.8 mt -62.31 -36.77 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.434 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 11.4 t90 -64.23 -51.27 64.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 5.4 ptp180 -60.69 -33.14 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -77.54 -25.73 62.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.126 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.2 mp -78.46 -34.28 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.642 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -73.16 -30.46 63.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.38 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.569 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 31' ' ' ILE . 1.8 tm? . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.691 0.282 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.71 -59.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.548 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -55.6 -19.61 10.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.13 -57.04 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 111.391 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -46.16 -45.07 16.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.428 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 33.7 m -83.34 -49.11 9.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.635 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.58 -27.19 25.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.245 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 tp -60.74 -17.19 47.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.737 0.304 . . . . 0.0 111.047 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.57 16.87 6.79 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.309 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -127.79 71.86 78.28 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.672 0.272 . . . . 0.0 111.174 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.428 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 87.6 Cg_endo -84.0 12.0 3.15 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.67 2.247 . . . . 0.0 112.854 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -138.73 16.21 2.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.674 0.273 . . . . 0.0 111.557 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -116.45 -23.05 8.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.765 0.317 . . . . 0.0 111.233 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -48.58 -43.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.26 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -56.01 -41.64 75.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -74.31 -33.63 63.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.685 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' CE1' HD22 ' A' ' 45' ' ' LEU . 9.1 m-85 -74.16 -51.26 16.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.865 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.9 p -48.87 -34.41 12.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.328 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -47.98 -26.56 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.564 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -101.45 -29.71 11.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.74 45.55 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.097 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -99.11 40.15 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.995 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.404 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 2.9 mt-30 -99.34 -30.08 12.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.784 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.27 109.05 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.917 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.447 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -43.62 -28.51 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 111.637 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.07 -23.91 62.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.766 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -80.27 -14.6 58.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.726 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -115.39 -1.5 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.81 -35.28 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.61 0.243 . . . . 0.0 111.508 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -108.6 15.66 23.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.475 ' CD2' ' CD2' ' A' ' 42' ' ' LEU . 14.7 tp -85.35 156.17 21.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.343 . . . . 0.0 110.792 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.416 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -140.14 174.35 10.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.481 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 5.0 tp -57.64 -35.25 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.405 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -58.74 -39.22 80.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.701 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -85.73 -32.8 21.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.475 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -52.35 -45.25 65.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.334 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.54 -0.26 72.44 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.644 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.17 -33.57 22.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.062 0.458 . . . . 0.0 110.252 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.483 HD22 ' CE1' ' A' ' 23' ' ' PHE . 7.3 mp -61.11 -14.88 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.656 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.27 17.66 2.0 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.096 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.445 HG13 ' CB ' ' A' ' 45' ' ' LEU . 6.2 mt -85.09 138.18 37.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.438 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 68.4 Cg_exo -38.63 138.94 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.705 2.27 . . . . 0.0 112.555 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' CB ' ' HD3' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -91.89 22.45 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.445 -178.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -55.58 -36.32 66.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.964 0.412 . . . . 0.0 110.51 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.17 28.77 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HD3' ' CB ' ' A' ' 49' ' ' GLU . 4.6 ttp180 -48.95 -58.2 5.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -46.37 79.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -50.99 -50.66 57.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.71 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.442 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 5.8 mt -57.06 -52.16 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.481 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 7.5 t90 -52.25 -47.74 65.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 60' ' ' GLN . 7.1 mmt180 -49.94 -42.54 48.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.615 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.53 -21.9 71.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.798 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.45 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -85.24 -24.64 27.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.985 0.421 . . . . 0.0 111.023 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 7.7 pt20 -73.57 -11.61 60.49 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 8' ' ' VAL . 2.1 tm? . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.745 0.307 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 26.2 m -59.81 -43.34 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . 1.7 t -57.68 -34.75 69.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -43.95 15.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -47.49 -55.06 9.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.032 0.444 . . . . 0.0 111.067 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.433 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 86.5 m -72.77 -49.34 31.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.61 -29.61 18.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.34 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 1.8 tp -63.93 -14.72 55.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.707 0.289 . . . . 0.0 111.281 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.78 12.78 8.33 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.291 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.4 m -114.18 64.84 1.36 Allowed Pre-proline 0 C--N 1.333 -0.133 0 CA-C-O 120.629 0.252 . . . . 0.0 111.052 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.433 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 59.1 Cg_endo -71.85 -19.72 26.84 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.473 2.115 . . . . 0.0 112.361 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.95 22.3 5.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.96 -29.37 7.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt -49.32 -36.69 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.032 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -44.13 80.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.61 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -72.44 -36.64 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.529 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.471 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 33.0 m-85 -69.63 -49.93 49.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.963 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.0 p -49.78 -38.88 36.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.139 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -22.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.174 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HG3' ' HG ' ' A' ' 45' ' ' LEU . 7.9 mm-40 -99.55 -23.46 15.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.27 44.94 0.54 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.15 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.435 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -99.61 38.91 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.928 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -99.27 -26.93 14.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.159 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.47 107.09 16.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.149 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.445 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.65 -29.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.948 0.404 . . . . 0.0 111.175 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -55.02 -22.36 15.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.621 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.01 -25.79 29.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -107.98 18.75 20.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.287 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -59.86 -44.39 94.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.088 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.85 -16.41 15.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.202 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.475 ' CD2' ' CD2' ' A' ' 42' ' ' LEU . 12.4 tp -44.39 153.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.982 0.42 . . . . 0.0 111.595 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.12 178.64 7.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.772 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 tp -61.85 -32.59 54.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.414 0.626 . . . . 0.0 109.409 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.8 -46.83 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.698 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.41 -31.55 26.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.794 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.475 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -50.04 -49.65 50.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.336 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' HA2' ' HD2' ' A' ' 52' ' ' ARG . . . -72.13 -18.11 77.72 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.403 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.98 -37.93 86.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.458 . . . . 0.0 110.388 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' A' ' 23' ' ' PHE . 8.6 mp -50.25 -27.38 5.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 84.04 19.65 0.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.762 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG13 ' CB ' ' A' ' 45' ' ' LEU . 4.5 mt -85.12 137.27 37.42 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 92.0 Cg_exo -41.75 139.31 2.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.573 2.182 . . . . 0.0 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -74.81 61.15 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -85.14 -52.33 6.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.11 36.01 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.685 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 2.1 ttp180 -59.84 -53.14 61.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.4 ptm -60.17 -41.19 92.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -59.44 -47.14 86.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 110.582 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 21.3 mt -58.51 -47.8 87.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.628 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.401 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 11.3 t90 -55.57 -59.67 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.319 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -47.22 -39.72 14.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.179 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.42 -26.87 64.69 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.999 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -78.29 -35.02 48.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 110.781 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.401 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 7.2 pt20 -70.22 -27.95 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.212 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.494 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.401 ' CD1' ' O ' ' A' ' 29' ' ' GLN . 1.6 tm? . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.76 0.314 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.14 -43.91 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.983 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.69 -36.37 62.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -81.93 -47.03 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.41 ' CD1' ' HB ' ' A' ' 20' ' ' ILE . 1.9 tm? -49.59 -33.95 16.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.2 m -83.2 -61.83 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.923 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.81 -28.72 3.93 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.874 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 55' ' ' ILE . 4.1 tt -51.84 -24.49 6.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.709 177.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.93 14.2 9.52 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.738 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 87.0 m -121.16 64.31 13.25 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.689 0.28 . . . . 0.0 111.118 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.51 -11.26 26.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.516 2.144 . . . . 0.0 112.686 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -131.41 19.73 4.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.221 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -111.85 -27.04 8.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.89 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 5.7 tt -49.6 -34.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.51 -45.62 77.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.755 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -74.63 -36.3 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.418 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -66.88 -44.71 80.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.3 p -58.53 -34.31 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.8 m -51.47 -24.17 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.162 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -100.7 -37.46 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.865 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.4 45.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.333 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.61 40.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.401 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 5.8 pt20 -99.07 -28.96 13.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.981 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.05 110.67 21.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.083 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.44 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -45.7 -28.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.937 0.399 . . . . 0.0 111.2 -178.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -57.93 -22.32 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.57 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -20.67 36.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.475 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.57 21.03 14.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.28 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.55 -18.94 64.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.385 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -134.28 18.17 3.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.444 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -81.54 145.82 30.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.66 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.471 HG22 ' CD1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -131.7 173.69 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.48 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 8.5 tp -57.94 -35.92 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.443 0.64 . . . . 0.0 109.293 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.14 -44.8 68.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.337 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -84.79 -34.33 22.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.729 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.45 ' CD1' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -50.88 -58.66 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.57 179.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.36 -20.0 35.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.469 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.06 -41.04 97.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.523 ' CD2' ' CE1' ' A' ' 23' ' ' PHE . 8.8 mp -48.16 -28.0 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.219 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 82.13 19.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.974 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.428 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 7.3 mt -76.45 137.89 67.52 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.568 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 1.9 Cg_endo -40.66 131.79 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.964 2.442 . . . . 0.0 112.206 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.96 63.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.275 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -85.19 -60.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -140.32 36.29 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.751 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.404 ' CZ ' ' HB ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -49.33 -45.99 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.271 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 57' ' ' ARG . 2.3 ptp -62.14 -47.56 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 m -54.2 -40.37 67.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.478 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 7.8 mt -63.29 -58.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.135 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.507 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 6.5 t90 -49.92 -45.6 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.396 . . . . 0.0 110.21 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.4 ' CG ' ' O ' ' A' ' 53' ' ' MET . 3.2 mmt180 -55.5 -51.56 66.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.625 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.58 -41.63 89.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.855 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.1 tp -62.13 -32.83 73.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.507 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 50.8 mt-30 -70.3 -26.84 63.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.303 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 8' ' ' VAL . 1.4 tm? . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.754 0.311 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.463 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 48.1 t -60.8 -43.9 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.223 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -23.56 63.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.166 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.22 -48.73 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.137 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -48.59 -52.16 24.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.986 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 54.3 m -73.6 -48.68 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.707 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.82 -30.33 28.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.37 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -60.13 -17.69 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 111.197 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 121.01 12.6 5.8 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.551 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.85 65.72 5.25 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.085 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 77.1 Cg_endo -77.4 -5.09 15.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -136.49 18.81 3.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.626 0.25 . . . . 0.0 111.457 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -116.63 -22.26 8.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.296 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 tt -51.53 -34.94 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.171 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -54.94 -46.06 74.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -76.04 -31.74 58.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.703 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE1' HD23 ' A' ' 45' ' ' LEU . 14.6 m-85 -70.3 -43.88 69.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.236 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.1 p -62.67 -28.81 70.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.779 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 t -51.22 -25.02 4.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -100.17 -52.25 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.74 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.7 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.472 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.59 37.34 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.407 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -99.69 -29.05 12.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.813 178.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.57 109.08 19.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.434 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -44.02 -29.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.955 0.407 . . . . 0.0 111.543 -178.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -56.36 -22.48 31.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.57 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -84.03 -20.55 32.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.472 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.33 14.83 21.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.49 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -20.53 65.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -133.41 24.36 4.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.31 . . . . 0.0 111.104 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.481 ' O ' ' CE3' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -85.37 121.25 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.828 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.502 HG22 ' CZ2' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -99.44 175.72 5.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.111 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 53' ' ' MET . 5.1 tp -64.85 -32.1 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.613 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.12 -45.03 83.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.29 -32.18 26.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.795 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.474 ' CD1' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -52.86 -64.38 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.359 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.41 ' HA3' ' NE ' ' A' ' 52' ' ' ARG . . . -58.3 -23.25 52.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.992 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.39 -37.32 64.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 110.519 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.457 HD23 ' CE1' ' A' ' 23' ' ' PHE . 8.2 mp -59.52 -15.6 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.777 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 1.6 mtmt 78.71 17.9 0.99 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.446 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 6.1 mm -80.52 138.76 51.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.269 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 4.7 Cg_exo -36.34 140.32 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.224 2.616 . . . . 0.0 112.519 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.13 23.46 3.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.593 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -67.96 -31.74 71.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.65 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.32 23.69 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.41 ' NE ' ' HA3' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -50.69 -58.38 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.99 0.424 . . . . 0.0 110.782 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.438 ' HA ' ' CD1' ' A' ' 39' ' ' ILE . 0.8 OUTLIER -53.95 -52.05 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 m -48.17 -43.99 32.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.474 ' CG2' ' CD1' ' A' ' 42' ' ' LEU . 10.3 mt -58.8 -59.09 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.502 ' CZ2' HG22 ' A' ' 38' ' ' THR . 0.1 OUTLIER -53.1 -55.31 24.93 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.856 0.36 . . . . 0.0 110.403 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -44.8 -40.07 5.82 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.837 0.351 . . . . 0.0 111.575 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.11 -25.14 67.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.153 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.443 HD21 ' CB ' ' A' ' 37' ' ' LEU . 1.1 mp -82.16 -35.19 28.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.763 0.316 . . . . 0.0 111.083 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.477 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.3 pt20 -71.51 -27.63 63.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.281 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.728 0.299 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.88 -57.08 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.319 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 p -55.79 -21.78 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.545 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -88.04 -53.86 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.775 0.321 . . . . 0.0 111.178 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.429 ' CD2' HD11 ' A' ' 28' ' ' LEU . 2.2 tm? -48.25 -52.0 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.109 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.445 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 54.0 m -71.65 -46.61 58.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.697 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.14 -33.37 30.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.358 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.438 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 2.6 tp -64.53 -13.42 52.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.677 0.275 . . . . 0.0 111.499 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.86 13.81 7.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.5 m -112.24 60.91 0.58 Allowed Pre-proline 0 CA--C 1.528 0.133 0 CA-C-O 120.665 0.269 . . . . 0.0 111.287 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 56.1 Cg_endo -69.81 -30.44 22.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -124.21 19.77 9.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.798 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.9 m -109.45 -27.31 9.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.666 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.2 tt -52.08 -31.71 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.702 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 8.9 pt-20 -59.76 -44.55 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.485 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 59.9 m-85 -72.0 -30.89 65.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.232 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -74.13 -51.82 14.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.758 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.4 p -49.4 -34.07 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -51.36 -24.23 4.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -99.86 -43.3 6.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 45.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.151 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' HG ' ' CD1' ' A' ' 23' ' ' PHE . 0.2 OUTLIER -98.97 39.98 1.24 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.87 0.367 . . . . 0.0 111.007 -179.178 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.51 -25.07 14.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.134 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 t -111.33 108.28 17.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -48.0 -26.72 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -59.5 -21.76 60.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.563 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.68 -19.03 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -111.48 11.8 21.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.622 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -61.77 -21.51 64.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.301 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -132.43 21.24 4.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.534 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.442 ' CB ' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -77.88 146.0 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.669 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.408 ' O ' ' CD2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -127.99 172.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 0.0 111.589 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.6 tp -58.94 -33.36 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.515 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.99 -49.29 76.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.625 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.8 -15.1 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD21 ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -69.51 -56.56 7.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.882 0.372 . . . . 0.0 110.246 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.77 63.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.049 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.4 53.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.043 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.493 ' CD2' ' CE1' ' A' ' 23' ' ' PHE . 4.6 mp -72.25 -3.9 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.95 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 15.4 ptpt 49.93 33.37 6.54 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 121.014 0.435 . . . . 0.0 111.427 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.448 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 36.6 mt -83.52 138.72 41.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.986 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 46.4 Cg_exo -35.39 119.37 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.008 2.472 . . . . 0.0 112.949 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.91 68.6 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.355 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -85.21 -65.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 0.0 110.665 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.68 36.64 2.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.4 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -43.31 36.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.232 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 mtt -59.44 -50.54 73.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.649 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -50.77 -47.79 59.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.438 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 11.1 mm -55.92 -55.85 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -50.36 -62.94 1.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.29 -30.44 50.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.149 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.8 -27.36 56.88 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.839 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.442 HD21 ' CB ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -75.99 -38.89 56.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 110.691 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.48 -26.01 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.327 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.673 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.436 ' CD2' HD12 ' A' ' 34' ' ' LEU . 1.3 tm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.28 -31.4 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -72.5 -25.16 61.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -54.52 4.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.684 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' A' ' 28' ' ' LEU . 4.9 tp -51.03 -54.23 26.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.18 0.514 . . . . 0.0 110.372 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.436 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 25.6 m -58.51 -50.87 72.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.497 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.36 -30.22 48.4 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.973 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tp -59.5 -18.17 37.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 111.046 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.3 17.15 6.3 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.158 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 4.3 m -118.93 61.41 5.15 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.681 0.277 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 49.2 Cg_endo -68.78 -19.8 40.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.455 2.104 . . . . 0.0 112.16 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -129.56 23.96 5.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.416 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -114.67 -24.61 8.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' THR . 13.1 tt -51.43 -46.91 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -51.42 -45.18 62.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.657 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.7 m-30 -64.84 -32.02 73.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.487 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 2.5 m-85 -79.28 -28.04 42.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.55 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' ILE . 45.2 p -70.73 -24.52 62.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.145 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.4 ' OG ' ' NE2' ' A' ' 26' ' ' GLN . 93.6 p -50.62 -24.81 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.4 ' NE2' ' OG ' ' A' ' 25' ' ' SER . 4.3 mm-40 -104.24 -51.56 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.08 55.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.113 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -99.58 38.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.095 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -25.4 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.283 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.15 104.76 13.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.887 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.454 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.99 -27.52 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.452 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -21.25 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.71 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.6 -23.71 31.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.958 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -106.27 16.98 24.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -73.23 -20.93 60.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.268 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -128.87 20.37 5.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.324 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.48 ' O ' ' CE3' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -85.12 120.6 26.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.053 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.491 HG22 ' CZ2' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -99.79 176.75 5.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.267 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.417 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 7.4 tp -65.16 -31.52 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -56.03 -42.84 77.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.266 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.09 -32.44 22.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.801 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.442 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -54.87 -52.49 62.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -71.12 -16.28 74.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.411 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.81 94.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.946 0.403 . . . . 0.0 110.488 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.487 ' CD2' ' CD1' ' A' ' 23' ' ' PHE . 10.0 mp -44.09 -28.38 0.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.749 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.7 tttt 88.22 17.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.434 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.444 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 4.0 mt -78.24 138.15 60.28 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.9 Cg_exo -40.42 144.65 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.534 2.156 . . . . 0.0 112.419 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.53 54.08 2.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.416 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 78.7 mt-30 -84.93 -44.62 12.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.791 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 50' ' ' GLN . 4.8 m-85 -140.23 29.08 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' NE ' ' HA2' ' A' ' 43' ' ' GLY . 0.5 OUTLIER -46.54 -61.8 1.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.106 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.408 ' N ' HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -55.66 -47.03 77.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.004 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 52.4 m -55.23 -38.86 69.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.436 ' CG2' ' CD1' ' A' ' 42' ' ' LEU . 10.8 mt -63.96 -56.24 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.838 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.491 ' CZ2' HG22 ' A' ' 38' ' ' THR . 0.3 OUTLIER -56.69 -61.28 2.54 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.477 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -47.04 -32.87 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.663 0.268 . . . . 0.0 111.348 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.62 -27.8 58.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.681 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.9 OUTLIER -79.01 -44.45 22.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.388 . . . . 0.0 110.725 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.5 pt20 -59.9 -27.02 66.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.155 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.315 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 8' ' ' VAL . 2.8 tm? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.697 0.284 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.473 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 3.5 m -50.07 -42.51 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.4 -27.92 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.037 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.67 -56.25 4.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 tp -47.41 -55.99 7.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 0.0 110.698 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.445 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 63.4 m -53.15 -52.05 60.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.35 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.57 -31.05 52.04 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.028 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.412 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 3.8 tp -56.95 -19.88 20.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 19.02 5.29 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.332 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.5 p -134.51 66.08 69.08 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.676 0.274 . . . . 0.0 111.246 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 11.8 Cg_exo -71.54 -9.95 25.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.754 2.303 . . . . 0.0 112.777 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -126.26 16.37 7.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.095 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -113.46 -22.91 10.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.179 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.435 HD11 ' CG1' ' A' ' 8' ' ' VAL . 16.0 tt -54.18 -35.31 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.988 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HA ' ' CG2' ' A' ' 24' ' ' THR . 0.0 OUTLIER -66.07 -41.67 90.42 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.193 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -63.74 -26.97 68.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.521 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 2.3 m-85 -91.31 -35.95 14.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.469 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.448 ' CG2' ' HA ' ' A' ' 21' ' ' GLU . 4.4 t -70.72 -16.17 62.76 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.422 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -61.5 -23.0 65.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.742 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.12 -57.37 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.12 39.42 0.03 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HG ' ' CD1' ' A' ' 23' ' ' PHE . 0.2 OUTLIER -99.68 37.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.377 -179.333 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -99.86 -29.85 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.3 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -104.12 107.92 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.451 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -43.63 -30.06 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 -177.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.4 -21.49 25.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.674 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -85.4 -26.86 26.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.457 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -97.84 14.94 25.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -63.08 -37.78 88.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.437 0.637 . . . . 0.0 111.424 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.03 -14.78 14.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.268 -176.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -44.11 145.53 0.75 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.438 ' HB ' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -133.67 173.81 11.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.175 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 tp -63.09 -34.6 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.638 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.438 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 2.9 pt-20 -61.98 -38.51 88.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.47 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -84.99 -27.65 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.383 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.454 ' CD1' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -56.42 -59.73 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.29 -19.81 60.1 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.118 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.64 -36.03 69.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.057 0.456 . . . . 0.0 110.284 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.521 ' CD2' ' CD1' ' A' ' 23' ' ' PHE . 6.8 mp -60.92 -15.53 32.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.607 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 73.77 17.47 3.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 111.248 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.443 HG13 ' CB ' ' A' ' 45' ' ' LEU . 12.0 mt -79.46 137.87 55.43 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.3 Cg_exo -44.44 136.04 8.83 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.524 2.149 . . . . 0.0 112.299 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -68.41 62.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.234 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -85.44 -58.05 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.759 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.36 36.98 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.597 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.7 -64.74 0.77 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -52.14 -42.91 63.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.9 m -53.13 -48.47 67.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.454 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 38.6 mt -62.94 -44.03 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -56.72 -55.23 36.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.438 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.3 ptm180 -59.46 -30.67 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.989 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.439 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -79.2 -26.33 57.87 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.822 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -81.08 -41.42 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.807 0.337 . . . . 0.0 110.485 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.77 -27.67 69.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.364 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.527 179.015 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.735 0.302 . . . . 0.0 111.065 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 m -43.0 -36.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.794 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -58.06 -51.52 69.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.104 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.54 -38.54 48.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.312 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.82 -57.25 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.05 0.452 . . . . 0.0 111.119 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 22.0 m -71.55 -50.52 30.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.804 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.2 -30.07 16.82 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.266 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 tp -58.15 -18.78 27.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.132 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 15.63 6.53 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.357 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 m -122.92 72.26 43.68 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.683 0.278 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 83.3 Cg_endo -83.33 6.49 5.77 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.67 2.247 . . . . 0.0 113.064 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -145.3 17.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.604 0.24 . . . . 0.0 111.534 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -118.23 -21.05 8.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.396 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.6 tt -50.26 -38.55 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.989 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.35 -46.25 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.54 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.345 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 29.3 m-85 -63.12 -54.71 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.7 p -51.72 -30.49 22.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.963 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 p -50.66 -25.79 4.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -101.24 -45.88 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.04 45.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.183 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.447 ' CD1' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.46 44.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 110.927 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -107.98 -19.4 13.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.453 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.417 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -121.57 103.16 8.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.606 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.446 ' HA ' ' CG ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -40.76 -31.64 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.137 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -56.09 -21.3 21.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.21 -24.66 27.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -103.21 16.52 26.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.105 0.479 . . . . 0.0 111.003 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -59.68 -39.82 85.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.34 -20.06 13.39 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.647 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -46.04 150.63 0.56 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.356 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.441 ' HB ' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -140.32 177.35 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.213 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.482 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 9.5 tp -59.1 -34.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.37 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -59.15 -39.2 81.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.227 178.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 -33.57 21.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.542 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.463 ' CD1' ' CG2' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -53.52 -50.19 65.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.479 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -22.16 68.95 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.029 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.28 69.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.0 mp -62.53 -14.77 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.494 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mttm 72.53 16.72 4.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.804 0.335 . . . . 0.0 111.366 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.44 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 9.0 mt -85.39 138.7 36.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.4 Cg_exo -44.95 130.74 10.42 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.232 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -68.01 64.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -85.04 -52.27 6.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.655 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -140.15 25.61 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -48.2 44.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.194 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.8 mtm -57.36 -56.57 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -49.79 -44.26 48.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.463 ' CG2' ' CD1' ' A' ' 42' ' ' LEU . 14.3 mt -57.11 -55.36 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.52 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 7.2 t90 -52.45 -50.4 62.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -52.79 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.92 -39.99 80.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 2.6 mp -66.19 -29.17 69.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.486 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.52 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 35.3 mt-30 -74.43 -28.03 60.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.391 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.77 179.385 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 8' ' ' VAL . 1.5 tm? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.685 0.279 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.46 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 2.9 m -53.28 -34.35 22.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.381 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 t -63.55 -33.15 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.381 . . . . 0.0 111.27 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.42 -48.47 7.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.58 -53.14 15.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -74.45 -48.0 30.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.731 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.18 -29.86 30.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.055 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 4.0 tp -59.31 -17.94 33.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.669 0.271 . . . . 0.0 111.274 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.26 19.36 5.9 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.181 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.0 m -126.87 73.74 76.0 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.709 0.29 . . . . 0.0 110.992 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -84.74 -0.26 9.23 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.068 2.512 . . . . 0.0 112.918 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.8 13.58 3.4 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.53 -20.19 9.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.601 0.239 . . . . 0.0 111.419 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.9 tt -51.67 -28.96 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.926 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.64 -43.38 76.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.256 0.551 . . . . 0.0 110.388 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.5 m-30 -68.33 -24.76 64.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.249 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.8 -32.38 15.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 t -69.32 -10.37 57.54 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.993 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -19.35 62.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.561 ' NE2' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.3 -20.74 11.73 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.362 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 33' ' ' HIS . . . 131.82 51.39 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.435 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.451 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -109.45 37.68 2.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.889 0.376 . . . . 0.0 111.129 179.005 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -99.36 -30.43 12.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.92 109.48 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.706 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.447 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -44.38 -27.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 111.657 -177.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -20.63 59.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.762 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.468 ' CG ' ' O ' ' A' ' 27' ' ' GLY . 46.5 t-80 -85.06 -19.11 32.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.997 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.16 14.0 21.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.528 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.21 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.053 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -125.06 16.95 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.33 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.438 HD21 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -85.11 140.44 30.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.386 . . . . 0.0 110.684 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.469 ' CG2' ' NE1' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -128.81 -179.84 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.047 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.446 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 3.8 tp -58.25 -34.26 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -52.19 -43.26 64.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.274 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.423 ' CB ' HD23 ' A' ' 37' ' ' LEU . 4.3 m-20 -83.99 -30.07 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.588 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.482 HD22 ' CZ ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -67.41 -36.98 82.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.794 178.313 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 52' ' ' ARG . . . -79.88 2.23 75.45 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.75 -41.13 16.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.561 ' CD2' ' NE2' ' A' ' 26' ' ' GLN . 3.7 mt -62.69 -12.31 22.82 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.069 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 71.31 15.23 6.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 111.264 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.442 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 25.1 mm -61.17 138.58 94.44 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.474 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 4.3 Cg_exo -37.02 153.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.581 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -92.69 23.12 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.429 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -85.07 -33.22 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.422 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 7.5 m-85 -135.16 12.32 3.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -54.09 -68.29 0.19 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 179.475 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 mtm -53.33 -42.26 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.871 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -51.4 -50.75 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.581 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.436 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 5.2 mt -56.65 -56.96 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.469 ' NE1' ' CG2' ' A' ' 38' ' ' THR . 7.2 t90 -49.85 -54.89 16.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -51.37 -32.32 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.53 -25.25 61.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.797 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.2 tp -80.94 -40.58 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.494 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -63.15 -27.76 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.071 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.11 178.403 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.419 HD22 ' CA ' ' A' ' 31' ' ' ILE . 2.1 tm? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.789 0.328 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.3 m -66.12 -37.31 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.168 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 p -63.19 -26.48 68.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -95.7 -46.78 6.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.17 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -49.58 -52.7 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.862 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -77.6 -46.74 21.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.472 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.11 -26.98 6.64 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.362 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.52 -22.5 13.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.774 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.64 16.91 5.76 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.353 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.41 ' HB3' ' CG ' ' A' ' 51' ' ' TYR . 4.6 p -130.12 80.54 70.7 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.772 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.61 6.1 5.09 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.714 2.276 . . . . 0.0 112.996 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -135.56 22.47 3.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.674 0.273 . . . . 0.0 111.143 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 t -114.27 -28.62 7.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.967 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 tt -50.87 -45.59 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.916 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -49.66 -44.45 47.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.84 -35.46 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.509 ' CZ ' ' CD1' ' A' ' 55' ' ' ILE . 3.2 m-85 -70.68 -49.6 45.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.73 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -55.28 -24.34 27.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -49.15 -30.37 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.244 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -99.99 -53.56 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.1 48.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.99 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.431 HD13 ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -99.51 40.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.047 -179.083 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -99.1 -27.45 13.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.867 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.1 104.39 12.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.444 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -43.81 -29.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.99 0.424 . . . . 0.0 111.278 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -55.23 -23.63 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.668 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.45 -21.16 35.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.955 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -114.06 22.04 14.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -32.41 71.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.55 -18.36 11.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.716 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -44.45 140.86 2.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.344 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.69 179.18 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.118 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.477 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 9.6 tp -57.3 -33.65 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.482 0.658 . . . . 0.0 109.276 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.75 -47.49 79.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.539 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.18 -27.52 38.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.673 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.436 ' N ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -55.18 -52.48 63.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.177 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -15.18 62.89 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.324 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.06 -40.31 90.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.561 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.445 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 8.9 mp -47.3 -27.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.347 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 5.9 ttmm 86.66 16.09 0.1 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.633 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.481 ' CD1' ' CD1' ' A' ' 23' ' ' PHE . 2.8 mt -86.21 137.69 34.83 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.816 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.431 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 3.0 Cg_endo -45.26 158.87 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.675 2.25 . . . . 0.0 112.023 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.45 57.8 4.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.177 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.47 -58.12 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.58 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 1.5 m-85 -137.15 33.48 2.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.616 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -56.52 -66.66 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.01 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.422 ' CG ' HD11 ' A' ' 39' ' ' ILE . 59.4 mtt -54.84 -34.81 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.2 m -58.14 -49.98 75.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.729 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 23' ' ' PHE . 60.0 mt -66.13 -35.72 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.602 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.477 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 10.6 t90 -59.48 -55.82 29.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.941 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.416 ' NH1' ' HB3' ' A' ' 53' ' ' MET . 0.0 OUTLIER -53.34 -39.48 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.621 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.96 -40.98 88.75 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.91 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 1.1 tp -64.26 -38.67 91.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.332 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.47 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 36.7 mt-30 -63.82 -31.15 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.199 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.216 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.688 0.28 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.5 m170 50.41 94.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.32 148.36 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.114 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -140.4 75.71 26.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 7' ' ' LEU . 35.5 Cg_exo -59.83 -37.45 86.31 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.571 2.181 . . . . 0.0 112.286 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -64.91 73.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.056 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.435 ' CD2' HD12 ' A' ' 34' ' ' LEU . 1.9 tm? 177.3 -50.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.85 -50.87 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.166 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -25.01 65.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.116 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -50.9 6.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.029 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.406 ' CD2' HD13 ' A' ' 28' ' ' LEU . 2.2 tm? -48.9 -53.03 21.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.015 0.436 . . . . 0.0 110.859 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 55.8 m -74.69 -46.88 34.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.46 -29.82 17.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.286 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 2.8 tp -62.38 -15.05 46.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.642 0.258 . . . . 0.0 111.277 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.59 12.78 8.48 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.419 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.1 m -116.12 67.21 3.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.684 0.278 . . . . 0.0 111.057 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 59.5 Cg_endo -72.55 -17.5 26.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.526 2.151 . . . . 0.0 112.521 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -130.04 21.36 5.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.028 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -28.07 8.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 tt -52.2 -34.76 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.817 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.96 -44.05 86.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.667 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -71.98 -33.57 68.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.482 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' CE1' HD22 ' A' ' 45' ' ' LEU . 10.2 m-85 -73.76 -45.19 53.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.58 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -55.73 -32.08 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.79 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -49.52 -25.92 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.996 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -99.9 -48.07 4.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.44 47.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.469 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.461 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.24 39.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.126 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -30.24 12.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.039 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.52 110.47 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.075 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.447 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -46.44 -27.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.004 0.431 . . . . 0.0 111.279 -178.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -21.82 49.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.63 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -21.52 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.214 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.3 19.25 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -28.61 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.329 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.75 -20.44 10.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.513 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.433 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -44.94 148.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.633 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.39 178.63 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.121 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.463 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 9.6 tp -59.65 -33.33 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.48 0.657 . . . . 0.0 109.23 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.18 -50.94 71.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.04 -24.27 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.9 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.509 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.63 -6.9 60.09 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.734 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.38 -43.63 32.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.964 0.412 . . . . 0.0 110.432 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.445 HD22 ' CE1' ' A' ' 23' ' ' PHE . 9.3 mp -47.35 -29.11 2.35 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.174 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER 82.44 21.37 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.439 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 4.5 mt -81.35 138.0 48.52 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.305 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.439 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.0 Cg_exo -39.66 136.76 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.527 2.151 . . . . 0.0 112.294 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -78.73 55.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.399 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.53 -43.16 13.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -140.36 30.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -50.71 -59.31 4.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.9 ptm -59.37 -44.49 92.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 m -51.7 -50.19 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.456 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.437 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 17.6 mt -59.74 -46.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.523 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 13.2 t90 -57.64 -61.65 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.56 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.8 ptm180 -51.78 -31.16 25.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -74.7 -36.58 47.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.714 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 2.6 tp -67.46 -42.08 83.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.253 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.523 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 37.3 mt-30 -61.02 -27.69 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.279 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -57.56 -40.24 78.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.292 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.22 -52.07 67.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.48 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -37.61 81.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.738 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -60.98 -80.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.734 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.86 140.06 8.27 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.674 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -120.39 102.69 8.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.742 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.42 120.46 6.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.938 -179.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -90.54 74.63 6.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.01 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.36 171.79 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -135.67 68.63 66.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.776 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.31 -28.81 27.92 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.542 2.161 . . . . 0.0 112.295 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.19 61.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.403 HD11 ' HA ' ' A' ' 29' ' ' GLN . 0.9 OUTLIER -179.17 -50.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.72 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.1 -33.84 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.02 64.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -85.7 -47.5 9.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.93 -48.45 67.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.363 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.7 m -81.06 -40.83 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.097 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.25 -30.83 11.56 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.195 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -20.46 25.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.94 19.06 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.185 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 78.85 35.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.638 0.256 . . . . 0.0 110.974 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.74 13.85 2.64 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.656 2.237 . . . . 0.0 112.93 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -143.0 25.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 111.022 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.18 -34.34 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.294 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -46.95 -28.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -59.8 -46.6 88.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.095 0.474 . . . . 0.0 110.625 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -78.72 -28.65 45.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -77.46 -43.85 30.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.841 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -67.49 -28.74 68.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.754 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m -54.12 -22.42 11.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.968 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -99.78 -56.72 2.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.33 43.51 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.213 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.461 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.2 40.78 1.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.833 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.403 ' HA ' HD11 ' A' ' 7' ' ' LEU . 7.5 pt20 -99.46 -27.53 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.09 109.95 18.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.116 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.432 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -46.48 -27.52 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 111.095 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -58.04 -22.22 49.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -84.18 -19.19 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.03 4.45 15.7 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.83 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -53.31 -36.48 61.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.724 0.297 . . . . 0.0 111.186 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -112.81 19.41 17.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.464 ' CD2' ' CD2' ' A' ' 42' ' ' LEU . 12.8 tp -84.79 155.98 21.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.27 177.38 7.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.478 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 9.5 tp -58.29 -34.16 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.419 0.628 . . . . 0.0 109.42 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.89 -47.33 77.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.715 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' CB ' HD12 ' A' ' 37' ' ' LEU . 21.0 m-20 -80.93 -31.0 35.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.551 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.464 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -51.3 -51.39 54.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.28 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.09 -20.33 77.87 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.324 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.04 -44.17 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.14 0.495 . . . . 0.0 110.202 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 8.1 mp -48.52 -29.46 4.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.318 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttpt 86.63 19.43 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.315 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 3.8 mt -83.98 138.62 39.96 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.242 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 61.7 Cg_exo -36.81 151.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.703 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -91.65 22.47 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 33.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -62.16 -51.14 69.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.376 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.3 ttp -66.22 -32.32 73.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.121 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.2 m -59.63 -50.36 74.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.1 mt -62.7 -41.42 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.805 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.512 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 9.4 t90 -57.19 -51.52 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.101 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -50.8 -46.85 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.441 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.95 93.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.585 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -61.61 -36.47 80.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 178.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.512 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 56.5 mt-30 -66.53 -28.6 68.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.203 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -64.24 -32.26 73.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.585 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -69.2 -46.11 68.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.842 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -53.17 59.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.961 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.12 -41.63 94.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.038 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.05 144.37 16.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.568 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -127.17 170.24 12.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.857 0.361 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -178.85 128.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.965 179.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.956 0.408 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -75.98 67.41 2.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -111.06 119.46 39.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.033 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -159.31 64.43 2.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.32 -20.47 61.87 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.595 2.196 . . . . 0.0 112.281 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 m -53.05 -22.93 6.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -66.6 -58.22 5.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.254 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 t -59.01 -45.05 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.433 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -59.38 -30.5 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -88.11 -51.87 5.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.336 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -45.66 -53.21 9.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 111.151 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.433 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 51.3 m -74.36 -47.69 32.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.37 -24.35 22.62 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.478 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tp -61.38 -18.17 57.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.742 0.306 . . . . 0.0 111.327 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.98 18.68 5.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.299 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -134.33 74.6 66.48 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.858 0.361 . . . . 0.0 110.759 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.433 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 71.6 Cg_endo -84.63 10.06 3.88 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.809 2.34 . . . . 0.0 112.821 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.3 16.04 2.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 111.221 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -115.28 -22.24 9.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 tt -50.18 -36.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 110.974 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 12.2 pt-20 -57.63 -43.84 85.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.479 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 64.3 m-85 -70.71 -32.63 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 22.3 m-85 -73.91 -52.81 11.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.536 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.3 p -50.67 -29.18 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.57 -27.64 7.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.231 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.17 -42.43 6.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.87 45.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.182 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.44 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -99.5 40.01 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -99.22 -27.58 13.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.992 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.48 107.44 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.025 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.435 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -45.75 -27.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.059 0.457 . . . . 0.0 111.348 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -21.01 34.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 -22.35 29.04 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -107.01 18.78 21.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 0.0 111.508 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -19.23 64.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.258 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -125.39 -8.69 6.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -61.14 153.88 24.63 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.828 0.347 . . . . 0.0 110.984 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.439 ' CG2' ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -140.15 178.31 7.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.063 0.459 . . . . 0.0 111.478 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.482 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 7.4 tp -60.42 -34.0 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.52 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.5 OUTLIER -57.91 -39.87 78.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.416 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.05 -34.69 20.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.642 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.443 ' CD1' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -48.38 -59.01 3.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.879 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.48 -19.12 32.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.388 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.02 71.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.444 ' CB ' HG13 ' A' ' 47' ' ' ILE . 6.4 mp -62.85 -17.52 61.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.488 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 74.19 17.45 3.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 111.369 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.444 HG13 ' CB ' ' A' ' 45' ' ' LEU . 7.4 mt -80.95 137.82 49.94 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.678 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 59.6 Cg_exo -37.66 112.81 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.83 2.354 . . . . 0.0 112.787 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -68.15 63.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.112 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -85.11 -50.33 7.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.558 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.06 28.64 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.433 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -30.54 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.283 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -50.03 48.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.2 m -54.62 -40.0 68.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.369 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 6.8 mm -61.7 -55.65 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.895 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.516 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 6.5 t90 -52.05 -45.58 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.243 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -51.24 -53.77 32.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.611 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.2 -41.78 54.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mp -65.37 -28.18 69.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 110.355 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.516 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 47.6 mt-30 -75.07 -28.49 60.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.478 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -67.09 -29.5 69.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.573 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -68.13 -49.26 62.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.7 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.05 -67.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.894 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 49.53 30.09 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.43 0.634 . . . . 0.0 111.292 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.75 64.65 0.85 Allowed Glycine 0 C--N 1.315 -0.624 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.477 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -102.67 149.07 24.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.341 . . . . 0.0 110.94 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 p30 176.3 132.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.798 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.92 -179.893 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.854 0.359 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -52.82 153.68 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.02 162.04 13.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.989 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 64.77 50.39 0.9 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 43.0 Cg_endo -67.3 -31.28 35.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.555 2.17 . . . . 0.0 112.238 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.3 m -84.93 54.33 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.014 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.418 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.8 tm? -147.91 -61.77 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' A' ' 11' ' ' LEU . 42.3 t -53.78 -59.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.056 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.1 -6.75 30.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.769 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.43 -59.61 1.97 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.48 ' CD1' ' N ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.04 -26.35 68.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.507 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.48 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 33.1 m -81.11 -50.43 9.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.282 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.23 -25.7 60.47 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.418 ' CD2' ' HA3' ' A' ' 58' ' ' GLY . 5.1 tp -49.63 -24.78 2.38 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.025 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.65 10.45 4.91 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.282 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 73.52 72.82 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 116.958 0.379 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 3.1 Cg_exo -77.67 4.03 6.38 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.897 2.398 . . . . 0.0 112.901 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -132.43 19.67 4.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.638 0.256 . . . . 0.0 111.264 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -114.01 -24.23 9.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.046 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.437 ' CD1' ' HG ' ' A' ' 11' ' ' LEU . 8.5 tp -49.89 -36.65 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.74 -40.67 92.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.548 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.1 m-30 -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.458 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.526 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 6.9 m-85 -80.89 -42.44 21.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 20' ' ' ILE . 11.9 p -52.88 -29.64 29.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -27.12 3.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.259 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -99.94 -58.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.957 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.44 46.86 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.446 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.477 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.4 39.89 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -99.66 -28.95 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.105 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -116.21 115.57 26.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.166 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -47.85 -26.74 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 111.049 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -59.91 -19.39 51.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -85.33 -30.22 23.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.864 0.364 . . . . 0.0 110.55 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -98.67 23.52 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.492 . . . . 0.0 110.757 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -68.1 -37.91 81.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.607 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.54 -18.17 12.47 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.661 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -44.78 148.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.303 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 173.71 11.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.108 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.484 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 6.9 tp -57.14 -33.77 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.392 0.615 . . . . 0.0 109.384 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.79 -45.35 78.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.332 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.62 -31.66 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.448 ' CD1' ' HB ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -54.49 -45.57 73.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.418 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -67.66 -10.27 57.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.58 -27.76 45.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.116 0.484 . . . . 0.0 110.403 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.526 ' CD2' ' CD2' ' A' ' 23' ' ' PHE . 8.1 mp -62.39 -11.74 17.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.146 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt 77.09 20.18 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.425 HG12 ' CB ' ' A' ' 45' ' ' LEU . 7.1 mm -82.35 131.74 54.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.66 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.7 176.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.667 2.245 . . . . 0.0 112.396 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.59 40.65 1.04 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.96 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -51.97 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.811 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -140.24 25.64 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.289 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.425 ' NE ' ' HA2' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -51.83 -57.72 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.7 mmm -59.98 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.915 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.0 m -50.36 -48.16 55.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.654 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 8.3 mt -55.53 -56.96 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.755 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.525 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 7.5 t90 -51.47 -52.44 46.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.855 0.359 . . . . 0.0 110.456 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -47.01 -59.6 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.018 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.418 ' HA3' ' CD2' ' A' ' 14' ' ' LEU . . . -51.67 -34.05 35.33 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.704 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 34' ' ' LEU . 1.8 mp -69.81 -31.25 69.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.427 . . . . 0.0 110.102 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.525 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 56.2 mt-30 -68.48 -28.9 67.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.941 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -30.41 69.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.375 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -75.91 -46.24 31.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.604 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.11 -45.97 61.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.8 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -57.03 -78.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.03 -168.96 16.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.446 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -113.1 129.17 56.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.373 . . . . 0.0 110.94 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.4 -161.24 1.16 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.145 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.962 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.2 t80 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 51.86 48.06 23.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.54 156.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.185 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.63 76.66 0.32 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.991 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.44 -25.7 21.1 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.532 2.155 . . . . 0.0 112.199 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -78.32 59.71 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.427 HD21 ' CA ' ' A' ' 31' ' ' ILE . 1.7 tm? -167.04 -59.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.96 -42.35 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.042 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -24.94 37.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.53 -44.72 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.403 ' CD2' ' HB ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -46.01 -54.18 8.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.97 0.414 . . . . 0.0 111.138 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -76.89 -49.79 14.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.91 -24.87 8.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.192 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.46 -18.8 31.55 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.779 0.323 . . . . 0.0 111.113 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.4 19.49 7.05 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.069 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' SG ' ' CD1' ' A' ' 51' ' ' TYR . 3.7 m -134.23 77.69 60.17 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 111.113 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.47 19.43 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.892 2.394 . . . . 0.0 112.833 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.47 20.34 1.87 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.472 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 p -120.36 -30.98 4.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.69 0.281 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 24' ' ' THR . 12.2 tt -46.75 -30.8 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.567 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.46 -44.19 88.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 110.349 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -75.15 -29.0 60.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.818 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.481 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 25.3 m-85 -78.17 -30.36 49.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.94 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 20' ' ' ILE . 7.1 p -69.39 -32.94 72.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -24.56 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.95 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -99.89 -49.25 4.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.18 51.38 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.328 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.69 39.28 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.0 110.948 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -99.39 -28.55 13.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.128 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.98 112.9 23.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.022 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.456 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -45.37 -28.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.975 0.416 . . . . 0.0 111.116 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 m-85 -57.15 -21.01 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.753 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 -31.2 25.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.961 0.41 . . . . 0.0 110.613 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.475 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.94 25.35 8.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.875 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.48 ' NE2' ' CD1' ' A' ' 62' ' ' LEU . 3.7 mm-40 -67.76 -42.99 80.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.612 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.61 -21.33 13.75 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.503 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -46.31 144.91 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.119 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.415 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -135.02 178.67 6.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.131 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.487 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 9.2 tp -59.25 -32.99 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.363 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.07 -48.05 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.704 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.34 -25.97 38.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD21 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -55.62 -49.21 73.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.83 -9.16 58.87 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.775 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.54 -43.69 38.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.058 0.456 . . . . 0.0 110.433 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.481 ' CD2' ' CD1' ' A' ' 23' ' ' PHE . 10.0 mp -46.15 -27.57 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.9 ttmm 86.17 19.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.237 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.432 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 4.9 mm -78.13 138.42 60.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.692 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 81.4 Cg_exo -41.05 149.42 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.515 2.143 . . . . 0.0 112.389 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -89.01 47.21 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.19 -53.71 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.448 ' CD1' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -136.77 31.88 2.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.065 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -54.89 -48.28 73.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -45.21 94.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.7 m -51.95 -45.93 64.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 17.9 mt -61.16 -42.97 95.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.766 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 11.3 t90 -59.73 -50.29 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -47.13 -56.69 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.734 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.52 -42.29 65.7 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.661 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 3.5 mp -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.518 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 39.6 mt-30 -71.53 -17.25 62.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.604 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.69 -27.79 28.78 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.848 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.48 ' CD1' ' NE2' ' A' ' 35' ' ' GLN . 0.8 OUTLIER -70.76 -40.72 72.51 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.855 0.836 . . . . 0.0 109.878 178.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' N ' ' HG ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -95.53 37.5 1.19 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.84 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -70.59 -30.24 66.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.842 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.74 -122.94 6.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.373 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -120.47 101.88 8.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -152.29 24.15 0.63 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.416 0.627 . . . . 0.0 111.979 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.309 -1.188 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.251 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.845 0.355 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -101.61 173.89 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.7 155.24 34.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.055 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -81.18 -50.26 0.97 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 6.3 Cg_exo -75.19 55.6 4.09 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.953 2.435 . . . . 0.0 112.249 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.3 t -85.35 -32.76 22.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.07 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -73.55 -65.34 0.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.147 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 m -43.95 -37.05 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.714 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -30.48 70.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.98 -47.28 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.36 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -48.69 -54.45 14.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.0 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -79.17 -44.25 22.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.261 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 -28.46 12.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.248 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.403 ' CD2' ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -55.09 -22.02 14.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.015 0.436 . . . . 0.0 110.844 178.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 20.95 5.75 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.086 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.7 p -134.96 83.6 39.8 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -87.28 21.48 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.785 2.323 . . . . 0.0 113.02 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -138.17 17.61 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.385 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.9 p -115.72 -26.73 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.2 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.85 -42.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.83 -42.29 75.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -74.16 -30.52 62.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.652 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 33.2 m-85 -76.83 -51.59 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.752 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 53.3 p -50.43 -27.61 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.153 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.3 t -53.23 -24.12 10.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -103.89 -38.72 6.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.058 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.68 47.08 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.9 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -99.19 44.62 1.02 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.309 0.576 . . . . 0.0 110.647 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -107.39 -13.98 14.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.314 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.43 ' N ' HD11 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -127.16 103.68 7.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.43 ' HA ' ' CG ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -43.04 -29.12 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 111.761 -177.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -56.76 -22.61 36.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -85.23 -11.47 54.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.496 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -122.37 14.81 10.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.404 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -24.28 62.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.21 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -115.38 -18.37 11.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.486 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.88 143.24 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.31 176.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.25 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.478 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 3.7 tp -55.84 -33.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.437 0.637 . . . . 0.0 109.46 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.02 -43.41 81.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.681 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.81 -28.62 26.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.762 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -52.45 -46.35 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.43 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.32 62.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.775 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.67 -44.94 18.0 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 9.4 mp -49.02 -28.14 3.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.249 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.6 tptt 83.34 21.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.317 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.445 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 6.1 mt -83.68 137.93 41.13 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.479 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 69.7 Cg_exo -38.07 153.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.783 2.322 . . . . 0.0 112.596 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.3 pm0 -91.84 21.18 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.403 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -58.58 -44.27 89.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.809 0.338 . . . . 0.0 110.828 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.476 ' CD2' ' HB3' ' A' ' 16' ' ' CYS . 12.4 m-85 -140.69 31.96 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.359 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.19 -61.15 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.381 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtm -56.54 -42.97 79.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.777 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.9 m -51.01 -50.47 58.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.43 HD13 ' CE2' ' A' ' 23' ' ' PHE . 6.6 mt -62.66 -37.66 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.478 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 11.0 t90 -61.63 -54.58 40.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.404 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -54.67 -36.75 64.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.853 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 14' ' ' LEU . . . -74.35 -31.58 59.0 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.114 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 3.6 tp -73.91 -36.34 64.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.801 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -69.1 -26.91 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.243 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.28 -28.73 69.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.421 HD12 ' CG1' ' A' ' 31' ' ' ILE . 6.3 mt -66.9 -35.45 80.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.416 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.92 32.66 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.214 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -53.55 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.872 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.66 87.87 0.42 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.463 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -130.57 134.31 46.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 111.018 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.1 t70 179.78 141.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.234 0.54 . . . . 0.0 110.739 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.412 ' OXT' ' CG ' ' A' ' 68' ' ' TYR . 2.4 t80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.615 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.91 0.386 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m170 63.57 167.93 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.003 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.47 121.49 5.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.073 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -173.89 -64.08 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 4' ' ' ASP . 48.1 Cg_endo -69.16 -20.28 37.88 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.532 2.155 . . . . 0.0 112.234 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.81 57.24 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 110.905 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.412 HD21 ' CD1' ' A' ' 31' ' ' ILE . 1.2 tm? -168.0 -51.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.636 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.403 HG13 HD12 ' A' ' 20' ' ' ILE . 39.0 t -68.82 -39.11 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.129 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 p -59.41 -34.35 72.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.87 -43.73 12.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -48.24 -52.8 19.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 55.4 m -75.68 -50.44 15.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.2 -23.61 12.96 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.328 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -58.59 -18.49 30.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 0.0 111.18 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.59 12.14 6.85 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.588 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.4 m -132.16 77.85 70.15 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.437 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 90.6 Cg_endo -79.97 4.7 6.52 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.7 2.267 . . . . 0.0 112.939 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.21 20.49 3.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.687 0.28 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 m -114.19 -28.25 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.976 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.403 HD12 HG13 ' A' ' 8' ' ' VAL . 1.7 tt -47.7 -44.15 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.07 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -49.97 -44.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.802 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.63 -32.79 62.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.556 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.515 ' CD1' ' CD1' ' A' ' 47' ' ' ILE . 4.0 m-85 -69.29 -51.08 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.4 p -58.16 -28.02 64.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.7 t -47.29 -27.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.239 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -101.61 -56.28 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.753 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.14 46.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.092 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 0.5 OUTLIER -99.4 38.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 111.14 -179.152 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.08 -27.83 13.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.785 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 108.04 17.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.852 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.441 ' CD1' HD22 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -43.23 -33.71 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.988 0.423 . . . . 0.0 111.548 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -55.92 -20.63 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.985 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.81 -15.77 47.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.675 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -113.28 9.84 18.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -36.38 65.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -99.88 -22.3 15.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 5.0 tp -47.79 135.2 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.42 ' CG2' ' NE1' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -132.67 178.55 6.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.009 0.433 . . . . 0.0 111.304 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.483 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 5.5 tp -58.97 -32.44 47.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.552 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -57.11 -45.37 83.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.833 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 2.4 m-20 -85.01 -27.11 26.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.441 ' CD2' ' HG ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -49.26 -53.31 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.855 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.428 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . -68.15 -8.83 55.77 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.733 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.13 -42.37 56.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 110.426 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 9.5 mp -47.87 -28.01 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.45 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.2 tttm 87.17 17.22 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.586 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.515 ' CD1' ' CD1' ' A' ' 23' ' ' PHE . 4.0 mt -85.91 138.49 35.13 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.595 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 2.7 Cg_endo -40.46 146.35 0.3 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.965 2.444 . . . . 0.0 112.108 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -90.21 42.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.76 -43.67 71.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.762 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -140.26 30.4 1.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.665 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 9.6 ttp180 -48.36 -50.75 29.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.9 mtt -61.2 -54.1 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.263 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -47.41 -48.93 26.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 0.0 111.034 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.6 mt -59.06 -41.51 83.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.743 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.483 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 7.9 t90 -62.43 -46.67 87.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.261 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.07 -60.03 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.43 -30.62 61.97 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.67 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -70.99 -25.96 62.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -69.24 -12.62 61.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.23 -37.39 26.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD22 ' CD1' ' A' ' 31' ' ' ILE . 0.3 OUTLIER -52.86 -36.02 58.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 110.163 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -62.89 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.242 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -42.04 -56.12 2.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.612 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.69 98.3 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.552 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -121.24 92.71 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.829 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 170.01 143.47 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.632 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.717 179.199 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.875 0.369 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -93.74 83.21 4.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.986 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.32 146.47 46.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.825 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 173.65 -63.92 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 4' ' ' ASP . 11.9 Cg_endo -55.13 -21.33 27.38 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.678 2.252 . . . . 0.0 112.346 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -84.17 7.75 17.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.672 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 8' ' ' VAL . 1.2 tm? -121.14 -60.82 1.61 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 9' ' ' SER . 34.9 m -57.21 -35.8 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.418 ' N ' HG22 ' A' ' 8' ' ' VAL . 83.6 p -64.38 -24.29 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.76 -48.74 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -48.26 -53.22 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.133 0.492 . . . . 0.0 110.876 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.432 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 93.0 m -70.67 -49.59 45.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.37 -32.7 22.93 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 tp -60.17 -17.14 38.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.81 11.23 6.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.611 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' CD1' ' A' ' 55' ' ' ILE . 1.3 m -114.91 72.41 2.86 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-O 120.739 0.304 . . . . 0.0 111.146 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 85.2 Cg_endo -80.64 -13.1 12.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.256 . . . . 0.0 112.943 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.87 22.08 4.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.112 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.6 m -114.83 -28.21 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.072 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 tt -48.52 -32.83 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.95 -44.82 96.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.69 -27.95 50.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.463 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE1' HD22 ' A' ' 45' ' ' LEU . 20.1 m-85 -76.54 -46.36 26.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.9 p -56.34 -30.75 63.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 p -55.79 -23.64 31.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.262 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.84 -34.98 9.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.75 41.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.304 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.79 39.53 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.024 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.22 -29.6 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.914 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.59 109.38 19.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.83 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -44.43 -28.34 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 111.526 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -58.64 -22.46 56.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.677 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -84.23 -19.9 33.16 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.468 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.56 13.38 22.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.679 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -17.46 64.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.408 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -128.36 17.86 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 0.1 OUTLIER -84.88 147.41 26.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.29 . . . . 0.0 110.654 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.438 ' HB ' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -131.02 172.72 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.012 0.434 . . . . 0.0 111.523 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.434 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 7.5 tp -56.98 -34.3 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.676 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.438 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -59.09 -38.85 80.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -85.47 -26.81 26.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.591 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -54.77 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.662 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -55.15 -20.44 20.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.369 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.83 85.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 0.0 110.358 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.457 HD22 ' CE1' ' A' ' 23' ' ' PHE . 6.8 mp -61.26 -15.41 34.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.485 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 74.81 19.3 2.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.93 0.395 . . . . 0.0 111.073 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.433 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 7.4 mm -79.23 138.17 56.21 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.513 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 87.7 Cg_exo -43.05 157.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.407 2.072 . . . . 0.0 112.136 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -85.56 -46.14 11.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -140.31 21.81 2.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.412 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -51.01 -57.34 8.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -41.86 94.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.628 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -54.4 -47.59 72.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.604 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.439 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 6.8 mt -62.31 -36.77 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.434 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 11.4 t90 -64.23 -51.27 64.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 5.4 ptp180 -60.69 -33.14 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -77.54 -25.73 62.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.126 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.2 mp -78.46 -34.28 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.642 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -73.16 -30.46 63.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.38 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.34 -32.73 74.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.569 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.33 -52.22 66.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.685 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -51.13 -53.79 31.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.802 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -54.94 -73.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.96 -74.11 0.29 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.348 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.93 132.87 53.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.744 0.307 . . . . 0.0 110.89 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 68' ' ' TYR . 17.4 t0 -179.73 142.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.235 0.541 . . . . 0.0 110.775 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.415 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 1.8 m-30 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.941 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 4.7 t80 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.893 0.378 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -132.44 49.01 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.12 -175.38 0.15 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 t70 57.65 65.98 3.14 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.65 140.81 38.01 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.915 5.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.1 p -85.48 -24.14 27.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.012 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 31' ' ' ILE . 1.8 tm? -95.43 -51.77 4.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.327 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.71 -59.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.548 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -55.6 -19.61 10.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.13 -57.04 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 111.391 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -46.16 -45.07 16.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.428 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 33.7 m -83.34 -49.11 9.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.635 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.58 -27.19 25.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.245 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 tp -60.74 -17.19 47.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.737 0.304 . . . . 0.0 111.047 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.57 16.87 6.79 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.309 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -127.79 71.86 78.28 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.672 0.272 . . . . 0.0 111.174 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.428 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 87.6 Cg_endo -84.0 12.0 3.15 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.67 2.247 . . . . 0.0 112.854 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -138.73 16.21 2.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.674 0.273 . . . . 0.0 111.557 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -116.45 -23.05 8.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.765 0.317 . . . . 0.0 111.233 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 tt -48.58 -43.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.26 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -56.01 -41.64 75.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -74.31 -33.63 63.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.685 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' CE1' HD22 ' A' ' 45' ' ' LEU . 9.1 m-85 -74.16 -51.26 16.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.865 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.9 p -48.87 -34.41 12.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.328 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -47.98 -26.56 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.564 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -101.45 -29.71 11.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.74 45.55 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.097 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -99.11 40.15 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.995 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.404 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 2.9 mt-30 -99.34 -30.08 12.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.784 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.27 109.05 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.917 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.447 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -43.62 -28.51 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 111.637 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.07 -23.91 62.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.766 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -80.27 -14.6 58.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.726 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -115.39 -1.5 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -49.81 -35.28 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.61 0.243 . . . . 0.0 111.508 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -108.6 15.66 23.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' CD2' ' CD2' ' A' ' 42' ' ' LEU . 14.7 tp -85.35 156.17 21.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.343 . . . . 0.0 110.792 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.416 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -140.14 174.35 10.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.481 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 5.0 tp -57.64 -35.25 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.405 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -58.74 -39.22 80.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.701 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -85.73 -32.8 21.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.475 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -52.35 -45.25 65.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.334 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.54 -0.26 72.44 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.644 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.17 -33.57 22.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.062 0.458 . . . . 0.0 110.252 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.483 HD22 ' CE1' ' A' ' 23' ' ' PHE . 7.3 mp -61.11 -14.88 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.656 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.27 17.66 2.0 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.096 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.445 HG13 ' CB ' ' A' ' 45' ' ' LEU . 6.2 mt -85.09 138.18 37.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.438 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 68.4 Cg_exo -38.63 138.94 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.705 2.27 . . . . 0.0 112.555 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' CB ' ' HD3' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -91.89 22.45 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.445 -178.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -55.58 -36.32 66.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.964 0.412 . . . . 0.0 110.51 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.17 28.77 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HD3' ' CB ' ' A' ' 49' ' ' GLU . 4.6 ttp180 -48.95 -58.2 5.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -46.37 79.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -50.99 -50.66 57.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.71 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.442 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 5.8 mt -57.06 -52.16 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.481 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 7.5 t90 -52.25 -47.74 65.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 60' ' ' GLN . 7.1 mmt180 -49.94 -42.54 48.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.615 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.53 -21.9 71.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.798 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.45 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -85.24 -24.64 27.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.985 0.421 . . . . 0.0 111.023 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 7.7 pt20 -73.57 -11.61 60.49 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -80.2 -38.33 31.4 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 177.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -52.31 -29.36 23.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.128 0.49 . . . . 0.0 109.86 178.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 -69.29 0.73 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.589 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.45 33.18 2.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.315 0.578 . . . . 0.0 111.632 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' ASP . . . -126.93 -1.0 6.98 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.068 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -139.9 125.02 18.69 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.923 0.361 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 169.78 146.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.543 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.769 179.692 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 2' ' ' HIS . 1.6 p80 -170.82 126.53 0.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.953 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.26 174.37 5.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -127.16 68.49 72.48 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.83 -33.73 72.47 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.487 2.125 . . . . 0.0 112.301 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.91 74.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.995 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 8' ' ' VAL . 2.1 tm? -173.15 -66.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.043 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 26.2 m -59.81 -43.34 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . 1.7 t -57.68 -34.75 69.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -43.95 15.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -47.49 -55.06 9.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.032 0.444 . . . . 0.0 111.067 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.433 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 86.5 m -72.77 -49.34 31.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.61 -29.61 18.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.34 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 1.8 tp -63.93 -14.72 55.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.707 0.289 . . . . 0.0 111.281 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.78 12.78 8.33 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.291 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.4 m -114.18 64.84 1.36 Allowed Pre-proline 0 C--N 1.333 -0.133 0 CA-C-O 120.629 0.252 . . . . 0.0 111.052 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.433 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 59.1 Cg_endo -71.85 -19.72 26.84 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.473 2.115 . . . . 0.0 112.361 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.95 22.3 5.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.96 -29.37 7.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt -49.32 -36.69 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.032 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -44.13 80.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.61 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -72.44 -36.64 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.529 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.471 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 33.0 m-85 -69.63 -49.93 49.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.963 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.0 p -49.78 -38.88 36.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.139 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -22.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.174 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HG3' ' HG ' ' A' ' 45' ' ' LEU . 7.9 mm-40 -99.55 -23.46 15.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.27 44.94 0.54 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.15 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.435 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -99.61 38.91 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.928 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -99.27 -26.93 14.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.159 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.47 107.09 16.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.149 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.445 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.65 -29.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.948 0.404 . . . . 0.0 111.175 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -55.02 -22.36 15.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.621 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.01 -25.79 29.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -107.98 18.75 20.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.287 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -59.86 -44.39 94.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.088 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.85 -16.41 15.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.202 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' CD2' ' CD2' ' A' ' 42' ' ' LEU . 12.4 tp -44.39 153.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.982 0.42 . . . . 0.0 111.595 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.12 178.64 7.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.772 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 tp -61.85 -32.59 54.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.414 0.626 . . . . 0.0 109.409 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.8 -46.83 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.698 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.41 -31.55 26.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.794 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.475 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -50.04 -49.65 50.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.336 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' HA2' ' HD2' ' A' ' 52' ' ' ARG . . . -72.13 -18.11 77.72 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.403 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.98 -37.93 86.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.458 . . . . 0.0 110.388 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' A' ' 23' ' ' PHE . 8.6 mp -50.25 -27.38 5.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 84.04 19.65 0.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.762 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG13 ' CB ' ' A' ' 45' ' ' LEU . 4.5 mt -85.12 137.27 37.42 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 92.0 Cg_exo -41.75 139.31 2.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.573 2.182 . . . . 0.0 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -74.81 61.15 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -85.14 -52.33 6.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.11 36.01 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.685 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 2.1 ttp180 -59.84 -53.14 61.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.4 ptm -60.17 -41.19 92.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -59.44 -47.14 86.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 110.582 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 21.3 mt -58.51 -47.8 87.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.628 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.401 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 11.3 t90 -55.57 -59.67 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.319 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -47.22 -39.72 14.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.179 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.42 -26.87 64.69 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.999 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -78.29 -35.02 48.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 110.781 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.401 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 7.2 pt20 -70.22 -27.95 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.212 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.05 -28.64 69.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.494 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.2 mt -63.32 -50.12 71.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.677 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -50.11 -45.27 52.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -81.53 -27.53 34.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.4 86.1 0.46 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.607 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -106.48 29.82 6.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.76 127.47 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.747 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.849 -179.718 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.895 0.379 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.99 131.15 36.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.45 164.09 11.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.07 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -162.89 60.46 0.99 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.709 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.52 -20.5 60.59 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.575 2.183 . . . . 0.0 112.419 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 t -75.45 63.8 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.401 ' CD1' ' O ' ' A' ' 29' ' ' GLN . 1.6 tm? -177.21 -60.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.809 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.14 -43.91 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.983 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.69 -36.37 62.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -81.93 -47.03 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.41 ' CD1' ' HB ' ' A' ' 20' ' ' ILE . 1.9 tm? -49.59 -33.95 16.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.2 m -83.2 -61.83 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.923 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.81 -28.72 3.93 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.874 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 55' ' ' ILE . 4.1 tt -51.84 -24.49 6.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.709 177.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.93 14.2 9.52 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.738 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 87.0 m -121.16 64.31 13.25 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.689 0.28 . . . . 0.0 111.118 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.51 -11.26 26.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.516 2.144 . . . . 0.0 112.686 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -131.41 19.73 4.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.221 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -111.85 -27.04 8.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.89 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 5.7 tt -49.6 -34.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.51 -45.62 77.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.755 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -74.63 -36.3 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.418 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -66.88 -44.71 80.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.3 p -58.53 -34.31 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.8 m -51.47 -24.17 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.162 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -100.7 -37.46 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.865 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.4 45.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.333 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.61 40.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.401 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 5.8 pt20 -99.07 -28.96 13.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.981 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.05 110.67 21.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.083 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.44 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -45.7 -28.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.937 0.399 . . . . 0.0 111.2 -178.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -57.93 -22.32 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.57 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -20.67 36.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.475 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.57 21.03 14.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.28 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.55 -18.94 64.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.385 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -134.28 18.17 3.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.444 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -81.54 145.82 30.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.66 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.471 HG22 ' CD1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -131.7 173.69 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.48 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 8.5 tp -57.94 -35.92 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.443 0.64 . . . . 0.0 109.293 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.14 -44.8 68.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.337 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -84.79 -34.33 22.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.729 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.45 ' CD1' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -50.88 -58.66 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.57 179.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.36 -20.0 35.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.469 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.06 -41.04 97.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.523 ' CD2' ' CE1' ' A' ' 23' ' ' PHE . 8.8 mp -48.16 -28.0 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.219 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 82.13 19.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.974 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.428 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 7.3 mt -76.45 137.89 67.52 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.568 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 1.9 Cg_endo -40.66 131.79 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.964 2.442 . . . . 0.0 112.206 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.96 63.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.275 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -85.19 -60.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -140.32 36.29 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.751 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' CZ ' ' HB ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -49.33 -45.99 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.271 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 57' ' ' ARG . 2.3 ptp -62.14 -47.56 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 m -54.2 -40.37 67.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.478 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 7.8 mt -63.29 -58.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.135 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.507 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 6.5 t90 -49.92 -45.6 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.396 . . . . 0.0 110.21 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.4 ' CG ' ' O ' ' A' ' 53' ' ' MET . 3.2 mmt180 -55.5 -51.56 66.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.625 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.58 -41.63 89.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.855 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.1 tp -62.13 -32.83 73.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.507 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 50.8 mt-30 -70.3 -26.84 63.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.303 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -62.42 -33.38 74.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 178.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.88 -49.74 69.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.632 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -59.18 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.753 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -23.36 67.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ASP . . . -85.6 -8.75 79.84 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.781 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -99.58 141.11 32.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.632 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.0 OUTLIER 51.15 98.39 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.004 -179.436 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.817 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 50.31 86.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.56 116.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.092 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -152.8 62.07 4.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.75 -33.01 77.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.623 2.215 . . . . 0.0 112.378 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.6 63.84 1.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 8' ' ' VAL . 1.4 tm? -174.92 -64.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.463 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 48.1 t -60.8 -43.9 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.223 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -23.56 63.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.166 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.22 -48.73 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.137 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -48.59 -52.16 24.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.986 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 54.3 m -73.6 -48.68 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.707 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.82 -30.33 28.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.37 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -60.13 -17.69 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 111.197 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 121.01 12.6 5.8 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.551 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.85 65.72 5.25 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.085 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 77.1 Cg_endo -77.4 -5.09 15.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -136.49 18.81 3.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.626 0.25 . . . . 0.0 111.457 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -116.63 -22.26 8.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.296 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 tt -51.53 -34.94 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.171 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -54.94 -46.06 74.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -76.04 -31.74 58.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.703 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE1' HD23 ' A' ' 45' ' ' LEU . 14.6 m-85 -70.3 -43.88 69.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.236 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.1 p -62.67 -28.81 70.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.779 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 t -51.22 -25.02 4.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -100.17 -52.25 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.74 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.7 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.472 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.59 37.34 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.407 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -99.69 -29.05 12.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.813 178.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.57 109.08 19.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.434 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -44.02 -29.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.955 0.407 . . . . 0.0 111.543 -178.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -56.36 -22.48 31.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.57 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -84.03 -20.55 32.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.472 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.33 14.83 21.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.49 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -20.53 65.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -133.41 24.36 4.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.31 . . . . 0.0 111.104 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.481 ' O ' ' CE3' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -85.37 121.25 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.828 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.502 HG22 ' CZ2' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -99.44 175.72 5.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.111 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 53' ' ' MET . 5.1 tp -64.85 -32.1 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.613 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.12 -45.03 83.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.29 -32.18 26.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.795 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.474 ' CD1' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -52.86 -64.38 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.359 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.41 ' HA3' ' NE ' ' A' ' 52' ' ' ARG . . . -58.3 -23.25 52.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.992 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.39 -37.32 64.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 110.519 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.457 HD23 ' CE1' ' A' ' 23' ' ' PHE . 8.2 mp -59.52 -15.6 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.777 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 1.6 mtmt 78.71 17.9 0.99 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.446 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 6.1 mm -80.52 138.76 51.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.269 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 4.7 Cg_exo -36.34 140.32 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.224 2.616 . . . . 0.0 112.519 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.13 23.46 3.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.593 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -67.96 -31.74 71.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.65 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.32 23.69 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.41 ' NE ' ' HA3' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -50.69 -58.38 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.99 0.424 . . . . 0.0 110.782 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.438 ' HA ' ' CD1' ' A' ' 39' ' ' ILE . 0.8 OUTLIER -53.95 -52.05 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 m -48.17 -43.99 32.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.474 ' CG2' ' CD1' ' A' ' 42' ' ' LEU . 10.3 mt -58.8 -59.09 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.502 ' CZ2' HG22 ' A' ' 38' ' ' THR . 0.1 OUTLIER -53.1 -55.31 24.93 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.856 0.36 . . . . 0.0 110.403 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -44.8 -40.07 5.82 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.837 0.351 . . . . 0.0 111.575 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.11 -25.14 67.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.153 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.443 HD21 ' CB ' ' A' ' 37' ' ' LEU . 1.1 mp -82.16 -35.19 28.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.763 0.316 . . . . 0.0 111.083 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.477 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.3 pt20 -71.51 -27.63 63.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -27.97 69.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.281 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -67.22 -49.88 62.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.57 -56.87 3.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.823 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 63.4 119.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.673 0.749 . . . . 0.0 111.115 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.77 -137.16 8.22 Favored Glycine 0 C--N 1.313 -0.722 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.507 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -132.46 128.15 36.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.95 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p30 168.07 145.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.113 0.482 . . . . 0.0 110.691 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.497 179.172 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 7.2 p90 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.778 0.323 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -145.39 161.28 40.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.62 164.2 13.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 1.6 t0 -138.09 50.95 3.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.141 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 56.9 Cg_endo -70.47 68.79 2.08 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.48 2.12 . . . . 0.0 112.209 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -79.81 -14.91 58.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.609 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.34 -53.68 4.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.728 0.299 . . . . 0.0 111.132 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.88 -57.08 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.319 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 p -55.79 -21.78 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.545 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -88.04 -53.86 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.775 0.321 . . . . 0.0 111.178 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.429 ' CD2' HD11 ' A' ' 28' ' ' LEU . 2.2 tm? -48.25 -52.0 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.109 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.445 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 54.0 m -71.65 -46.61 58.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.697 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.14 -33.37 30.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.358 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.438 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 2.6 tp -64.53 -13.42 52.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.677 0.275 . . . . 0.0 111.499 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.86 13.81 7.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.5 m -112.24 60.91 0.58 Allowed Pre-proline 0 CA--C 1.528 0.133 0 CA-C-O 120.665 0.269 . . . . 0.0 111.287 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 56.1 Cg_endo -69.81 -30.44 22.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -124.21 19.77 9.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.798 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.9 m -109.45 -27.31 9.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.666 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.2 tt -52.08 -31.71 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.702 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 8.9 pt-20 -59.76 -44.55 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.485 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 59.9 m-85 -72.0 -30.89 65.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.232 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -74.13 -51.82 14.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.758 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.4 p -49.4 -34.07 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -51.36 -24.23 4.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -99.86 -43.3 6.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 45.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.151 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' HG ' ' CD1' ' A' ' 23' ' ' PHE . 0.2 OUTLIER -98.97 39.98 1.24 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.87 0.367 . . . . 0.0 111.007 -179.178 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.51 -25.07 14.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.134 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 t -111.33 108.28 17.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -48.0 -26.72 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -59.5 -21.76 60.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.563 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.68 -19.03 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -111.48 11.8 21.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.622 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -61.77 -21.51 64.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.301 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -132.43 21.24 4.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.534 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.442 ' CB ' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -77.88 146.0 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.669 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.408 ' O ' ' CD2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -127.99 172.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 0.0 111.589 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.6 tp -58.94 -33.36 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.515 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.99 -49.29 76.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.625 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.8 -15.1 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD21 ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -69.51 -56.56 7.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.882 0.372 . . . . 0.0 110.246 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.77 63.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.049 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.4 53.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.043 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.493 ' CD2' ' CE1' ' A' ' 23' ' ' PHE . 4.6 mp -72.25 -3.9 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.95 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 15.4 ptpt 49.93 33.37 6.54 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 121.014 0.435 . . . . 0.0 111.427 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.448 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 36.6 mt -83.52 138.72 41.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.986 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 46.4 Cg_exo -35.39 119.37 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.008 2.472 . . . . 0.0 112.949 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.91 68.6 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.355 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -85.21 -65.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 0.0 110.665 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.68 36.64 2.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.4 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -43.31 36.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.232 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.4 mtt -59.44 -50.54 73.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.649 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -50.77 -47.79 59.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.438 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 11.1 mm -55.92 -55.85 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -50.36 -62.94 1.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.29 -30.44 50.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.149 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.8 -27.36 56.88 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.839 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD21 ' CB ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -75.99 -38.89 56.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 110.691 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.48 -26.01 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.327 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -27.77 68.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.673 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -62.5 -48.64 78.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.838 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -46.33 -51.31 14.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.241 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -131.43 -80.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.876 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.77 92.05 0.1 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.618 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.485 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 2.0 m-70 -111.81 103.89 12.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.359 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 p30 170.19 146.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.549 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.702 179.816 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.988 0.423 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.31 160.3 19.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.963 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.5 169.13 4.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.742 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -139.01 61.85 23.45 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.1 -21.92 13.44 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.607 2.205 . . . . 0.0 112.293 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -68.05 72.36 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.842 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.436 ' CD2' HD12 ' A' ' 34' ' ' LEU . 1.3 tm? -174.91 -58.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.28 -31.4 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -72.5 -25.16 61.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -54.52 4.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.684 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' A' ' 28' ' ' LEU . 4.9 tp -51.03 -54.23 26.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.18 0.514 . . . . 0.0 110.372 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.436 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 25.6 m -58.51 -50.87 72.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.497 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.36 -30.22 48.4 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.973 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tp -59.5 -18.17 37.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 111.046 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.3 17.15 6.3 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.158 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 4.3 m -118.93 61.41 5.15 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.681 0.277 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 49.2 Cg_endo -68.78 -19.8 40.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.455 2.104 . . . . 0.0 112.16 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -129.56 23.96 5.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.416 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -114.67 -24.61 8.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' THR . 13.1 tt -51.43 -46.91 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -51.42 -45.18 62.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.657 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.7 m-30 -64.84 -32.02 73.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.487 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 2.5 m-85 -79.28 -28.04 42.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.55 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' ILE . 45.2 p -70.73 -24.52 62.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.145 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.4 ' OG ' ' NE2' ' A' ' 26' ' ' GLN . 93.6 p -50.62 -24.81 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.4 ' NE2' ' OG ' ' A' ' 25' ' ' SER . 4.3 mm-40 -104.24 -51.56 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.08 55.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.113 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -99.58 38.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.095 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -25.4 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.283 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.15 104.76 13.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.887 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.454 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.99 -27.52 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.452 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -21.25 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.71 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.6 -23.71 31.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.958 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -106.27 16.98 24.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -73.23 -20.93 60.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.268 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -128.87 20.37 5.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.324 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.48 ' O ' ' CE3' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -85.12 120.6 26.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.053 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.491 HG22 ' CZ2' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -99.79 176.75 5.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.267 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.417 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 7.4 tp -65.16 -31.52 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -56.03 -42.84 77.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.266 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.09 -32.44 22.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.801 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.442 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -54.87 -52.49 62.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -71.12 -16.28 74.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.411 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.81 94.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.946 0.403 . . . . 0.0 110.488 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.487 ' CD2' ' CD1' ' A' ' 23' ' ' PHE . 10.0 mp -44.09 -28.38 0.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.749 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.7 tttt 88.22 17.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.434 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.444 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 4.0 mt -78.24 138.15 60.28 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.9 Cg_exo -40.42 144.65 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.534 2.156 . . . . 0.0 112.419 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.53 54.08 2.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.416 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 78.7 mt-30 -84.93 -44.62 12.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.791 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 50' ' ' GLN . 4.8 m-85 -140.23 29.08 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' NE ' ' HA2' ' A' ' 43' ' ' GLY . 0.5 OUTLIER -46.54 -61.8 1.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.106 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.408 ' N ' HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -55.66 -47.03 77.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.004 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 52.4 m -55.23 -38.86 69.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.436 ' CG2' ' CD1' ' A' ' 42' ' ' LEU . 10.8 mt -63.96 -56.24 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.838 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.491 ' CZ2' HG22 ' A' ' 38' ' ' THR . 0.3 OUTLIER -56.69 -61.28 2.54 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.477 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -47.04 -32.87 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.663 0.268 . . . . 0.0 111.348 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.62 -27.8 58.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.681 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.9 OUTLIER -79.01 -44.45 22.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.388 . . . . 0.0 110.725 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.5 pt20 -59.9 -27.02 66.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.155 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.78 -31.2 69.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.315 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.7 mt -70.4 -50.3 40.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.687 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.09 -62.15 1.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.84 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -64.1 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.77 -170.06 26.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -117.97 -179.91 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 110.916 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.91 126.32 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.478 ' OXT' ' CG ' ' A' ' 68' ' ' TYR . 20.8 t80 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.907 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 22.9 t80 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -101.89 71.18 1.27 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.863 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.48 114.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.072 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.431 ' CB ' ' HD3' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -87.95 -53.53 0.37 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 4' ' ' ASP . 53.0 Cg_exo -54.5 -21.9 25.79 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.501 2.134 . . . . 0.0 112.235 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 t -73.69 61.47 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 8' ' ' VAL . 2.8 tm? -162.25 -73.4 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.473 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 3.5 m -50.07 -42.51 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.4 -27.92 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.037 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.67 -56.25 4.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 tp -47.41 -55.99 7.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 0.0 110.698 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.445 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 63.4 m -53.15 -52.05 60.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.35 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.57 -31.05 52.04 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.028 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.412 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 3.8 tp -56.95 -19.88 20.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 19.02 5.29 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.332 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.5 p -134.51 66.08 69.08 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.676 0.274 . . . . 0.0 111.246 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 11.8 Cg_exo -71.54 -9.95 25.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.754 2.303 . . . . 0.0 112.777 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -126.26 16.37 7.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.095 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -113.46 -22.91 10.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.179 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.435 HD11 ' CG1' ' A' ' 8' ' ' VAL . 16.0 tt -54.18 -35.31 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.988 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HA ' ' CG2' ' A' ' 24' ' ' THR . 0.0 OUTLIER -66.07 -41.67 90.42 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.193 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -63.74 -26.97 68.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.521 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 2.3 m-85 -91.31 -35.95 14.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.469 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.448 ' CG2' ' HA ' ' A' ' 21' ' ' GLU . 4.4 t -70.72 -16.17 62.76 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.422 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -61.5 -23.0 65.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.742 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.12 -57.37 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.12 39.42 0.03 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HG ' ' CD1' ' A' ' 23' ' ' PHE . 0.2 OUTLIER -99.68 37.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.377 -179.333 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -99.86 -29.85 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.3 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -104.12 107.92 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.451 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -43.63 -30.06 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 -177.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.4 -21.49 25.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.674 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -85.4 -26.86 26.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.457 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -97.84 14.94 25.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -63.08 -37.78 88.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.437 0.637 . . . . 0.0 111.424 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.03 -14.78 14.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.268 -176.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -44.11 145.53 0.75 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.438 ' HB ' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -133.67 173.81 11.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.175 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 tp -63.09 -34.6 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.638 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.438 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 2.9 pt-20 -61.98 -38.51 88.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.47 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -84.99 -27.65 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.383 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.454 ' CD1' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -56.42 -59.73 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.29 -19.81 60.1 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.118 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.64 -36.03 69.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.057 0.456 . . . . 0.0 110.284 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' CD2' ' CD1' ' A' ' 23' ' ' PHE . 6.8 mp -60.92 -15.53 32.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.607 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 73.77 17.47 3.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 111.248 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.443 HG13 ' CB ' ' A' ' 45' ' ' LEU . 12.0 mt -79.46 137.87 55.43 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.3 Cg_exo -44.44 136.04 8.83 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.524 2.149 . . . . 0.0 112.299 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -68.41 62.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.234 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -85.44 -58.05 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.759 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.36 36.98 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.597 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.7 -64.74 0.77 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -52.14 -42.91 63.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.9 m -53.13 -48.47 67.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.454 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 38.6 mt -62.94 -44.03 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -56.72 -55.23 36.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.438 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.3 ptm180 -59.46 -30.67 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.989 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.439 ' N ' ' HG3' ' A' ' 57' ' ' ARG . . . -79.2 -26.33 57.87 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.822 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -81.08 -41.42 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.807 0.337 . . . . 0.0 110.485 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.77 -27.67 69.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.364 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -63.17 -30.71 71.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.527 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' A' ' 31' ' ' ILE . 10.3 mt -66.2 -51.27 59.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.652 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -55.84 -45.73 78.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.117 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -46.84 -44.88 19.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.46 -20.95 9.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.525 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 138.04 38.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.995 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 174.32 132.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.473 ' O ' ' CD1' ' A' ' 68' ' ' TYR . 23.8 t80 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.871 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.818 0.342 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 69.78 -174.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.93 136.58 37.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.444 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -65.42 -51.43 52.11 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 84.3 Cg_endo -83.4 59.05 6.32 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.71 2.274 . . . . 0.0 112.393 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 t -79.96 -28.97 39.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -90.06 -60.89 1.81 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.065 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 m -43.0 -36.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.794 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -58.06 -51.52 69.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.104 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.54 -38.54 48.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.312 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.82 -57.25 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.05 0.452 . . . . 0.0 111.119 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 17' ' ' PRO . 22.0 m -71.55 -50.52 30.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.804 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.2 -30.07 16.82 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.266 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 tp -58.15 -18.78 27.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.132 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 15.63 6.53 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.357 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 m -122.92 72.26 43.68 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.683 0.278 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 83.3 Cg_endo -83.33 6.49 5.77 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.67 2.247 . . . . 0.0 113.064 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -145.3 17.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.604 0.24 . . . . 0.0 111.534 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -118.23 -21.05 8.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.396 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.6 tt -50.26 -38.55 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.989 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.35 -46.25 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.54 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.345 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 29.3 m-85 -63.12 -54.71 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.7 p -51.72 -30.49 22.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.963 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 p -50.66 -25.79 4.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -101.24 -45.88 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.04 45.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.183 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.447 ' CD1' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.46 44.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 110.927 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -107.98 -19.4 13.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.453 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.417 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -121.57 103.16 8.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.606 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.446 ' HA ' ' CG ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -40.76 -31.64 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.137 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -56.09 -21.3 21.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.21 -24.66 27.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -103.21 16.52 26.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.105 0.479 . . . . 0.0 111.003 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -59.68 -39.82 85.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.34 -20.06 13.39 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.647 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -46.04 150.63 0.56 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.356 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.441 ' HB ' ' CG ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -140.32 177.35 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.213 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.482 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 9.5 tp -59.1 -34.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.37 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -59.15 -39.2 81.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.227 178.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 -33.57 21.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.542 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.463 ' CD1' ' CG2' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -53.52 -50.19 65.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.479 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -22.16 68.95 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.029 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.28 69.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.0 mp -62.53 -14.77 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.494 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mttm 72.53 16.72 4.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.804 0.335 . . . . 0.0 111.366 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.44 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 9.0 mt -85.39 138.7 36.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.4 Cg_exo -44.95 130.74 10.42 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.232 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -68.01 64.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -85.04 -52.27 6.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.655 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -140.15 25.61 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -48.2 44.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.194 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.8 mtm -57.36 -56.57 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -49.79 -44.26 48.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.463 ' CG2' ' CD1' ' A' ' 42' ' ' LEU . 14.3 mt -57.11 -55.36 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.52 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 7.2 t90 -52.45 -50.4 62.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -52.79 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.92 -39.99 80.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 2.6 mp -66.19 -29.17 69.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.486 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.52 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 35.3 mt-30 -74.43 -28.03 60.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.391 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -67.17 -26.57 66.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.77 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.0 mt -78.7 -47.29 17.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.002 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -62.89 -43.3 99.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.118 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -65.28 -41.87 93.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.08 167.5 35.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.76 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.26 159.61 19.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.837 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p30 174.64 129.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 68' ' ' TYR . 55.2 t80 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.956 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.827 0.346 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -60.99 137.55 58.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.031 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.03 165.2 25.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -133.57 64.2 67.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 47.1 Cg_exo -55.76 -21.55 32.95 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.565 2.176 . . . . 0.0 112.303 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.17 -40.02 22.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.388 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 8' ' ' VAL . 1.5 tm? -75.05 -64.97 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.258 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.46 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 2.9 m -53.28 -34.35 22.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.381 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 t -63.55 -33.15 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.381 . . . . 0.0 111.27 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.42 -48.47 7.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.58 -53.14 15.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -74.45 -48.0 30.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.731 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.18 -29.86 30.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.055 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' CD2' ' HA ' ' A' ' 55' ' ' ILE . 4.0 tp -59.31 -17.94 33.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.669 0.271 . . . . 0.0 111.274 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.26 19.36 5.9 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.181 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.0 m -126.87 73.74 76.0 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.709 0.29 . . . . 0.0 110.992 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -84.74 -0.26 9.23 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.068 2.512 . . . . 0.0 112.918 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.8 13.58 3.4 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.53 -20.19 9.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.601 0.239 . . . . 0.0 111.419 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.9 tt -51.67 -28.96 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.926 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.64 -43.38 76.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.256 0.551 . . . . 0.0 110.388 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.5 m-30 -68.33 -24.76 64.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.249 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.8 -32.38 15.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 t -69.32 -10.37 57.54 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.993 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -19.35 62.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.561 ' NE2' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.3 -20.74 11.73 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.362 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 33' ' ' HIS . . . 131.82 51.39 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.435 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.451 ' CD1' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -109.45 37.68 2.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.889 0.376 . . . . 0.0 111.129 179.005 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -99.36 -30.43 12.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.92 109.48 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.706 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.447 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -44.38 -27.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 111.657 -177.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -20.63 59.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.762 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.468 ' CG ' ' O ' ' A' ' 27' ' ' GLY . 46.5 t-80 -85.06 -19.11 32.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.997 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.16 14.0 21.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.528 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.21 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.053 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -125.06 16.95 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.33 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.438 HD21 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -85.11 140.44 30.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.386 . . . . 0.0 110.684 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.469 ' CG2' ' NE1' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -128.81 -179.84 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.047 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.446 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 3.8 tp -58.25 -34.26 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -52.19 -43.26 64.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.274 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.423 ' CB ' HD23 ' A' ' 37' ' ' LEU . 4.3 m-20 -83.99 -30.07 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.588 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.482 HD22 ' CZ ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -67.41 -36.98 82.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.794 178.313 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 52' ' ' ARG . . . -79.88 2.23 75.45 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.75 -41.13 16.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.561 ' CD2' ' NE2' ' A' ' 26' ' ' GLN . 3.7 mt -62.69 -12.31 22.82 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.069 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 71.31 15.23 6.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 111.264 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.442 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 25.1 mm -61.17 138.58 94.44 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.474 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 4.3 Cg_exo -37.02 153.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.581 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -92.69 23.12 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.429 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -85.07 -33.22 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.422 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 7.5 m-85 -135.16 12.32 3.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -54.09 -68.29 0.19 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 179.475 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 mtm -53.33 -42.26 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.871 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -51.4 -50.75 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.581 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.436 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 5.2 mt -56.65 -56.96 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.469 ' NE1' ' CG2' ' A' ' 38' ' ' THR . 7.2 t90 -49.85 -54.89 16.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -51.37 -32.32 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.53 -25.25 61.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.797 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.2 tp -80.94 -40.58 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.494 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -63.15 -27.76 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.071 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -55.34 -37.75 67.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.11 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.14 -45.87 92.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.392 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.16 37.61 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.79 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -51.32 -39.74 57.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.077 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.42 -90.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -137.31 128.84 28.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 111.015 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.42 -161.26 1.15 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.17 0.51 . . . . 0.0 110.612 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.1 t80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.595 -179.001 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 16.8 t80 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.803 0.335 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.93 179.31 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.89 172.22 12.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.91 67.95 18.15 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.7 -20.18 23.29 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.596 2.198 . . . . 0.0 112.343 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 t -68.55 65.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.053 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.419 HD22 ' CA ' ' A' ' 31' ' ' ILE . 2.1 tm? -177.17 -58.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.3 m -66.12 -37.31 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.168 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 p -63.19 -26.48 68.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -95.7 -46.78 6.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.17 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -49.58 -52.7 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.862 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -77.6 -46.74 21.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.472 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.11 -26.98 6.64 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.362 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.52 -22.5 13.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.774 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.64 16.91 5.76 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.353 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.41 ' HB3' ' CG ' ' A' ' 51' ' ' TYR . 4.6 p -130.12 80.54 70.7 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.772 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.61 6.1 5.09 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.714 2.276 . . . . 0.0 112.996 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -135.56 22.47 3.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.674 0.273 . . . . 0.0 111.143 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 t -114.27 -28.62 7.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.967 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 tt -50.87 -45.59 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.916 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -49.66 -44.45 47.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.84 -35.46 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.509 ' CZ ' ' CD1' ' A' ' 55' ' ' ILE . 3.2 m-85 -70.68 -49.6 45.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.73 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -55.28 -24.34 27.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -49.15 -30.37 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.244 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -99.99 -53.56 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.1 48.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.99 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.431 HD13 ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -99.51 40.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.047 -179.083 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -99.1 -27.45 13.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.867 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.1 104.39 12.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.444 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -43.81 -29.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.99 0.424 . . . . 0.0 111.278 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -55.23 -23.63 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.668 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.45 -21.16 35.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.955 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -114.06 22.04 14.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -32.41 71.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.55 -18.36 11.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.716 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -44.45 140.86 2.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.344 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.69 179.18 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.118 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.477 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 9.6 tp -57.3 -33.65 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.482 0.658 . . . . 0.0 109.276 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.75 -47.49 79.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.539 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.18 -27.52 38.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.673 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.436 ' N ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -55.18 -52.48 63.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.177 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -15.18 62.89 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.324 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.06 -40.31 90.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.561 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.445 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 8.9 mp -47.3 -27.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.347 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 5.9 ttmm 86.66 16.09 0.1 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.633 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.481 ' CD1' ' CD1' ' A' ' 23' ' ' PHE . 2.8 mt -86.21 137.69 34.83 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.816 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.431 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 3.0 Cg_endo -45.26 158.87 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.675 2.25 . . . . 0.0 112.023 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.45 57.8 4.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.177 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.47 -58.12 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.58 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 1.5 m-85 -137.15 33.48 2.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.616 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -56.52 -66.66 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.01 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.422 ' CG ' HD11 ' A' ' 39' ' ' ILE . 59.4 mtt -54.84 -34.81 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.2 m -58.14 -49.98 75.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.729 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 23' ' ' PHE . 60.0 mt -66.13 -35.72 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.602 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.477 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 10.6 t90 -59.48 -55.82 29.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.941 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.416 ' NH1' ' HB3' ' A' ' 53' ' ' MET . 0.0 OUTLIER -53.34 -39.48 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.621 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.96 -40.98 88.75 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.91 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 1.1 tp -64.26 -38.67 91.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.332 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.47 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 36.7 mt-30 -63.82 -31.15 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.199 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -33.62 66.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.216 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.93 -42.02 98.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.431 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.15 38.55 1.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.658 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -132.41 -44.47 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.22 -88.07 0.77 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.379 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 -177.02 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.807 0.337 . . . . 0.0 110.912 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.71 128.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.963 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.616 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.9 tm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.829 0.347 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 7' ' ' LEU . 46.4 t -67.85 -50.87 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.166 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -25.01 65.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.116 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -50.9 6.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.029 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.795 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.2 tm? -48.9 -53.03 21.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.015 0.436 . . . . 0.0 110.859 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.838 HG23 ' HA ' ' A' ' 17' ' ' PRO . 55.8 m -74.69 -46.88 34.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.46 -29.82 17.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.286 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.8 tp -62.38 -15.05 46.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.642 0.258 . . . . 0.0 111.277 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.59 12.78 8.48 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.419 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 55' ' ' ILE . 34.1 m -116.12 67.21 3.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.684 0.278 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.838 ' HA ' HG23 ' A' ' 12' ' ' THR . 59.5 Cg_endo -72.55 -17.5 26.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.526 2.151 . . . . 0.0 112.521 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -130.04 21.36 5.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.028 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -28.07 8.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.795 ' HB ' HD12 ' A' ' 11' ' ' LEU . 2.4 tt -52.2 -34.76 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.817 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.96 -44.05 86.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.667 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -71.98 -33.57 68.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.482 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.534 ' CE1' HD22 ' A' ' 45' ' ' LEU . 10.2 m-85 -73.76 -45.19 53.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.58 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' ILE . 65.9 p -55.73 -32.08 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.79 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -49.52 -25.92 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.996 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -99.9 -48.07 4.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.44 47.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.469 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.137 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.24 39.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.126 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -30.24 12.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.039 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.52 110.47 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.075 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.537 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -46.44 -27.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.004 0.431 . . . . 0.0 111.279 -178.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -21.82 49.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.63 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -21.52 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.214 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.137 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.3 19.25 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -28.61 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.329 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -114.75 -20.44 10.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.513 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -44.94 148.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.633 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.668 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -140.39 178.63 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.121 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.6 tp -59.65 -33.33 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.48 0.657 . . . . 0.0 109.23 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.18 -50.94 71.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -78.04 -24.27 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.9 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.509 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.63 -6.9 60.09 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.734 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -77.38 -43.63 32.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.964 0.412 . . . . 0.0 110.432 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.681 HD23 HD11 ' A' ' 47' ' ' ILE . 9.3 mp -47.35 -29.11 2.35 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.174 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER 82.44 21.37 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.681 HD11 HD23 ' A' ' 45' ' ' LEU . 4.5 mt -81.35 138.0 48.52 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.305 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.0 Cg_exo -39.66 136.76 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.527 2.151 . . . . 0.0 112.294 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -78.73 55.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.399 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.53 -43.16 13.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -140.36 30.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -50.71 -59.31 4.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.572 ' HA ' HD13 ' A' ' 39' ' ' ILE . 5.9 ptm -59.37 -44.49 92.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.408 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 54.9 m -51.7 -50.19 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.456 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.69 ' HA ' HD23 ' A' ' 14' ' ' LEU . 17.6 mt -59.74 -46.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.668 ' NE1' HG22 ' A' ' 38' ' ' THR . 13.2 t90 -57.64 -61.65 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.56 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.8 ptm180 -51.78 -31.16 25.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.684 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -74.7 -36.58 47.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.714 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 34' ' ' LEU . 2.6 tp -67.46 -42.08 83.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.253 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -61.02 -27.69 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.279 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.292 178.916 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.643 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.836 0.351 . . . . 0.0 110.72 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.585 ' N ' HD13 ' A' ' 7' ' ' LEU . 7.8 p -66.1 -33.84 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.02 64.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -85.7 -47.5 9.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -52.93 -48.45 67.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.363 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.7 m -81.06 -40.83 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.097 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.25 -30.83 11.56 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.195 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -57.1 -20.46 25.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 178.53 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.94 19.06 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.185 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 78.85 35.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.638 0.256 . . . . 0.0 110.974 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 12' ' ' THR . 87.7 Cg_endo -84.74 13.85 2.64 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.656 2.237 . . . . 0.0 112.93 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 18' ' ' ASN . 1.6 t30 -143.0 25.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 111.022 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.18 -34.34 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.294 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.683 ' O ' HG22 ' A' ' 24' ' ' THR . 0.5 OUTLIER -46.95 -28.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -59.8 -46.6 88.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.095 0.474 . . . . 0.0 110.625 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.43 ' HB2' HD13 ' A' ' 47' ' ' ILE . 38.7 m-85 -78.72 -28.65 45.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -77.46 -43.85 30.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.841 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 20' ' ' ILE . 14.8 t -67.49 -28.74 68.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.754 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m -54.12 -22.42 11.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.968 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.406 ' HG3' ' HG ' ' A' ' 45' ' ' LEU . 1.1 mm-40 -99.78 -56.72 2.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.33 43.51 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.213 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.035 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.2 40.78 1.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.833 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -99.46 -27.53 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.09 109.95 18.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.116 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.526 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -46.48 -27.52 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 111.095 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -58.04 -22.22 49.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -84.18 -19.19 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.03 4.45 15.7 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.83 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -53.31 -36.48 61.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.724 0.297 . . . . 0.0 111.186 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -112.81 19.41 17.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' ' 41' ' ' ASP . 12.8 tp -84.79 155.98 21.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.641 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -139.27 177.38 7.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.877 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.5 tp -58.29 -34.16 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.419 0.628 . . . . 0.0 109.42 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.89 -47.33 77.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.715 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.75 ' HB3' HD11 ' A' ' 37' ' ' LEU . 21.0 m-20 -80.93 -31.0 35.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.551 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -51.3 -51.39 54.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.28 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.09 -20.33 77.87 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.324 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -58.04 -44.17 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.14 0.495 . . . . 0.0 110.202 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.639 HD23 HD11 ' A' ' 47' ' ' ILE . 8.1 mp -48.52 -29.46 4.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.318 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttpt 86.63 19.43 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.315 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.639 HD11 HD23 ' A' ' 45' ' ' LEU . 3.8 mt -83.98 138.62 39.96 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.242 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.463 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 61.7 Cg_exo -36.81 151.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.703 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 1.9 pt-20 -91.65 22.47 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 33.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HB3' HD11 ' A' ' 39' ' ' ILE . 1.4 ttp180 -62.16 -51.14 69.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.376 . . . . 0.0 111.009 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.877 ' HA ' HD13 ' A' ' 39' ' ' ILE . 2.3 ttp -66.22 -32.32 73.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.121 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 14' ' ' LEU . 56.2 m -59.63 -50.36 74.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . 45.1 mt -62.7 -41.42 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.805 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.613 ' NE1' HG22 ' A' ' 38' ' ' THR . 9.4 t90 -57.19 -51.52 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.101 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -50.8 -46.85 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.441 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.675 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -65.97 -37.95 93.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.585 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.86 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -61.61 -36.47 80.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 178.399 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -66.53 -28.6 68.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.203 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.585 179.169 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.5 tm? . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.755 0.312 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.64 ' N ' HD13 ' A' ' 7' ' ' LEU . 14.5 t -59.01 -45.05 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.433 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -59.38 -30.5 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -88.11 -51.87 5.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.336 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.63 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.5 tm? -45.66 -53.21 9.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 111.151 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.857 HG23 ' HA ' ' A' ' 17' ' ' PRO . 51.3 m -74.36 -47.69 32.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.37 -24.35 22.62 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.478 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.618 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.8 tp -61.38 -18.17 57.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.742 0.306 . . . . 0.0 111.327 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.98 18.68 5.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.299 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -134.33 74.6 66.48 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.858 0.361 . . . . 0.0 110.759 179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.857 ' HA ' HG23 ' A' ' 12' ' ' THR . 71.6 Cg_endo -84.63 10.06 3.88 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.809 2.34 . . . . 0.0 112.821 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.3 16.04 2.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 111.221 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -115.28 -22.24 9.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.63 ' HB ' HD12 ' A' ' 11' ' ' LEU . 3.2 tt -50.18 -36.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 110.974 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.501 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 12.2 pt-20 -57.63 -43.84 85.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.501 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 64.3 m-85 -70.71 -32.63 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 22.3 m-85 -73.91 -52.81 11.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.536 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 20' ' ' ILE . 40.3 p -50.67 -29.18 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 0.5 OUTLIER -50.57 -27.64 7.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.231 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.17 -42.43 6.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.87 45.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.182 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.035 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.5 40.01 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -99.22 -27.58 13.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.992 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.48 107.44 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.025 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.526 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -45.75 -27.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.059 0.457 . . . . 0.0 111.348 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -21.01 34.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 -22.35 29.04 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -107.01 18.78 21.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 0.0 111.508 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -19.23 64.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.258 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -125.39 -8.69 6.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -61.14 153.88 24.63 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.828 0.347 . . . . 0.0 110.984 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.709 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -140.15 178.31 7.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.063 0.459 . . . . 0.0 111.478 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.487 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 7.4 tp -60.42 -34.0 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.52 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -39.87 78.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.416 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.65 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.4 m-20 -86.05 -34.69 20.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.642 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -48.38 -59.01 3.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.879 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.48 -19.12 32.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.388 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -67.21 -31.02 71.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.4 mp -62.85 -17.52 61.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.488 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 2.3 mtmt 74.19 17.45 3.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 111.369 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.449 HG13 ' CB ' ' A' ' 45' ' ' LEU . 7.4 mt -80.95 137.82 49.94 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.678 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 59.6 Cg_exo -37.66 112.81 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.83 2.354 . . . . 0.0 112.787 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -68.15 63.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.112 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -85.11 -50.33 7.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.558 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.06 28.64 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.433 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -46.7 -30.54 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.283 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -50.03 48.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.2 m -54.62 -40.0 68.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.369 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.618 ' HA ' HD23 ' A' ' 14' ' ' LEU . 6.8 mm -61.7 -55.65 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.895 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.709 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.5 t90 -52.05 -45.58 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.243 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -51.24 -53.77 32.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.611 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.2 -41.78 54.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 34' ' ' LEU . 3.3 mp -65.37 -28.18 69.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 110.355 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -75.07 -28.49 60.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.478 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.573 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.8 tm? . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.809 0.338 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.65 ' N ' HD13 ' A' ' 7' ' ' LEU . 42.3 t -53.78 -59.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.056 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.1 -6.75 30.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.769 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.43 -59.61 1.97 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.974 HD13 ' N ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.04 -26.35 68.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.507 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.974 ' N ' HD13 ' A' ' 11' ' ' LEU . 33.1 m -81.11 -50.43 9.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.282 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.23 -25.7 60.47 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.421 ' CD2' ' HA3' ' A' ' 58' ' ' GLY . 5.1 tp -49.63 -24.78 2.38 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.025 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.65 10.45 4.91 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.282 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 73.52 72.82 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 116.958 0.379 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.873 ' HA ' HG23 ' A' ' 12' ' ' THR . 3.1 Cg_exo -77.67 4.03 6.38 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.897 2.398 . . . . 0.0 112.901 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -132.43 19.67 4.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.638 0.256 . . . . 0.0 111.264 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -114.01 -24.23 9.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.046 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.79 HD13 ' HG ' ' A' ' 11' ' ' LEU . 8.5 tp -49.89 -36.65 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.74 -40.67 92.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.548 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.1 m-30 -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.458 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.526 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 6.9 m-85 -80.89 -42.44 21.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 20' ' ' ILE . 11.9 p -52.88 -29.64 29.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -27.12 3.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.259 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -99.94 -58.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.957 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.44 46.86 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.446 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.055 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.4 39.89 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -99.66 -28.95 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.105 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -116.21 115.57 26.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.166 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.535 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -47.85 -26.74 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 111.049 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 19.8 m-85 -59.91 -19.39 51.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -85.33 -30.22 23.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.864 0.364 . . . . 0.0 110.55 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.055 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -98.67 23.52 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.492 . . . . 0.0 110.757 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 32' ' ' TYR . 1.3 mm-40 -68.1 -37.91 81.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.607 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -112.54 -18.17 12.47 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.661 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.797 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -44.78 148.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.303 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.575 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -140.26 173.71 11.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.108 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.496 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 6.9 tp -57.14 -33.77 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.392 0.615 . . . . 0.0 109.384 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.79 -45.35 78.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.332 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -84.62 -31.66 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.797 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -54.49 -45.57 73.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.418 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.445 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -67.66 -10.27 57.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -78.58 -27.76 45.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.116 0.484 . . . . 0.0 110.403 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.526 ' CD2' ' CD2' ' A' ' 23' ' ' PHE . 8.1 mp -62.39 -11.74 17.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.146 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt 77.09 20.18 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 45' ' ' LEU . 7.1 mm -82.35 131.74 54.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.66 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HG2' ' HG3' ' A' ' 50' ' ' GLN . 7.6 Cg_endo -49.7 176.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.667 2.245 . . . . 0.0 112.396 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.59 40.65 1.04 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.96 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.4 ' HG3' ' HG2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -82.5 -51.97 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.811 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -140.24 25.64 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.289 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -51.83 -57.72 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.7 mmm -59.98 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.915 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.0 m -50.36 -48.16 55.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.654 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 52' ' ' ARG . 8.3 mt -55.53 -56.96 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.755 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.575 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.5 t90 -51.47 -52.44 46.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.855 0.359 . . . . 0.0 110.456 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -47.01 -59.6 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.018 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' A' ' 14' ' ' LEU . . . -51.67 -34.05 35.33 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.704 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.8 mp -69.81 -31.25 69.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.427 . . . . 0.0 110.102 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -68.48 -28.9 67.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.941 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.375 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.623 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.7 tm? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.924 0.392 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.612 ' N ' HD13 ' A' ' 7' ' ' LEU . 60.4 t -67.96 -42.35 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.042 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -24.94 37.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.53 -44.72 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.796 HD11 HD12 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -46.01 -54.18 8.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.97 0.414 . . . . 0.0 111.138 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.697 HG23 ' HA ' ' A' ' 17' ' ' PRO . 23.8 m -76.89 -49.79 14.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.91 -24.87 8.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.192 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.5 tp -58.46 -18.8 31.55 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.779 0.323 . . . . 0.0 111.113 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.4 19.49 7.05 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.069 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.7 m -134.23 77.69 60.17 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 111.113 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.697 ' HA ' HG23 ' A' ' 12' ' ' THR . 90.4 Cg_endo -87.47 19.43 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.892 2.394 . . . . 0.0 112.833 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.47 20.34 1.87 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.472 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 p -120.36 -30.98 4.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.69 0.281 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.727 ' O ' HG23 ' A' ' 24' ' ' THR . 12.2 tt -46.75 -30.8 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.567 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.46 -44.19 88.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 110.349 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.498 ' CB ' HD12 ' A' ' 47' ' ' ILE . 40.3 m-85 -75.15 -29.0 60.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.818 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' CE1' HD22 ' A' ' 45' ' ' LEU . 25.3 m-85 -78.17 -30.36 49.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.94 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 20' ' ' ILE . 7.1 p -69.39 -32.94 72.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -24.56 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.95 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -99.89 -49.25 4.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.18 51.38 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.328 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.97 ' CD1' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.69 39.28 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.0 110.948 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.7 pt20 -99.39 -28.55 13.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.128 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.98 112.9 23.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.022 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.512 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -45.37 -28.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.975 0.416 . . . . 0.0 111.116 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 m-85 -57.15 -21.01 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.753 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 -31.2 25.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.961 0.41 . . . . 0.0 110.613 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.97 HD22 ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.94 25.35 8.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.875 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.445 ' HG3' ' HA ' ' A' ' 32' ' ' TYR . 3.7 mm-40 -67.76 -42.99 80.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.612 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -103.61 -21.33 13.75 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.503 -176.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -46.31 144.91 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.119 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.715 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -135.02 178.67 6.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.131 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.589 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.2 tp -59.25 -32.99 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.363 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.07 -48.05 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.704 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 6.5 m-20 -80.34 -25.97 38.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -55.62 -49.21 73.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.83 -9.16 58.87 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.775 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -76.54 -43.69 38.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.058 0.456 . . . . 0.0 110.433 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.513 HD22 ' CE1' ' A' ' 23' ' ' PHE . 10.0 mp -46.15 -27.57 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.9 ttmm 86.17 19.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.237 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.498 HD12 ' CB ' ' A' ' 22' ' ' TYR . 4.9 mm -78.13 138.42 60.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.692 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 47' ' ' ILE . 81.4 Cg_exo -41.05 149.42 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.515 2.143 . . . . 0.0 112.389 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -89.01 47.21 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -85.19 -53.71 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.77 31.88 2.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.065 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.0 ttp180 -54.89 -48.28 73.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.589 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -60.57 -45.21 94.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.7 m -51.95 -45.93 64.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 14' ' ' LEU . 17.9 mt -61.16 -42.97 95.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.766 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.503 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.3 t90 -59.73 -50.29 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -47.13 -56.69 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.734 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.52 -42.29 65.7 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.661 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 34' ' ' LEU . 3.5 mp -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.414 ' CD ' ' CE2' ' A' ' 56' ' ' TRP . 38.9 mt-30 -71.53 -17.25 62.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.604 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.848 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.814 0.34 . . . . 0.0 111.147 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 m -43.95 -37.05 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.714 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -30.48 70.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.98 -47.28 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.36 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 7' ' ' LEU . 1.8 tm? -48.69 -54.45 14.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.0 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.634 HG23 ' HA ' ' A' ' 17' ' ' PRO . 87.8 m -79.17 -44.25 22.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.261 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 -28.46 12.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.248 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.898 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -55.09 -22.02 14.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.015 0.436 . . . . 0.0 110.844 178.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 20.95 5.75 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.086 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.7 p -134.96 83.6 39.8 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.634 ' HA ' HG23 ' A' ' 12' ' ' THR . 96.8 Cg_endo -87.28 21.48 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.785 2.323 . . . . 0.0 113.02 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -138.17 17.61 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.385 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.9 p -115.72 -26.73 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.2 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.679 HG13 HG23 ' A' ' 24' ' ' THR . 1.0 OUTLIER -48.85 -42.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -55.83 -42.29 75.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -74.16 -30.52 62.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.652 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CE1' HD12 ' A' ' 47' ' ' ILE . 33.2 m-85 -76.83 -51.59 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.752 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.679 HG23 HG13 ' A' ' 20' ' ' ILE . 53.3 p -50.43 -27.61 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.153 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.3 t -53.23 -24.12 10.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -103.89 -38.72 6.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.058 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.68 47.08 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.9 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.988 HD13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -99.19 44.62 1.02 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.309 0.576 . . . . 0.0 110.647 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.468 ' C ' HD12 ' A' ' 7' ' ' LEU . 5.6 pt20 -107.39 -13.98 14.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.314 177.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.645 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -127.16 103.68 7.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.467 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -43.04 -29.12 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 111.761 -177.232 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -56.76 -22.61 36.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -85.23 -11.47 54.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.496 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.993 HD12 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -122.37 14.81 10.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.404 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -24.28 62.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.21 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -115.38 -18.37 11.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.486 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.88 143.24 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.674 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -137.31 176.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.25 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.479 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 3.7 tp -55.84 -33.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.437 0.637 . . . . 0.0 109.46 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.02 -43.41 81.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.681 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.6 m-20 -84.81 -28.62 26.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.762 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -52.45 -46.35 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.43 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.32 62.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.775 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -80.67 -44.94 18.0 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 47' ' ' ILE . 9.4 mp -49.02 -28.14 3.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.249 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.6 tptt 83.34 21.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.317 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 45' ' ' LEU . 6.1 mt -83.68 137.93 41.13 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.479 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.454 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 69.7 Cg_exo -38.07 153.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.783 2.322 . . . . 0.0 112.596 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 10.3 pm0 -91.84 21.18 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.403 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -58.58 -44.27 89.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.809 0.338 . . . . 0.0 110.828 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 16' ' ' CYS . 12.4 m-85 -140.69 31.96 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.359 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -55.19 -61.15 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.381 . . . . 0.0 110.773 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtm -56.54 -42.97 79.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.777 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.629 ' CG2' HD12 ' A' ' 14' ' ' LEU . 85.9 m -51.01 -50.47 58.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.498 HD13 ' CZ ' ' A' ' 23' ' ' PHE . 6.6 mt -62.66 -37.66 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.674 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.0 t90 -61.63 -54.58 40.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.404 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 5.5 mtm180 -54.67 -36.75 64.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.853 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.898 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -74.35 -31.58 59.0 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.114 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.993 HD11 HD12 ' A' ' 34' ' ' LEU . 3.6 tp -73.91 -36.34 64.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.801 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 5.0 pt20 -69.1 -26.91 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.243 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.84 HD23 HD12 ' A' ' 31' ' ' ILE . 1.2 tm? . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.943 0.402 . . . . 0.0 110.636 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' N ' HD13 ' A' ' 7' ' ' LEU . 39.0 t -68.82 -39.11 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.129 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 p -59.41 -34.35 72.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.87 -43.73 12.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.513 HD12 ' HB ' ' A' ' 20' ' ' ILE . 1.7 tm? -48.24 -52.8 19.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.818 HG23 ' HA ' ' A' ' 17' ' ' PRO . 55.4 m -75.68 -50.44 15.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.2 -23.61 12.96 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.328 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.6 tp -58.59 -18.49 30.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 0.0 111.18 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.59 12.14 6.85 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.588 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 3.4 m -132.16 77.85 70.15 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.818 ' HA ' HG23 ' A' ' 12' ' ' THR . 90.6 Cg_endo -79.97 4.7 6.52 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.7 2.267 . . . . 0.0 112.939 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.21 20.49 3.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.687 0.28 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 8.3 m -114.19 -28.25 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.976 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.606 HG13 HG23 ' A' ' 24' ' ' THR . 1.7 tt -47.7 -44.15 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.07 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.478 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.4 mm-40 -49.97 -44.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.802 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.63 -32.79 62.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.556 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HE2' HG21 ' A' ' 55' ' ' ILE . 4.0 m-85 -69.29 -51.08 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.606 HG23 HG13 ' A' ' 20' ' ' ILE . 80.4 p -58.16 -28.02 64.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.7 t -47.29 -27.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.239 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -101.61 -56.28 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.753 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.14 46.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.092 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.979 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -99.4 38.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 111.14 -179.152 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.08 -27.83 13.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.785 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 108.04 17.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.852 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.84 HD12 HD23 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -43.23 -33.71 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.988 0.423 . . . . 0.0 111.548 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -55.92 -20.63 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.985 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.81 -15.77 47.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.675 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.112 HD12 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -113.28 9.84 18.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -36.38 65.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -99.88 -22.3 15.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 41' ' ' ASP . 5.0 tp -47.79 135.2 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.701 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -132.67 178.55 6.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.009 0.433 . . . . 0.0 111.304 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 53' ' ' MET . 5.5 tp -58.97 -32.44 47.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.552 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -57.11 -45.37 83.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.833 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.4 m-20 -85.01 -27.11 26.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.701 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -49.26 -53.31 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.855 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.441 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . -68.15 -8.83 55.77 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.733 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -75.13 -42.37 56.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 110.426 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 47' ' ' ILE . 9.5 mp -47.87 -28.01 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.45 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.2 tttm 87.17 17.22 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.586 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.598 HD12 ' CE1' ' A' ' 23' ' ' PHE . 4.0 mt -85.91 138.49 35.13 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.595 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 2.7 Cg_endo -40.46 146.35 0.3 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.965 2.444 . . . . 0.0 112.108 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -90.21 42.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.76 -43.67 71.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.762 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -140.26 30.4 1.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.665 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 9.6 ttp180 -48.36 -50.75 29.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.825 ' HA ' HD13 ' A' ' 39' ' ' ILE . 4.9 mtt -61.2 -54.1 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.263 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -47.41 -48.93 26.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 0.0 111.034 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.667 HG21 ' HE2' ' A' ' 23' ' ' PHE . 6.6 mt -59.06 -41.51 83.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.743 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.603 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.9 t90 -62.43 -46.67 87.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.261 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.07 -60.03 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.43 -30.62 61.97 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.67 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.112 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -70.99 -25.96 62.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.24 -12.62 61.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.728 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.2 tm? . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.728 ' N ' HD13 ' A' ' 7' ' ' LEU . 34.9 m -57.21 -35.8 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.6 p -64.38 -24.29 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.073 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.76 -48.74 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.571 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.5 tm? -48.26 -53.22 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.133 0.492 . . . . 0.0 110.876 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.849 HG23 ' HA ' ' A' ' 17' ' ' PRO . 93.0 m -70.67 -49.59 45.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.37 -32.7 22.93 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.9 tp -60.17 -17.14 38.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.81 11.23 6.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.611 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.847 ' SG ' HD11 ' A' ' 55' ' ' ILE . 1.3 m -114.91 72.41 2.86 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-O 120.739 0.304 . . . . 0.0 111.146 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.849 ' HA ' HG23 ' A' ' 12' ' ' THR . 85.2 Cg_endo -80.64 -13.1 12.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.256 . . . . 0.0 112.943 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.87 22.08 4.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.112 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 87.6 m -114.83 -28.21 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.072 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 24' ' ' THR . 2.5 tt -48.52 -32.83 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.95 -44.82 96.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.533 ' HB2' HD12 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -77.69 -27.95 50.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.463 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE1' HD22 ' A' ' 45' ' ' LEU . 20.1 m-85 -76.54 -46.36 26.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 20' ' ' ILE . 37.9 p -56.34 -30.75 63.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 p -55.79 -23.64 31.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.262 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.84 -34.98 9.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.75 41.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.304 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.037 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.79 39.53 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.024 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.22 -29.6 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.914 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.59 109.38 19.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.83 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.554 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -44.43 -28.34 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 111.526 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -58.64 -22.46 56.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.677 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -84.23 -19.9 33.16 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.037 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.56 13.38 22.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.679 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -17.46 64.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.408 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -128.36 17.86 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -84.88 147.41 26.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.29 . . . . 0.0 110.654 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.747 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -131.02 172.72 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.012 0.434 . . . . 0.0 111.523 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.44 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 7.5 tp -56.98 -34.3 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.676 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -59.09 -38.85 80.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.624 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 32.5 m-20 -85.47 -26.81 26.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.591 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -54.77 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.662 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -55.15 -20.44 20.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.369 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -61.73 -37.83 85.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 0.0 110.358 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.493 HD22 ' CE1' ' A' ' 23' ' ' PHE . 6.8 mp -61.26 -15.41 34.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.485 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 74.81 19.3 2.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.93 0.395 . . . . 0.0 111.073 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 22' ' ' TYR . 7.4 mm -79.23 138.17 56.21 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.513 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 87.7 Cg_exo -43.05 157.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.407 2.072 . . . . 0.0 112.136 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -85.56 -46.14 11.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -140.31 21.81 2.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.412 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -51.01 -57.34 8.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.438 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -60.36 -41.86 94.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.628 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.414 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 53.4 m -54.4 -47.59 72.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.604 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.847 HD11 ' SG ' ' A' ' 16' ' ' CYS . 6.8 mt -62.31 -36.77 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.619 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.4 t90 -64.23 -51.27 64.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 5.4 ptp180 -60.69 -33.14 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.623 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -77.54 -25.73 62.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.126 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 34' ' ' LEU . 1.2 mp -78.46 -34.28 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.642 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -73.16 -30.46 63.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.38 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.569 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.761 HD23 HD12 ' A' ' 31' ' ' ILE . 1.8 tm? . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.691 0.282 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.483 ' N ' HD13 ' A' ' 7' ' ' LEU . 46.6 t -53.71 -59.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.548 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -55.6 -19.61 10.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.13 -57.04 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 111.391 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 11' ' ' LEU . 1.9 tm? -46.16 -45.07 16.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.86 HG23 ' HA ' ' A' ' 17' ' ' PRO . 33.7 m -83.34 -49.11 9.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.635 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.58 -27.19 25.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.245 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' A' ' 55' ' ' ILE . 6.4 tp -60.74 -17.19 47.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.737 0.304 . . . . 0.0 111.047 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.57 16.87 6.79 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.309 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -127.79 71.86 78.28 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.672 0.272 . . . . 0.0 111.174 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.86 ' HA ' HG23 ' A' ' 12' ' ' THR . 87.6 Cg_endo -84.0 12.0 3.15 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.67 2.247 . . . . 0.0 112.854 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -138.73 16.21 2.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.674 0.273 . . . . 0.0 111.557 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -116.45 -23.05 8.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.765 0.317 . . . . 0.0 111.233 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.612 ' O ' HG23 ' A' ' 24' ' ' THR . 1.4 tt -48.58 -43.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.26 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.3 pt-20 -56.01 -41.64 75.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.482 ' CB ' HG23 ' A' ' 47' ' ' ILE . 52.3 m-85 -74.31 -33.63 63.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.685 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.516 ' CE1' HD22 ' A' ' 45' ' ' LEU . 9.1 m-85 -74.16 -51.26 16.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.865 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 20' ' ' ILE . 64.9 p -48.87 -34.41 12.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.328 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -47.98 -26.56 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.564 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -101.45 -29.71 11.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.74 45.55 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.097 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.033 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.11 40.15 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.995 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 7' ' ' LEU . 2.9 mt-30 -99.34 -30.08 12.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.784 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.27 109.05 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.917 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.761 HD12 HD23 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -43.62 -28.51 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 111.637 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.07 -23.91 62.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.766 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -80.27 -14.6 58.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.726 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -115.39 -1.5 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.81 -35.28 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.61 0.243 . . . . 0.0 111.508 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -108.6 15.66 23.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.783 ' HB3' HD23 ' A' ' 59' ' ' LEU . 14.7 tp -85.35 156.17 21.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.343 . . . . 0.0 110.792 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -140.14 174.35 10.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.488 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 5.0 tp -57.64 -35.25 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -39.22 80.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.701 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.58 ' HB3' HD11 ' A' ' 37' ' ' LEU . 14.0 m-20 -85.73 -32.8 21.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -52.35 -45.25 65.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.334 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HD2' ' A' ' 52' ' ' ARG . . . -77.54 -0.26 72.44 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.644 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -85.17 -33.57 22.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.062 0.458 . . . . 0.0 110.252 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.516 HD22 ' CE1' ' A' ' 23' ' ' PHE . 7.3 mp -61.11 -14.88 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.656 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.27 17.66 2.0 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.096 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.482 HG23 ' CB ' ' A' ' 22' ' ' TYR . 6.2 mt -85.09 138.18 37.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 68.4 Cg_exo -38.63 138.94 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.705 2.27 . . . . 0.0 112.555 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.89 22.45 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.445 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -55.58 -36.32 66.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.964 0.412 . . . . 0.0 110.51 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.17 28.77 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.6 ttp180 -48.95 -58.2 5.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -46.37 79.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -50.99 -50.66 57.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.71 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.568 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.8 mt -57.06 -52.16 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.488 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 7.5 t90 -52.25 -47.74 65.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 60' ' ' GLN . 7.1 mmt180 -49.94 -42.54 48.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.615 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -77.53 -21.9 71.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.798 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.016 HD11 HD12 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -85.24 -24.64 27.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.985 0.421 . . . . 0.0 111.023 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 14.1 pt20 -73.57 -11.61 60.49 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 8' ' ' VAL . 2.1 tm? . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.745 0.307 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 7' ' ' LEU . 26.2 m -59.81 -43.34 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 8' ' ' VAL . 1.7 t -57.68 -34.75 69.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -43.95 15.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.666 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.0 tm? -47.49 -55.06 9.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.032 0.444 . . . . 0.0 111.067 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.86 HG23 ' HA ' ' A' ' 17' ' ' PRO . 86.5 m -72.77 -49.34 31.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.61 -29.61 18.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.34 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 55' ' ' ILE . 1.8 tp -63.93 -14.72 55.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.707 0.289 . . . . 0.0 111.281 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.78 12.78 8.33 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.291 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.78 ' SG ' HD11 ' A' ' 55' ' ' ILE . 3.4 m -114.18 64.84 1.36 Allowed Pre-proline 0 C--N 1.333 -0.133 0 CA-C-O 120.629 0.252 . . . . 0.0 111.052 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.86 ' HA ' HG23 ' A' ' 12' ' ' THR . 59.1 Cg_endo -71.85 -19.72 26.84 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.473 2.115 . . . . 0.0 112.361 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.95 22.3 5.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.96 -29.37 7.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.726 ' O ' HG23 ' A' ' 24' ' ' THR . 1.1 tt -49.32 -36.69 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.032 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -44.13 80.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.61 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -72.44 -36.64 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.529 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.643 ' CZ ' HD13 ' A' ' 55' ' ' ILE . 33.0 m-85 -69.63 -49.93 49.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.963 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 20' ' ' ILE . 77.0 p -49.78 -38.88 36.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.139 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -22.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.174 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HG3' ' HG ' ' A' ' 45' ' ' LEU . 7.9 mm-40 -99.55 -23.46 15.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.27 44.94 0.54 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.15 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.029 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.61 38.91 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.928 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -99.27 -26.93 14.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.159 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.47 107.09 16.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.149 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.518 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.65 -29.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.948 0.404 . . . . 0.0 111.175 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 83.1 m-85 -55.02 -22.36 15.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.621 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.01 -25.79 29.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.029 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -107.98 18.75 20.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.287 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.434 ' HG3' ' HA ' ' A' ' 32' ' ' TYR . 1.4 mm-40 -59.86 -44.39 94.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.088 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -103.85 -16.41 15.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.202 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.612 HD11 ' HB3' ' A' ' 41' ' ' ASP . 12.4 tp -44.39 153.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.982 0.42 . . . . 0.0 111.595 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.617 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -140.12 178.64 7.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.772 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.808 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.2 tp -61.85 -32.59 54.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.414 0.626 . . . . 0.0 109.409 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.8 -46.83 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.698 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.612 ' HB3' HD11 ' A' ' 37' ' ' LEU . 4.5 m-20 -83.41 -31.55 26.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -50.04 -49.65 50.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.336 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 52' ' ' ARG . . . -72.13 -18.11 77.72 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.403 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -61.98 -37.93 86.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.458 . . . . 0.0 110.388 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 47' ' ' ILE . 8.6 mp -50.25 -27.38 5.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 84.04 19.65 0.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.762 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.621 HD11 HD23 ' A' ' 45' ' ' LEU . 4.5 mt -85.12 137.27 37.42 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HD2' HG22 ' A' ' 47' ' ' ILE . 92.0 Cg_exo -41.75 139.31 2.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.573 2.182 . . . . 0.0 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -74.81 61.15 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -85.14 -52.33 6.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.11 36.01 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.685 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HB3' HD11 ' A' ' 39' ' ' ILE . 2.1 ttp180 -59.84 -53.14 61.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.808 ' HA ' HD13 ' A' ' 39' ' ' ILE . 1.4 ptm -60.17 -41.19 92.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -59.44 -47.14 86.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 110.582 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.78 HD11 ' SG ' ' A' ' 16' ' ' CYS . 21.3 mt -58.51 -47.8 87.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.628 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.42 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.3 t90 -55.57 -59.67 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.319 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 0.3 OUTLIER -47.22 -39.72 14.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.179 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.42 -26.87 64.69 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.999 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.809 HD11 HD12 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -78.29 -35.02 48.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 110.781 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 17.6 pt20 -70.22 -27.95 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.212 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.494 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.6 tm? . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.76 0.314 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.671 ' N ' HD13 ' A' ' 7' ' ' LEU . 21.4 t -59.14 -43.91 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.983 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.69 -36.37 62.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -81.93 -47.03 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 20' ' ' ILE . 1.9 tm? -49.59 -33.95 16.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.616 HG23 ' HA ' ' A' ' 17' ' ' PRO . 2.2 m -83.2 -61.83 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.923 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.81 -28.72 3.93 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.874 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.707 HD11 ' HA ' ' A' ' 55' ' ' ILE . 4.1 tt -51.84 -24.49 6.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.709 177.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.93 14.2 9.52 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.738 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 87.0 m -121.16 64.31 13.25 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.689 0.28 . . . . 0.0 111.118 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.616 ' HA ' HG23 ' A' ' 12' ' ' THR . 60.5 Cg_endo -72.51 -11.26 26.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.516 2.144 . . . . 0.0 112.686 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -131.41 19.73 4.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.221 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.42 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -111.85 -27.04 8.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.89 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.7 tt -49.6 -34.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.51 -45.62 77.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.755 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -74.63 -36.3 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.418 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -66.88 -44.71 80.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 20' ' ' ILE . 56.3 p -58.53 -34.31 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.8 m -51.47 -24.17 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.162 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -100.7 -37.46 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.865 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.4 45.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.333 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.06 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.61 40.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 7' ' ' LEU . 5.8 pt20 -99.07 -28.96 13.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.981 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.05 110.67 21.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.083 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.565 ' HB ' HD23 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -45.7 -28.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.937 0.399 . . . . 0.0 111.2 -178.634 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -57.93 -22.32 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.57 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -20.67 36.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.06 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.57 21.03 14.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.28 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.55 -18.94 64.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.385 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -134.28 18.17 3.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.681 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -81.54 145.82 30.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.66 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.7 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -131.7 173.69 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.485 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 8.5 tp -57.94 -35.92 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.443 0.64 . . . . 0.0 109.293 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.14 -44.8 68.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.337 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 26.7 m-20 -84.79 -34.33 22.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.729 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.681 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -50.88 -58.66 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.57 179.55 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.36 -20.0 35.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.469 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -64.06 -41.04 97.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.682 HD23 HD11 ' A' ' 47' ' ' ILE . 8.8 mp -48.16 -28.0 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.219 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 82.13 19.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.974 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HD23 ' A' ' 45' ' ' LEU . 7.3 mt -76.45 137.89 67.52 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.568 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 1.9 Cg_endo -40.66 131.79 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.964 2.442 . . . . 0.0 112.206 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.96 63.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.275 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' A' ' 48' ' ' PRO . 3.4 mm-40 -85.19 -60.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -140.32 36.29 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.751 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.916 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -49.33 -45.99 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.271 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 57' ' ' ARG . 2.3 ptp -62.14 -47.56 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 m -54.2 -40.37 67.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 52' ' ' ARG . 7.8 mt -63.29 -58.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.135 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.7 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.5 t90 -49.92 -45.6 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.396 . . . . 0.0 110.21 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.4 ' CG ' ' O ' ' A' ' 53' ' ' MET . 3.2 mmt180 -55.5 -51.56 66.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.625 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.58 -41.63 89.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.855 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 34' ' ' LEU . 1.1 tp -62.13 -32.83 73.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -70.3 -26.84 63.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.303 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.4 tm? . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.754 0.311 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.775 ' N ' HD13 ' A' ' 7' ' ' LEU . 48.1 t -60.8 -43.9 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.223 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -23.56 63.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.166 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.22 -48.73 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.137 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.544 HD12 ' HB ' ' A' ' 20' ' ' ILE . 3.1 tm? -48.59 -52.16 24.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.986 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.846 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.3 m -73.6 -48.68 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.707 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.82 -30.33 28.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.37 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.6 tp -60.13 -17.69 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 111.197 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 121.01 12.6 5.8 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.551 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.85 65.72 5.25 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.085 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.846 ' HA ' HG23 ' A' ' 12' ' ' THR . 77.1 Cg_endo -77.4 -5.09 15.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -136.49 18.81 3.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.626 0.25 . . . . 0.0 111.457 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -116.63 -22.26 8.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.296 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.544 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.5 tt -51.53 -34.94 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.171 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -54.94 -46.06 74.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.703 ' HB2' HD12 ' A' ' 47' ' ' ILE . 6.1 m-85 -76.04 -31.74 58.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.703 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.503 ' CE1' HD22 ' A' ' 45' ' ' LEU . 14.6 m-85 -70.3 -43.88 69.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.236 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 20' ' ' ILE . 41.1 p -62.67 -28.81 70.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.779 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 t -51.22 -25.02 4.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -100.17 -52.25 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.74 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.7 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.001 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.59 37.34 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.422 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -99.69 -29.05 12.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.813 178.078 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.57 109.08 19.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.521 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -44.02 -29.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.955 0.407 . . . . 0.0 111.543 -178.064 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -56.36 -22.48 31.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.57 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -84.03 -20.55 32.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.001 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.33 14.83 21.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.49 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -20.53 65.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -133.41 24.36 4.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.31 . . . . 0.0 111.104 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.651 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.37 121.25 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.828 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.517 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -99.44 175.72 5.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.111 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.854 HD13 ' HA ' ' A' ' 53' ' ' MET . 5.1 tp -64.85 -32.1 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.613 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.12 -45.03 83.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.2 m-20 -83.29 -32.18 26.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.795 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.651 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -52.86 -64.38 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.359 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.429 ' HA3' ' NE ' ' A' ' 52' ' ' ARG . . . -58.3 -23.25 52.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.992 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -54.39 -37.32 64.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 110.519 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.503 HD22 ' CE1' ' A' ' 23' ' ' PHE . 8.2 mp -59.52 -15.6 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.777 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 1.6 mtmt 78.71 17.9 0.99 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 22' ' ' TYR . 6.1 mm -80.52 138.76 51.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.269 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 4.7 Cg_exo -36.34 140.32 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.224 2.616 . . . . 0.0 112.519 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -91.13 23.46 3.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.593 -178.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -67.96 -31.74 71.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.65 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.32 23.69 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.82 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -50.69 -58.38 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.99 0.424 . . . . 0.0 110.782 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.854 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -53.95 -52.05 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 m -48.17 -43.99 32.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 52' ' ' ARG . 10.3 mt -58.8 -59.09 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.516 ' CZ2' HG23 ' A' ' 38' ' ' THR . 0.1 OUTLIER -53.1 -55.31 24.93 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.856 0.36 . . . . 0.0 110.403 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 1.2 mtt180 -44.8 -40.07 5.82 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.837 0.351 . . . . 0.0 111.575 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.11 -25.14 67.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.153 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 34' ' ' LEU . 1.1 mp -82.16 -35.19 28.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.763 0.316 . . . . 0.0 111.083 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.493 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.3 pt20 -71.51 -27.63 63.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.281 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.629 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.6 tm? . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.728 0.299 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.544 ' N ' HD13 ' A' ' 7' ' ' LEU . 40.4 t -56.88 -57.08 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.319 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 p -55.79 -21.78 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.545 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -88.04 -53.86 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.775 0.321 . . . . 0.0 111.178 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.794 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.2 tm? -48.25 -52.0 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.109 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.836 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.0 m -71.65 -46.61 58.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.697 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.14 -33.37 30.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.358 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.6 tp -64.53 -13.42 52.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.677 0.275 . . . . 0.0 111.499 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.86 13.81 7.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.5 m -112.24 60.91 0.58 Allowed Pre-proline 0 CA--C 1.528 0.133 0 CA-C-O 120.665 0.269 . . . . 0.0 111.287 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.836 ' HA ' HG23 ' A' ' 12' ' ' THR . 56.1 Cg_endo -69.81 -30.44 22.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -124.21 19.77 9.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.798 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.9 m -109.45 -27.31 9.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.666 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' A' ' 11' ' ' LEU . 13.2 tt -52.08 -31.71 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.702 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 8.9 pt-20 -59.76 -44.55 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.507 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 59.9 m-85 -72.0 -30.89 65.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.232 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -74.13 -51.82 14.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.758 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 20' ' ' ILE . 60.4 p -49.4 -34.07 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -51.36 -24.23 4.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -99.86 -43.3 6.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 45.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.151 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.908 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.97 39.98 1.24 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.87 0.367 . . . . 0.0 111.007 -179.178 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.51 -25.07 14.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.134 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 t -111.33 108.28 17.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.527 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -48.0 -26.72 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -59.5 -21.76 60.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.563 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.68 -19.03 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.908 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.48 11.8 21.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.622 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -61.77 -21.51 64.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.301 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -132.43 21.24 4.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.534 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -77.88 146.0 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.669 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.608 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -127.99 172.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 0.0 111.589 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' A' ' 53' ' ' MET . 7.6 tp -58.94 -33.36 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.515 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.99 -49.29 76.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.625 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' HB3' HD21 ' A' ' 37' ' ' LEU . 1.7 m-20 -82.8 -15.1 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.789 HD23 HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -69.51 -56.56 7.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.882 0.372 . . . . 0.0 110.246 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.77 63.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.049 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.4 53.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.043 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 47' ' ' ILE . 4.6 mp -72.25 -3.9 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.95 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 15.4 ptpt 49.93 33.37 6.54 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 121.014 0.435 . . . . 0.0 111.427 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.546 HD11 HD23 ' A' ' 45' ' ' LEU . 36.6 mt -83.52 138.72 41.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.986 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 46.4 Cg_exo -35.39 119.37 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.008 2.472 . . . . 0.0 112.949 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.91 68.6 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.355 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -85.21 -65.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 0.0 110.665 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.68 36.64 2.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.4 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -48.63 -43.31 36.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.232 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.594 ' HA ' HD13 ' A' ' 39' ' ' ILE . 12.4 mtt -59.44 -50.54 73.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.649 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -50.77 -47.79 59.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.658 ' HA ' HD23 ' A' ' 14' ' ' LEU . 11.1 mm -55.92 -55.85 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.608 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.0 t90 -50.36 -62.94 1.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.29 -30.44 50.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.149 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -78.8 -27.36 56.88 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.839 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -75.99 -38.89 56.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 110.691 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.48 -26.01 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.327 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.673 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.3 tm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.66 ' N ' HD13 ' A' ' 7' ' ' LEU . 29.2 m -65.28 -31.4 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -72.5 -25.16 61.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -54.52 4.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.684 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.494 HD13 HD12 ' A' ' 28' ' ' LEU . 4.9 tp -51.03 -54.23 26.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.18 0.514 . . . . 0.0 110.372 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.929 HG23 ' HA ' ' A' ' 17' ' ' PRO . 25.6 m -58.51 -50.87 72.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.497 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.36 -30.22 48.4 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.973 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.693 HD11 ' HA3' ' A' ' 58' ' ' GLY . 3.8 tp -59.5 -18.17 37.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 111.046 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.3 17.15 6.3 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.158 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.439 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 4.3 m -118.93 61.41 5.15 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.681 0.277 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.929 ' HA ' HG23 ' A' ' 12' ' ' THR . 49.2 Cg_endo -68.78 -19.8 40.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.455 2.104 . . . . 0.0 112.16 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -129.56 23.96 5.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -114.67 -24.61 8.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.823 ' O ' HG23 ' A' ' 24' ' ' THR . 13.1 tt -51.43 -46.91 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.3 mm-40 -51.42 -45.18 62.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.657 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.7 m-30 -64.84 -32.02 73.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.574 ' CE1' HD22 ' A' ' 45' ' ' LEU . 2.5 m-85 -79.28 -28.04 42.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.55 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 20' ' ' ILE . 45.2 p -70.73 -24.52 62.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.145 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.6 p -50.62 -24.81 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.24 -51.56 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.08 55.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.113 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.08 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.58 38.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.095 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -25.4 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.283 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.15 104.76 13.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.887 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.55 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.99 -27.52 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.452 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -21.25 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.71 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.6 -23.71 31.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.958 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.08 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -106.27 16.98 24.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -73.23 -20.93 60.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.268 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -128.87 20.37 5.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.324 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.621 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.12 120.6 26.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.053 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.492 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -99.79 176.75 5.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.267 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' A' ' 53' ' ' MET . 7.4 tp -65.16 -31.52 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -56.03 -42.84 77.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.266 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.507 ' HB3' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -85.09 -32.44 22.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.801 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.621 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -54.87 -52.49 62.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.456 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -71.12 -16.28 74.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.411 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -63.02 -44.81 94.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.946 0.403 . . . . 0.0 110.488 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.574 HD22 ' CE1' ' A' ' 23' ' ' PHE . 10.0 mp -44.09 -28.38 0.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.749 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.7 tttt 88.22 17.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.434 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.56 HD11 HD23 ' A' ' 45' ' ' LEU . 4.0 mt -78.24 138.15 60.28 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.9 Cg_exo -40.42 144.65 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.534 2.156 . . . . 0.0 112.419 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.53 54.08 2.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.416 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 78.7 mt-30 -84.93 -44.62 12.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.791 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 50' ' ' GLN . 4.8 m-85 -140.23 29.08 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.669 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -46.54 -61.8 1.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.106 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.733 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -55.66 -47.03 77.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.004 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 52.4 m -55.23 -38.86 69.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 52' ' ' ARG . 10.8 mt -63.96 -56.24 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.838 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.509 ' CH2' ' HB3' ' A' ' 60' ' ' GLN . 0.3 OUTLIER -56.69 -61.28 2.54 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.477 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -47.04 -32.87 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.663 0.268 . . . . 0.0 111.348 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.693 ' HA3' HD11 ' A' ' 14' ' ' LEU . . . -77.62 -27.8 58.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.681 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -79.01 -44.45 22.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.388 . . . . 0.0 110.725 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.509 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.5 pt20 -59.9 -27.02 66.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.155 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.315 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.731 ' CD2' HD11 ' A' ' 34' ' ' LEU . 2.8 tm? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.697 0.284 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.922 HG12 HD11 ' A' ' 20' ' ' ILE . 3.5 m -50.07 -42.51 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.4 -27.92 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.037 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.67 -56.25 4.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.533 HD23 ' HB ' ' A' ' 20' ' ' ILE . 7.1 tp -47.41 -55.99 7.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 0.0 110.698 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.824 HG23 ' HA ' ' A' ' 17' ' ' PRO . 63.4 m -53.15 -52.05 60.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.35 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.57 -31.05 52.04 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.028 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.8 tp -56.95 -19.88 20.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 19.02 5.29 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.332 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.5 p -134.51 66.08 69.08 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.676 0.274 . . . . 0.0 111.246 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.824 ' HA ' HG23 ' A' ' 12' ' ' THR . 11.8 Cg_exo -71.54 -9.95 25.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.754 2.303 . . . . 0.0 112.777 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -126.26 16.37 7.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.095 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -113.46 -22.91 10.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.179 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HG12 ' A' ' 8' ' ' VAL . 16.0 tt -54.18 -35.31 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.988 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.792 ' HA ' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -66.07 -41.67 90.42 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.193 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.462 ' CB ' HD13 ' A' ' 47' ' ' ILE . 62.5 m-85 -63.74 -26.97 68.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.612 ' CE1' HD22 ' A' ' 45' ' ' LEU . 2.3 m-85 -91.31 -35.95 14.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.469 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.792 HG22 ' HA ' ' A' ' 21' ' ' GLU . 4.4 t -70.72 -16.17 62.76 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.422 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -61.5 -23.0 65.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.742 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.12 -57.37 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.12 39.42 0.03 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.057 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.68 37.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.377 -179.333 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -99.86 -29.85 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.3 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -104.12 107.92 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.534 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -43.63 -30.06 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 -177.573 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.4 -21.49 25.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.674 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -85.4 -26.86 26.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -97.84 14.94 25.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -63.08 -37.78 88.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.437 0.637 . . . . 0.0 111.424 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -110.03 -14.78 14.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.268 -176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.726 HD12 HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -44.11 145.53 0.75 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -133.67 173.81 11.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.175 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.745 HD13 ' HA ' ' A' ' 53' ' ' MET . 8.8 tp -63.09 -34.6 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.638 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 2.9 pt-20 -61.98 -38.51 88.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.47 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 58.1 m-20 -84.99 -27.65 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.383 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.726 HD23 HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -56.42 -59.73 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.29 -19.81 60.1 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.118 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -56.64 -36.03 69.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.057 0.456 . . . . 0.0 110.284 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 23' ' ' PHE . 6.8 mp -60.92 -15.53 32.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.607 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 73.77 17.47 3.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 111.248 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.482 HD11 HD23 ' A' ' 45' ' ' LEU . 12.0 mt -79.46 137.87 55.43 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.3 Cg_exo -44.44 136.04 8.83 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.524 2.149 . . . . 0.0 112.299 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -68.41 62.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.234 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -85.44 -58.05 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.759 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.36 36.98 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.597 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.7 -64.74 0.77 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.745 ' HA ' HD13 ' A' ' 39' ' ' ILE . 3.3 ppp? -52.14 -42.91 63.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 52.9 m -53.13 -48.47 67.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.604 ' HA ' HD23 ' A' ' 14' ' ' LEU . 38.6 mt -62.94 -44.03 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.4 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 9.5 t90 -56.72 -55.23 36.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.438 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.3 ptm180 -59.46 -30.67 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.989 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -79.2 -26.33 57.87 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.822 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -81.08 -41.42 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.807 0.337 . . . . 0.0 110.485 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.77 -27.67 69.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.364 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.527 179.015 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.735 0.302 . . . . 0.0 111.065 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 m -43.0 -36.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.794 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -58.06 -51.52 69.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.104 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.54 -38.54 48.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.312 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.785 HD21 HD12 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -46.82 -57.25 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.05 0.452 . . . . 0.0 111.119 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.883 HG23 ' HA ' ' A' ' 17' ' ' PRO . 22.0 m -71.55 -50.52 30.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.804 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.2 -30.07 16.82 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.266 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.7 tp -58.15 -18.78 27.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.132 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 15.63 6.53 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.357 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 m -122.92 72.26 43.68 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.683 0.278 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.883 ' HA ' HG23 ' A' ' 12' ' ' THR . 83.3 Cg_endo -83.33 6.49 5.77 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.67 2.247 . . . . 0.0 113.064 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -145.3 17.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.604 0.24 . . . . 0.0 111.534 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -118.23 -21.05 8.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.396 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 24' ' ' THR . 6.6 tt -50.26 -38.55 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.989 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.35 -46.25 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.54 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.345 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.682 ' HZ ' HD13 ' A' ' 55' ' ' ILE . 29.3 m-85 -63.12 -54.71 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 20' ' ' ILE . 80.7 p -51.72 -30.49 22.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.963 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 p -50.66 -25.79 4.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -101.24 -45.88 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.04 45.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.183 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.46 44.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 110.927 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.643 ' C ' HD12 ' A' ' 7' ' ' LEU . 2.8 pt20 -107.98 -19.4 13.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.453 177.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.562 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -121.57 103.16 8.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.606 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.524 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -40.76 -31.64 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.137 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -56.09 -21.3 21.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.21 -24.66 27.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.978 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -103.21 16.52 26.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.105 0.479 . . . . 0.0 111.003 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -59.68 -39.82 85.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -107.34 -20.06 13.39 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.647 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -46.04 150.63 0.56 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.356 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.774 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -140.32 177.35 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.213 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.49 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 9.5 tp -59.1 -34.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.37 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -59.15 -39.2 81.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.227 178.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -85.53 -33.57 21.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.542 178.765 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.595 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -53.52 -50.19 65.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.479 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -22.16 68.95 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.029 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -62.86 -27.28 69.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.0 mp -62.53 -14.77 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.494 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 5.0 mttm 72.53 16.72 4.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.804 0.335 . . . . 0.0 111.366 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 9.0 mt -85.39 138.7 36.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.4 Cg_exo -44.95 130.74 10.42 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.232 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -68.01 64.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -85.04 -52.27 6.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.655 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -140.15 25.61 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.798 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -49.04 -48.2 44.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.194 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.483 ' HA ' HD13 ' A' ' 39' ' ' ILE . 35.8 mtm -57.36 -56.57 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -49.79 -44.26 48.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 52' ' ' ARG . 14.3 mt -57.11 -55.36 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.774 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.2 t90 -52.45 -50.4 62.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -52.79 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.92 -39.99 80.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 34' ' ' LEU . 2.6 mp -66.19 -29.17 69.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.486 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -74.43 -28.03 60.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.391 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.77 179.385 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.784 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.5 tm? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.685 0.279 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.784 ' N ' HD13 ' A' ' 7' ' ' LEU . 2.9 m -53.28 -34.35 22.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.381 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 t -63.55 -33.15 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.381 . . . . 0.0 111.27 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.42 -48.47 7.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.645 HD11 HD12 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -47.58 -53.14 15.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.783 HG23 ' HA ' ' A' ' 17' ' ' PRO . 50.9 m -74.45 -48.0 30.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.731 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.18 -29.86 30.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.055 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.715 HD21 ' HA3' ' A' ' 58' ' ' GLY . 4.0 tp -59.31 -17.94 33.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.669 0.271 . . . . 0.0 111.274 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.26 19.36 5.9 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.181 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 85.0 m -126.87 73.74 76.0 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.709 0.29 . . . . 0.0 110.992 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.783 ' HA ' HG23 ' A' ' 12' ' ' THR . 7.7 Cg_endo -84.74 -0.26 9.23 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.068 2.512 . . . . 0.0 112.918 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.8 13.58 3.4 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 1.3 m -117.53 -20.19 9.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.601 0.239 . . . . 0.0 111.419 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.525 ' CG1' HD22 ' A' ' 11' ' ' LEU . 13.9 tt -51.67 -28.96 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.926 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.506 ' HA ' HG22 ' A' ' 24' ' ' THR . 4.8 mm-40 -68.64 -43.38 76.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.256 0.551 . . . . 0.0 110.388 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.5 m-30 -68.33 -24.76 64.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.249 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.8 -32.38 15.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 21' ' ' GLU . 2.6 t -69.32 -10.37 57.54 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.993 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -19.35 62.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.714 ' CD ' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.3 -20.74 11.73 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.362 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 33' ' ' HIS . . . 131.82 51.39 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.435 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.067 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -109.45 37.68 2.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.889 0.376 . . . . 0.0 111.129 179.005 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -99.36 -30.43 12.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.92 109.48 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.706 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.547 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -44.38 -27.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 111.657 -177.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -20.63 59.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.762 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.468 ' CG ' ' O ' ' A' ' 27' ' ' GLY . 46.5 t-80 -85.06 -19.11 32.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.997 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.067 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.16 14.0 21.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.528 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.21 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.053 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -125.06 16.95 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.33 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.563 HD13 HD21 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -85.11 140.44 30.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.386 . . . . 0.0 110.684 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.637 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -128.81 -179.84 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.047 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.801 HD13 ' HA ' ' A' ' 53' ' ' MET . 3.8 tp -58.25 -34.26 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -52.19 -43.26 64.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.274 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.444 ' HB3' ' CD2' ' A' ' 37' ' ' LEU . 4.3 m-20 -83.99 -30.07 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.588 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -67.41 -36.98 82.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.794 178.313 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.459 ' HA2' ' CZ ' ' A' ' 52' ' ' ARG . . . -79.88 2.23 75.45 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.75 -41.13 16.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.714 HD11 ' CD ' ' A' ' 26' ' ' GLN . 3.7 mt -62.69 -12.31 22.82 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.069 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 71.31 15.23 6.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 111.264 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 48' ' ' PRO . 25.1 mm -61.17 138.58 94.44 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.474 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 47' ' ' ILE . 4.3 Cg_exo -37.02 153.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.581 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 11.1 tt0 -92.69 23.12 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.429 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -85.07 -33.22 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.54 ' O ' HD12 ' A' ' 55' ' ' ILE . 7.5 m-85 -135.16 12.32 3.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.459 ' CZ ' ' HA2' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -54.09 -68.29 0.19 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 179.475 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.801 ' HA ' HD13 ' A' ' 39' ' ' ILE . 2.9 mtm -53.33 -42.26 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.871 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -51.4 -50.75 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.581 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.664 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.2 mt -56.65 -56.96 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.637 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.2 t90 -49.85 -54.89 16.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 6.6 mmt180 -51.37 -32.32 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.715 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -78.53 -25.25 61.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.797 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.967 HD11 HD12 ' A' ' 34' ' ' LEU . 1.2 tp -80.94 -40.58 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.494 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 4.4 pt20 -63.15 -27.76 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.071 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.11 178.403 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.1 tm? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.789 0.328 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' N ' HD13 ' A' ' 7' ' ' LEU . 35.3 m -66.12 -37.31 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.168 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 p -63.19 -26.48 68.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -95.7 -46.78 6.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.17 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tm? -49.58 -52.7 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.862 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 17' ' ' PRO . 91.5 m -77.6 -46.74 21.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.472 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.11 -26.98 6.64 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.362 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.809 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -54.52 -22.5 13.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.774 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.64 16.91 5.76 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.353 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.425 ' HB3' ' CG ' ' A' ' 51' ' ' TYR . 4.6 p -130.12 80.54 70.7 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.772 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.747 ' HA ' HG23 ' A' ' 12' ' ' THR . 71.6 Cg_endo -78.61 6.1 5.09 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.714 2.276 . . . . 0.0 112.996 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -135.56 22.47 3.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.674 0.273 . . . . 0.0 111.143 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 4.8 t -114.27 -28.62 7.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.967 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 24' ' ' THR . 1.6 tt -50.87 -45.59 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.916 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.511 ' N ' HG23 ' A' ' 20' ' ' ILE . 2.1 pt-20 -49.66 -44.45 47.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.427 ' HB2' HD13 ' A' ' 47' ' ' ILE . 70.5 m-85 -69.84 -35.46 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.692 ' CE1' HD12 ' A' ' 47' ' ' ILE . 3.2 m-85 -70.68 -49.6 45.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.73 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 20' ' ' ILE . 71.7 p -55.28 -24.34 27.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -49.15 -30.37 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.244 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -99.99 -53.56 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.1 48.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.99 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.105 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -99.51 40.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.047 -179.083 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -99.1 -27.45 13.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.867 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.1 104.39 12.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.527 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -43.81 -29.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.99 0.424 . . . . 0.0 111.278 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -55.23 -23.63 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.668 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.45 -21.16 35.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.955 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.105 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.06 22.04 14.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -32.41 71.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.55 -18.36 11.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.716 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.466 HD23 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -44.45 140.86 2.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.344 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.645 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -128.69 179.18 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.118 -179.424 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.848 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.6 tp -57.3 -33.65 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.482 0.658 . . . . 0.0 109.276 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.75 -47.49 79.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.539 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.1 m-20 -80.18 -27.52 38.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.673 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -55.18 -52.48 63.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.177 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -15.18 62.89 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.324 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -66.06 -40.31 90.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.561 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 47' ' ' ILE . 8.9 mp -47.3 -27.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.347 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 5.9 ttmm 86.66 16.09 0.1 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.633 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.692 HD12 ' CE1' ' A' ' 23' ' ' PHE . 2.8 mt -86.21 137.69 34.83 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.816 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 3.0 Cg_endo -45.26 158.87 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.675 2.25 . . . . 0.0 112.023 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.45 57.8 4.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.177 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.47 -58.12 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.58 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.425 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 1.5 m-85 -137.15 33.48 2.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.616 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.1 ttp180 -56.52 -66.66 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.01 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.848 ' HA ' HD13 ' A' ' 39' ' ' ILE . 59.4 mtt -54.84 -34.81 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.68 ' CG2' HD12 ' A' ' 14' ' ' LEU . 55.2 m -58.14 -49.98 75.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.729 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.618 HD13 ' CE2' ' A' ' 23' ' ' PHE . 60.0 mt -66.13 -35.72 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.602 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.645 ' NE1' HG22 ' A' ' 38' ' ' THR . 10.6 t90 -59.48 -55.82 29.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.941 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.433 ' NH1' ' HB3' ' A' ' 53' ' ' MET . 0.0 OUTLIER -53.34 -39.48 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.621 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.809 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -67.96 -40.98 88.75 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.91 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 34' ' ' LEU . 1.1 tp -64.26 -38.67 91.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.332 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -63.82 -31.15 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.199 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.216 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.688 0.28 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 31.5 m170 50.41 94.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 2' ' ' HIS . . . 67.32 148.36 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.114 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -140.4 75.71 26.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 7' ' ' LEU . 35.5 Cg_exo -59.83 -37.45 86.31 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.571 2.181 . . . . 0.0 112.286 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -64.91 73.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.056 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.616 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.9 tm? 177.3 -50.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 7' ' ' LEU . 46.4 t -67.85 -50.87 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.166 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -25.01 65.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.116 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -50.9 6.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.029 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.795 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.2 tm? -48.9 -53.03 21.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.015 0.436 . . . . 0.0 110.859 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.838 HG23 ' HA ' ' A' ' 17' ' ' PRO . 55.8 m -74.69 -46.88 34.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.46 -29.82 17.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.286 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.8 tp -62.38 -15.05 46.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.642 0.258 . . . . 0.0 111.277 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.59 12.78 8.48 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.419 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 55' ' ' ILE . 34.1 m -116.12 67.21 3.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.684 0.278 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.838 ' HA ' HG23 ' A' ' 12' ' ' THR . 59.5 Cg_endo -72.55 -17.5 26.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.526 2.151 . . . . 0.0 112.521 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -130.04 21.36 5.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.028 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -28.07 8.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.795 ' HB ' HD12 ' A' ' 11' ' ' LEU . 2.4 tt -52.2 -34.76 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.817 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.96 -44.05 86.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.667 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -71.98 -33.57 68.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.482 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.534 ' CE1' HD22 ' A' ' 45' ' ' LEU . 10.2 m-85 -73.76 -45.19 53.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.58 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' ILE . 65.9 p -55.73 -32.08 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.79 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -49.52 -25.92 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.996 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -99.9 -48.07 4.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.44 47.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.469 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.137 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.24 39.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.126 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -30.24 12.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.039 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.52 110.47 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.075 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.537 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -46.44 -27.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.004 0.431 . . . . 0.0 111.279 -178.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -21.82 49.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.63 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -21.52 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.214 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.137 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.3 19.25 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -28.61 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.329 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -114.75 -20.44 10.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.513 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -44.94 148.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.633 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.668 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -140.39 178.63 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.121 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.6 tp -59.65 -33.33 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.48 0.657 . . . . 0.0 109.23 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.18 -50.94 71.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -78.04 -24.27 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.9 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.509 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.63 -6.9 60.09 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.734 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -77.38 -43.63 32.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.964 0.412 . . . . 0.0 110.432 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.681 HD23 HD11 ' A' ' 47' ' ' ILE . 9.3 mp -47.35 -29.11 2.35 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.174 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER 82.44 21.37 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.681 HD11 HD23 ' A' ' 45' ' ' LEU . 4.5 mt -81.35 138.0 48.52 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.305 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.0 Cg_exo -39.66 136.76 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.527 2.151 . . . . 0.0 112.294 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -78.73 55.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.399 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.53 -43.16 13.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -140.36 30.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -50.71 -59.31 4.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.572 ' HA ' HD13 ' A' ' 39' ' ' ILE . 5.9 ptm -59.37 -44.49 92.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.408 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 54.9 m -51.7 -50.19 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.456 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.69 ' HA ' HD23 ' A' ' 14' ' ' LEU . 17.6 mt -59.74 -46.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.668 ' NE1' HG22 ' A' ' 38' ' ' THR . 13.2 t90 -57.64 -61.65 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.56 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.8 ptm180 -51.78 -31.16 25.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.684 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -74.7 -36.58 47.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.714 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 34' ' ' LEU . 2.6 tp -67.46 -42.08 83.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.253 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -61.02 -27.69 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.279 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -57.56 -40.24 78.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.292 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.22 -52.07 67.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.48 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -37.61 81.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.738 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -60.98 -80.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.734 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.86 140.06 8.27 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.674 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -120.39 102.69 8.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.742 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.42 120.46 6.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.938 -179.871 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -90.54 74.63 6.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.01 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.36 171.79 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -135.67 68.63 66.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.776 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.31 -28.81 27.92 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.542 2.161 . . . . 0.0 112.295 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.19 61.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.643 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -179.17 -50.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.72 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.585 ' N ' HD13 ' A' ' 7' ' ' LEU . 7.8 p -66.1 -33.84 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.02 64.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -85.7 -47.5 9.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -52.93 -48.45 67.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.363 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.7 m -81.06 -40.83 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.097 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.25 -30.83 11.56 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.195 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -57.1 -20.46 25.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 178.53 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.94 19.06 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.185 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 78.85 35.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.638 0.256 . . . . 0.0 110.974 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 12' ' ' THR . 87.7 Cg_endo -84.74 13.85 2.64 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.656 2.237 . . . . 0.0 112.93 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 18' ' ' ASN . 1.6 t30 -143.0 25.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 111.022 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.18 -34.34 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.294 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.683 ' O ' HG22 ' A' ' 24' ' ' THR . 0.5 OUTLIER -46.95 -28.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -59.8 -46.6 88.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.095 0.474 . . . . 0.0 110.625 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.43 ' HB2' HD13 ' A' ' 47' ' ' ILE . 38.7 m-85 -78.72 -28.65 45.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -77.46 -43.85 30.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.841 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 20' ' ' ILE . 14.8 t -67.49 -28.74 68.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.754 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m -54.12 -22.42 11.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.968 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.406 ' HG3' ' HG ' ' A' ' 45' ' ' LEU . 1.1 mm-40 -99.78 -56.72 2.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.33 43.51 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.213 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.035 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.2 40.78 1.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.833 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -99.46 -27.53 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.09 109.95 18.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.116 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -46.48 -27.52 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 111.095 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -58.04 -22.22 49.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -84.18 -19.19 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.03 4.45 15.7 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.83 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -53.31 -36.48 61.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.724 0.297 . . . . 0.0 111.186 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -112.81 19.41 17.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' ' 41' ' ' ASP . 12.8 tp -84.79 155.98 21.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.641 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -139.27 177.38 7.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.877 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.5 tp -58.29 -34.16 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.419 0.628 . . . . 0.0 109.42 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.89 -47.33 77.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.715 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.75 ' HB3' HD11 ' A' ' 37' ' ' LEU . 21.0 m-20 -80.93 -31.0 35.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.551 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -51.3 -51.39 54.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.28 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.09 -20.33 77.87 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.324 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -58.04 -44.17 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.14 0.495 . . . . 0.0 110.202 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.639 HD23 HD11 ' A' ' 47' ' ' ILE . 8.1 mp -48.52 -29.46 4.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.318 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttpt 86.63 19.43 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.315 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.639 HD11 HD23 ' A' ' 45' ' ' LEU . 3.8 mt -83.98 138.62 39.96 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.242 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.463 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 61.7 Cg_exo -36.81 151.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.703 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 1.9 pt-20 -91.65 22.47 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 33.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HB3' HD11 ' A' ' 39' ' ' ILE . 1.4 ttp180 -62.16 -51.14 69.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.376 . . . . 0.0 111.009 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.877 ' HA ' HD13 ' A' ' 39' ' ' ILE . 2.3 ttp -66.22 -32.32 73.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.121 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 14' ' ' LEU . 56.2 m -59.63 -50.36 74.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . 45.1 mt -62.7 -41.42 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.805 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.613 ' NE1' HG22 ' A' ' 38' ' ' THR . 9.4 t90 -57.19 -51.52 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.101 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -50.8 -46.85 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.441 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.675 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -65.97 -37.95 93.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.585 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.86 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -61.61 -36.47 80.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 178.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -66.53 -28.6 68.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.203 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -64.24 -32.26 73.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.585 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.574 ' CD1' HD11 ' A' ' 31' ' ' ILE . 8.0 mt -69.2 -46.11 68.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.842 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -53.17 59.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.961 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.12 -41.63 94.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.038 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.05 144.37 16.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.568 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -127.17 170.24 12.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.857 0.361 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -178.85 128.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.965 179.891 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.956 0.408 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -75.98 67.41 2.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -111.06 119.46 39.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.033 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -159.31 64.43 2.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.32 -20.47 61.87 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.595 2.196 . . . . 0.0 112.281 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 m -53.05 -22.93 6.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.5 tm? -66.6 -58.22 5.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.254 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.64 ' N ' HD13 ' A' ' 7' ' ' LEU . 14.5 t -59.01 -45.05 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.433 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -59.38 -30.5 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -88.11 -51.87 5.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.336 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.63 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.5 tm? -45.66 -53.21 9.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 111.151 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.857 HG23 ' HA ' ' A' ' 17' ' ' PRO . 51.3 m -74.36 -47.69 32.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.37 -24.35 22.62 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.478 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.618 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.8 tp -61.38 -18.17 57.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.742 0.306 . . . . 0.0 111.327 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.98 18.68 5.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.299 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -134.33 74.6 66.48 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.858 0.361 . . . . 0.0 110.759 179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.857 ' HA ' HG23 ' A' ' 12' ' ' THR . 71.6 Cg_endo -84.63 10.06 3.88 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.809 2.34 . . . . 0.0 112.821 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.3 16.04 2.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 111.221 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -115.28 -22.24 9.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.63 ' HB ' HD12 ' A' ' 11' ' ' LEU . 3.2 tt -50.18 -36.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 110.974 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.501 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 12.2 pt-20 -57.63 -43.84 85.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.501 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 64.3 m-85 -70.71 -32.63 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 22.3 m-85 -73.91 -52.81 11.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.536 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 20' ' ' ILE . 40.3 p -50.67 -29.18 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 0.5 OUTLIER -50.57 -27.64 7.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.231 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.17 -42.43 6.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.87 45.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.182 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.035 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.5 40.01 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -99.22 -27.58 13.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.992 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.48 107.44 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.025 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.773 HD11 HD11 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -45.75 -27.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.059 0.457 . . . . 0.0 111.348 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -21.01 34.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 -22.35 29.04 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -107.01 18.78 21.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 0.0 111.508 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -19.23 64.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.258 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -125.39 -8.69 6.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -61.14 153.88 24.63 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.828 0.347 . . . . 0.0 110.984 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.709 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -140.15 178.31 7.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.063 0.459 . . . . 0.0 111.478 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.487 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 7.4 tp -60.42 -34.0 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.52 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -39.87 78.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.416 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.65 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.4 m-20 -86.05 -34.69 20.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.642 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -48.38 -59.01 3.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.879 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.48 -19.12 32.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.388 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -67.21 -31.02 71.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.4 mp -62.85 -17.52 61.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.488 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 2.3 mtmt 74.19 17.45 3.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 111.369 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.449 HG13 ' CB ' ' A' ' 45' ' ' LEU . 7.4 mt -80.95 137.82 49.94 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.678 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 59.6 Cg_exo -37.66 112.81 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.83 2.354 . . . . 0.0 112.787 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -68.15 63.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.112 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -85.11 -50.33 7.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.558 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.06 28.64 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.433 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -46.7 -30.54 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.283 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -50.03 48.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.2 m -54.62 -40.0 68.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.369 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.618 ' HA ' HD23 ' A' ' 14' ' ' LEU . 6.8 mm -61.7 -55.65 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.895 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.709 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.5 t90 -52.05 -45.58 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.243 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -51.24 -53.77 32.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.611 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.2 -41.78 54.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 34' ' ' LEU . 3.3 mp -65.37 -28.18 69.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 110.355 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -75.07 -28.49 60.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.478 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -67.09 -29.5 69.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.573 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.773 HD11 HD11 ' A' ' 31' ' ' ILE . 15.3 mt -68.13 -49.26 62.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.7 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.05 -67.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.894 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 49.53 30.09 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.43 0.634 . . . . 0.0 111.292 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.75 64.65 0.85 Allowed Glycine 0 C--N 1.315 -0.624 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.477 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -102.67 149.07 24.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.341 . . . . 0.0 110.94 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 p30 176.3 132.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.798 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.92 -179.893 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.854 0.359 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -52.82 153.68 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.02 162.04 13.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.989 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 64.77 50.39 0.9 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 43.0 Cg_endo -67.3 -31.28 35.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.555 2.17 . . . . 0.0 112.238 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.3 m -84.93 54.33 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.014 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.8 tm? -147.91 -61.77 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.65 ' N ' HD13 ' A' ' 7' ' ' LEU . 42.3 t -53.78 -59.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.056 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.1 -6.75 30.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.769 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.43 -59.61 1.97 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.974 HD13 ' N ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.04 -26.35 68.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.507 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.974 ' N ' HD13 ' A' ' 11' ' ' LEU . 33.1 m -81.11 -50.43 9.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.282 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.23 -25.7 60.47 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.421 ' CD2' ' HA3' ' A' ' 58' ' ' GLY . 5.1 tp -49.63 -24.78 2.38 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.025 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.65 10.45 4.91 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.282 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 73.52 72.82 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 116.958 0.379 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.873 ' HA ' HG23 ' A' ' 12' ' ' THR . 3.1 Cg_exo -77.67 4.03 6.38 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.897 2.398 . . . . 0.0 112.901 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -132.43 19.67 4.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.638 0.256 . . . . 0.0 111.264 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -114.01 -24.23 9.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.046 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.79 HD13 ' HG ' ' A' ' 11' ' ' LEU . 8.5 tp -49.89 -36.65 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.74 -40.67 92.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.548 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.1 m-30 -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.458 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.526 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 6.9 m-85 -80.89 -42.44 21.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 20' ' ' ILE . 11.9 p -52.88 -29.64 29.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -27.12 3.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.259 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -99.94 -58.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.957 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.44 46.86 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.446 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.055 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.4 39.89 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -99.66 -28.95 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.105 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -116.21 115.57 26.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.166 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.535 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -47.85 -26.74 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 111.049 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 19.8 m-85 -59.91 -19.39 51.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -85.33 -30.22 23.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.864 0.364 . . . . 0.0 110.55 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.055 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -98.67 23.52 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.492 . . . . 0.0 110.757 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 32' ' ' TYR . 1.3 mm-40 -68.1 -37.91 81.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.607 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -112.54 -18.17 12.47 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.661 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.797 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -44.78 148.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.303 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.575 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -140.26 173.71 11.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.108 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.496 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 6.9 tp -57.14 -33.77 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.392 0.615 . . . . 0.0 109.384 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.79 -45.35 78.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.332 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -84.62 -31.66 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.797 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -54.49 -45.57 73.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.418 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.445 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -67.66 -10.27 57.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -78.58 -27.76 45.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.116 0.484 . . . . 0.0 110.403 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.526 ' CD2' ' CD2' ' A' ' 23' ' ' PHE . 8.1 mp -62.39 -11.74 17.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.146 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt 77.09 20.18 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 45' ' ' LEU . 7.1 mm -82.35 131.74 54.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.66 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HG2' ' HG3' ' A' ' 50' ' ' GLN . 7.6 Cg_endo -49.7 176.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.667 2.245 . . . . 0.0 112.396 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.59 40.65 1.04 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.96 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.4 ' HG3' ' HG2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -82.5 -51.97 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.811 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -140.24 25.64 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.289 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -51.83 -57.72 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.7 mmm -59.98 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.915 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.0 m -50.36 -48.16 55.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.654 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 52' ' ' ARG . 8.3 mt -55.53 -56.96 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.755 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.575 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.5 t90 -51.47 -52.44 46.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.855 0.359 . . . . 0.0 110.456 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -47.01 -59.6 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.018 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' A' ' 14' ' ' LEU . . . -51.67 -34.05 35.33 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.704 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.8 mp -69.81 -31.25 69.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.427 . . . . 0.0 110.102 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -68.48 -28.9 67.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.941 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -30.41 69.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.375 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.431 HD11 HD11 ' A' ' 31' ' ' ILE . 9.2 mt -75.91 -46.24 31.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.604 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.11 -45.97 61.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.8 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -57.03 -78.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.03 -168.96 16.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.446 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -113.1 129.17 56.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.373 . . . . 0.0 110.94 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.4 -161.24 1.16 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.145 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.962 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.2 t80 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.0 OUTLIER 51.86 48.06 23.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 2' ' ' HIS . . . 70.54 156.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.185 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.63 76.66 0.32 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.991 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.44 -25.7 21.1 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.532 2.155 . . . . 0.0 112.199 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -78.32 59.71 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.623 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.7 tm? -167.04 -59.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.612 ' N ' HD13 ' A' ' 7' ' ' LEU . 60.4 t -67.96 -42.35 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.042 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -24.94 37.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.53 -44.72 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.796 HD11 HD12 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -46.01 -54.18 8.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.97 0.414 . . . . 0.0 111.138 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.697 HG23 ' HA ' ' A' ' 17' ' ' PRO . 23.8 m -76.89 -49.79 14.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.91 -24.87 8.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.192 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.5 tp -58.46 -18.8 31.55 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.779 0.323 . . . . 0.0 111.113 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.4 19.49 7.05 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.069 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.7 m -134.23 77.69 60.17 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 111.113 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.697 ' HA ' HG23 ' A' ' 12' ' ' THR . 90.4 Cg_endo -87.47 19.43 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.892 2.394 . . . . 0.0 112.833 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.47 20.34 1.87 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.472 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 p -120.36 -30.98 4.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.69 0.281 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.727 ' O ' HG23 ' A' ' 24' ' ' THR . 12.2 tt -46.75 -30.8 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.567 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.46 -44.19 88.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 110.349 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.498 ' CB ' HD12 ' A' ' 47' ' ' ILE . 40.3 m-85 -75.15 -29.0 60.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.818 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' CE1' HD22 ' A' ' 45' ' ' LEU . 25.3 m-85 -78.17 -30.36 49.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.94 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 20' ' ' ILE . 7.1 p -69.39 -32.94 72.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -24.56 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.95 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -99.89 -49.25 4.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.18 51.38 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.328 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.97 ' CD1' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.69 39.28 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.0 110.948 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.7 pt20 -99.39 -28.55 13.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.128 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.98 112.9 23.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.022 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.512 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -45.37 -28.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.975 0.416 . . . . 0.0 111.116 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 m-85 -57.15 -21.01 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.753 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 -31.2 25.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.961 0.41 . . . . 0.0 110.613 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.97 HD22 ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.94 25.35 8.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.875 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.555 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -67.76 -42.99 80.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.612 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -103.61 -21.33 13.75 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.503 -176.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -46.31 144.91 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.119 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.715 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -135.02 178.67 6.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.131 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.589 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.2 tp -59.25 -32.99 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.363 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.07 -48.05 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.704 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 6.5 m-20 -80.34 -25.97 38.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -55.62 -49.21 73.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.83 -9.16 58.87 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.775 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -76.54 -43.69 38.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.058 0.456 . . . . 0.0 110.433 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.513 HD22 ' CE1' ' A' ' 23' ' ' PHE . 10.0 mp -46.15 -27.57 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.9 ttmm 86.17 19.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.237 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.498 HD12 ' CB ' ' A' ' 22' ' ' TYR . 4.9 mm -78.13 138.42 60.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.692 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 47' ' ' ILE . 81.4 Cg_exo -41.05 149.42 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.515 2.143 . . . . 0.0 112.389 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -89.01 47.21 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -85.19 -53.71 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.77 31.88 2.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.065 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.0 ttp180 -54.89 -48.28 73.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.589 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -60.57 -45.21 94.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.7 m -51.95 -45.93 64.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 14' ' ' LEU . 17.9 mt -61.16 -42.97 95.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.766 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.503 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.3 t90 -59.73 -50.29 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -47.13 -56.69 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.734 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.52 -42.29 65.7 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.661 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.612 ' HA ' HD23 ' A' ' 62' ' ' LEU . 3.5 mp -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.414 ' CD ' ' CE2' ' A' ' 56' ' ' TRP . 38.9 mt-30 -71.53 -17.25 62.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.604 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.69 -27.79 28.78 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.848 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -70.76 -40.72 72.51 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.855 0.836 . . . . 0.0 109.878 178.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD2' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -95.53 37.5 1.19 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.84 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -70.59 -30.24 66.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.842 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.74 -122.94 6.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.373 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -120.47 101.88 8.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -152.29 24.15 0.63 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.416 0.627 . . . . 0.0 111.979 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.309 -1.188 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.251 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.845 0.355 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.61 173.89 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.7 155.24 34.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.055 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -81.18 -50.26 0.97 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 6.3 Cg_exo -75.19 55.6 4.09 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.953 2.435 . . . . 0.0 112.249 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.3 t -85.35 -32.76 22.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.07 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -73.55 -65.34 0.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.147 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 m -43.95 -37.05 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.714 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -30.48 70.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.98 -47.28 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.36 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 7' ' ' LEU . 1.8 tm? -48.69 -54.45 14.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.0 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.634 HG23 ' HA ' ' A' ' 17' ' ' PRO . 87.8 m -79.17 -44.25 22.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.261 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 -28.46 12.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.248 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.898 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -55.09 -22.02 14.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.015 0.436 . . . . 0.0 110.844 178.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 20.95 5.75 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.086 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.7 p -134.96 83.6 39.8 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.634 ' HA ' HG23 ' A' ' 12' ' ' THR . 96.8 Cg_endo -87.28 21.48 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.785 2.323 . . . . 0.0 113.02 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -138.17 17.61 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.385 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.9 p -115.72 -26.73 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.2 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.679 HG13 HG23 ' A' ' 24' ' ' THR . 1.0 OUTLIER -48.85 -42.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -55.83 -42.29 75.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -74.16 -30.52 62.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.652 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CE1' HD12 ' A' ' 47' ' ' ILE . 33.2 m-85 -76.83 -51.59 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.752 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.679 HG23 HG13 ' A' ' 20' ' ' ILE . 53.3 p -50.43 -27.61 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.153 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.3 t -53.23 -24.12 10.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -103.89 -38.72 6.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.058 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.68 47.08 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.9 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.988 HD13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -99.19 44.62 1.02 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.309 0.576 . . . . 0.0 110.647 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.468 ' C ' HD12 ' A' ' 7' ' ' LEU . 5.6 pt20 -107.39 -13.98 14.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.314 177.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.645 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -127.16 103.68 7.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.735 HD11 HD11 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -43.04 -29.12 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 111.761 -177.232 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -56.76 -22.61 36.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -85.23 -11.47 54.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.496 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.993 HD12 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -122.37 14.81 10.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.404 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -24.28 62.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.21 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -115.38 -18.37 11.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.486 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.88 143.24 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.674 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -137.31 176.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.25 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.479 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 3.7 tp -55.84 -33.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.437 0.637 . . . . 0.0 109.46 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.02 -43.41 81.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.681 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.6 m-20 -84.81 -28.62 26.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.762 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -52.45 -46.35 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.43 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.32 62.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.775 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -80.67 -44.94 18.0 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 47' ' ' ILE . 9.4 mp -49.02 -28.14 3.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.249 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.6 tptt 83.34 21.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.317 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 45' ' ' LEU . 6.1 mt -83.68 137.93 41.13 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.479 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.454 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 69.7 Cg_exo -38.07 153.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.783 2.322 . . . . 0.0 112.596 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 10.3 pm0 -91.84 21.18 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.403 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -58.58 -44.27 89.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.809 0.338 . . . . 0.0 110.828 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 16' ' ' CYS . 12.4 m-85 -140.69 31.96 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.359 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -55.19 -61.15 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.381 . . . . 0.0 110.773 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtm -56.54 -42.97 79.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.777 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.629 ' CG2' HD12 ' A' ' 14' ' ' LEU . 85.9 m -51.01 -50.47 58.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.498 HD13 ' CZ ' ' A' ' 23' ' ' PHE . 6.6 mt -62.66 -37.66 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.674 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.0 t90 -61.63 -54.58 40.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.404 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 5.5 mtm180 -54.67 -36.75 64.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.853 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.898 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -74.35 -31.58 59.0 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.114 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.993 HD11 HD12 ' A' ' 34' ' ' LEU . 3.6 tp -73.91 -36.34 64.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.801 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 5.0 pt20 -69.1 -26.91 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.243 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.28 -28.73 69.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.735 HD11 HD11 ' A' ' 31' ' ' ILE . 6.3 mt -66.9 -35.45 80.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.416 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.92 32.66 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.214 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -53.55 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.872 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.66 87.87 0.42 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.463 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -130.57 134.31 46.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 111.018 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.1 t70 179.78 141.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.234 0.54 . . . . 0.0 110.739 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.412 ' OXT' ' CG ' ' A' ' 68' ' ' TYR . 2.4 t80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.615 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.91 0.386 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m170 63.57 167.93 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.003 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.47 121.49 5.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.073 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -173.89 -64.08 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 4' ' ' ASP . 48.1 Cg_endo -69.16 -20.28 37.88 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.532 2.155 . . . . 0.0 112.234 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.81 57.24 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 110.905 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.84 HD23 HD12 ' A' ' 31' ' ' ILE . 1.2 tm? -168.0 -51.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.636 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' N ' HD13 ' A' ' 7' ' ' LEU . 39.0 t -68.82 -39.11 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.129 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 p -59.41 -34.35 72.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.87 -43.73 12.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.513 HD12 ' HB ' ' A' ' 20' ' ' ILE . 1.7 tm? -48.24 -52.8 19.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.818 HG23 ' HA ' ' A' ' 17' ' ' PRO . 55.4 m -75.68 -50.44 15.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.2 -23.61 12.96 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.328 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.6 tp -58.59 -18.49 30.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 0.0 111.18 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.59 12.14 6.85 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.588 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 3.4 m -132.16 77.85 70.15 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.818 ' HA ' HG23 ' A' ' 12' ' ' THR . 90.6 Cg_endo -79.97 4.7 6.52 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.7 2.267 . . . . 0.0 112.939 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.21 20.49 3.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.687 0.28 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 8.3 m -114.19 -28.25 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.976 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.606 HG13 HG23 ' A' ' 24' ' ' THR . 1.7 tt -47.7 -44.15 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.07 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.4 mm-40 -49.97 -44.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.802 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.63 -32.79 62.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.556 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HE2' HG21 ' A' ' 55' ' ' ILE . 4.0 m-85 -69.29 -51.08 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.606 HG23 HG13 ' A' ' 20' ' ' ILE . 80.4 p -58.16 -28.02 64.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.7 t -47.29 -27.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.239 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -101.61 -56.28 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.753 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.14 46.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.092 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.979 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -99.4 38.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 111.14 -179.152 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.08 -27.83 13.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.785 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 108.04 17.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.852 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.84 HD12 HD23 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -43.23 -33.71 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.988 0.423 . . . . 0.0 111.548 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -55.92 -20.63 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.985 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.81 -15.77 47.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.675 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.112 HD12 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -113.28 9.84 18.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.417 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -54.87 -36.38 65.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -99.88 -22.3 15.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 41' ' ' ASP . 5.0 tp -47.79 135.2 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.701 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -132.67 178.55 6.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.009 0.433 . . . . 0.0 111.304 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 53' ' ' MET . 5.5 tp -58.97 -32.44 47.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.552 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -57.11 -45.37 83.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.833 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.4 m-20 -85.01 -27.11 26.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.701 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -49.26 -53.31 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.855 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.441 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . -68.15 -8.83 55.77 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.733 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -75.13 -42.37 56.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 110.426 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 47' ' ' ILE . 9.5 mp -47.87 -28.01 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.45 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.2 tttm 87.17 17.22 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.586 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.598 HD12 ' CE1' ' A' ' 23' ' ' PHE . 4.0 mt -85.91 138.49 35.13 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.595 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 2.7 Cg_endo -40.46 146.35 0.3 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.965 2.444 . . . . 0.0 112.108 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -90.21 42.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.76 -43.67 71.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.762 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -140.26 30.4 1.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.665 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 9.6 ttp180 -48.36 -50.75 29.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.825 ' HA ' HD13 ' A' ' 39' ' ' ILE . 4.9 mtt -61.2 -54.1 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.263 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -47.41 -48.93 26.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 0.0 111.034 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.667 HG21 ' HE2' ' A' ' 23' ' ' PHE . 6.6 mt -59.06 -41.51 83.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.743 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.603 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.9 t90 -62.43 -46.67 87.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.261 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.07 -60.03 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.43 -30.62 61.97 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.67 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.112 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -70.99 -25.96 62.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.24 -12.62 61.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.23 -37.39 26.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.84 HD13 HG13 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -52.86 -36.02 58.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 110.163 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -62.89 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.242 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -42.04 -56.12 2.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.612 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.69 98.3 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.552 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -121.24 92.71 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.829 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 170.01 143.47 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.632 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.717 179.199 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.875 0.369 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -93.74 83.21 4.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.986 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.32 146.47 46.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.825 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 173.65 -63.92 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 4' ' ' ASP . 11.9 Cg_endo -55.13 -21.33 27.38 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.678 2.252 . . . . 0.0 112.346 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -84.17 7.75 17.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.672 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.728 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.2 tm? -121.14 -60.82 1.61 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.728 ' N ' HD13 ' A' ' 7' ' ' LEU . 34.9 m -57.21 -35.8 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.6 p -64.38 -24.29 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.073 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.76 -48.74 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.571 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.5 tm? -48.26 -53.22 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.133 0.492 . . . . 0.0 110.876 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.849 HG23 ' HA ' ' A' ' 17' ' ' PRO . 93.0 m -70.67 -49.59 45.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.37 -32.7 22.93 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.9 tp -60.17 -17.14 38.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.81 11.23 6.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.611 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.847 ' SG ' HD11 ' A' ' 55' ' ' ILE . 1.3 m -114.91 72.41 2.86 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-O 120.739 0.304 . . . . 0.0 111.146 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.849 ' HA ' HG23 ' A' ' 12' ' ' THR . 85.2 Cg_endo -80.64 -13.1 12.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.256 . . . . 0.0 112.943 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.87 22.08 4.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.112 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 87.6 m -114.83 -28.21 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.072 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 24' ' ' THR . 2.5 tt -48.52 -32.83 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.95 -44.82 96.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.533 ' HB2' HD12 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -77.69 -27.95 50.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.463 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE1' HD22 ' A' ' 45' ' ' LEU . 20.1 m-85 -76.54 -46.36 26.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 20' ' ' ILE . 37.9 p -56.34 -30.75 63.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 p -55.79 -23.64 31.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.262 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.84 -34.98 9.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.75 41.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.304 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.037 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.79 39.53 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.024 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.22 -29.6 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.914 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.59 109.38 19.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.83 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.554 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -44.43 -28.34 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 111.526 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -58.64 -22.46 56.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.677 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -84.23 -19.9 33.16 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.037 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.56 13.38 22.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.679 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -17.46 64.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.408 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -128.36 17.86 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -84.88 147.41 26.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.29 . . . . 0.0 110.654 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.747 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -131.02 172.72 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.012 0.434 . . . . 0.0 111.523 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.44 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 7.5 tp -56.98 -34.3 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.676 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -59.09 -38.85 80.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.624 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 32.5 m-20 -85.47 -26.81 26.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.591 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -54.77 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.662 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -55.15 -20.44 20.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.369 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -61.73 -37.83 85.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 0.0 110.358 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.493 HD22 ' CE1' ' A' ' 23' ' ' PHE . 6.8 mp -61.26 -15.41 34.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.485 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 74.81 19.3 2.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.93 0.395 . . . . 0.0 111.073 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 22' ' ' TYR . 7.4 mm -79.23 138.17 56.21 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.513 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 87.7 Cg_exo -43.05 157.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.407 2.072 . . . . 0.0 112.136 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -85.56 -46.14 11.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -140.31 21.81 2.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.412 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -51.01 -57.34 8.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.438 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -60.36 -41.86 94.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.628 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.414 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 53.4 m -54.4 -47.59 72.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.604 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.847 HD11 ' SG ' ' A' ' 16' ' ' CYS . 6.8 mt -62.31 -36.77 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.619 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.4 t90 -64.23 -51.27 64.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 5.4 ptp180 -60.69 -33.14 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.623 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -77.54 -25.73 62.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.126 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.816 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.2 mp -78.46 -34.28 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.642 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -73.16 -30.46 63.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.38 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.34 -32.73 74.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.569 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 59' ' ' LEU . 10.2 mt -60.33 -52.22 66.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.685 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -51.13 -53.79 31.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.802 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -54.94 -73.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.96 -74.11 0.29 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.348 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.93 132.87 53.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.744 0.307 . . . . 0.0 110.89 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 68' ' ' TYR . 17.4 t0 -179.73 142.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.235 0.541 . . . . 0.0 110.775 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.415 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 1.8 m-30 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.941 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 4.7 t80 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.893 0.378 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -132.44 49.01 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 6' ' ' SER . . . -64.12 -175.38 0.15 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 t70 57.65 65.98 3.14 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.65 140.81 38.01 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.915 5.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.631 ' HB3' ' HB1' ' A' ' 3' ' ' ALA . 92.1 p -85.48 -24.14 27.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.012 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.761 HD23 HD12 ' A' ' 31' ' ' ILE . 1.8 tm? -95.43 -51.77 4.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.327 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.483 ' N ' HD13 ' A' ' 7' ' ' LEU . 46.6 t -53.71 -59.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.548 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -55.6 -19.61 10.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.13 -57.04 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 111.391 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 11' ' ' LEU . 1.9 tm? -46.16 -45.07 16.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.86 HG23 ' HA ' ' A' ' 17' ' ' PRO . 33.7 m -83.34 -49.11 9.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.635 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.58 -27.19 25.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.245 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' A' ' 55' ' ' ILE . 6.4 tp -60.74 -17.19 47.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.737 0.304 . . . . 0.0 111.047 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.57 16.87 6.79 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.309 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -127.79 71.86 78.28 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.672 0.272 . . . . 0.0 111.174 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.86 ' HA ' HG23 ' A' ' 12' ' ' THR . 87.6 Cg_endo -84.0 12.0 3.15 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.67 2.247 . . . . 0.0 112.854 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -138.73 16.21 2.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.674 0.273 . . . . 0.0 111.557 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -116.45 -23.05 8.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.765 0.317 . . . . 0.0 111.233 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.612 ' O ' HG23 ' A' ' 24' ' ' THR . 1.4 tt -48.58 -43.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.26 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.3 pt-20 -56.01 -41.64 75.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.482 ' CB ' HG23 ' A' ' 47' ' ' ILE . 52.3 m-85 -74.31 -33.63 63.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.685 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.516 ' CE1' HD22 ' A' ' 45' ' ' LEU . 9.1 m-85 -74.16 -51.26 16.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.865 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 20' ' ' ILE . 64.9 p -48.87 -34.41 12.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.328 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -47.98 -26.56 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.564 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -101.45 -29.71 11.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.74 45.55 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.097 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.033 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.11 40.15 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.995 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 7' ' ' LEU . 2.9 mt-30 -99.34 -30.08 12.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.784 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.27 109.05 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.917 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.761 HD12 HD23 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -43.62 -28.51 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 111.637 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.07 -23.91 62.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.766 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -80.27 -14.6 58.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.726 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -115.39 -1.5 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.466 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -49.81 -35.28 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.61 0.243 . . . . 0.0 111.508 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -108.6 15.66 23.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.783 ' HB3' HD23 ' A' ' 59' ' ' LEU . 14.7 tp -85.35 156.17 21.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.343 . . . . 0.0 110.792 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -140.14 174.35 10.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.488 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 5.0 tp -57.64 -35.25 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -39.22 80.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.701 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.58 ' HB3' HD11 ' A' ' 37' ' ' LEU . 14.0 m-20 -85.73 -32.8 21.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -52.35 -45.25 65.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.334 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HD2' ' A' ' 52' ' ' ARG . . . -77.54 -0.26 72.44 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.644 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -85.17 -33.57 22.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.062 0.458 . . . . 0.0 110.252 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.516 HD22 ' CE1' ' A' ' 23' ' ' PHE . 7.3 mp -61.11 -14.88 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.656 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.27 17.66 2.0 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.096 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.482 HG23 ' CB ' ' A' ' 22' ' ' TYR . 6.2 mt -85.09 138.18 37.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 68.4 Cg_exo -38.63 138.94 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.705 2.27 . . . . 0.0 112.555 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.89 22.45 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.445 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -55.58 -36.32 66.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.964 0.412 . . . . 0.0 110.51 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.17 28.77 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.6 ttp180 -48.95 -58.2 5.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -46.37 79.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -50.99 -50.66 57.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.71 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.568 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.8 mt -57.06 -52.16 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.488 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 7.5 t90 -52.25 -47.74 65.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 60' ' ' GLN . 7.1 mmt180 -49.94 -42.54 48.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.615 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -77.53 -21.9 71.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.798 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.016 HD11 HD12 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -85.24 -24.64 27.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.985 0.421 . . . . 0.0 111.023 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 14.1 pt20 -73.57 -11.61 60.49 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -80.2 -38.33 31.4 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 177.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.584 HD13 HG13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -52.31 -29.36 23.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.128 0.49 . . . . 0.0 109.86 178.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 -69.29 0.73 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.589 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.45 33.18 2.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.315 0.578 . . . . 0.0 111.632 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' ASP . . . -126.93 -1.0 6.98 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.068 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -139.9 125.02 18.69 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.923 0.361 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 169.78 146.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.543 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.769 179.692 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -170.82 126.53 0.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.953 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.26 174.37 5.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -127.16 68.49 72.48 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.83 -33.73 72.47 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.487 2.125 . . . . 0.0 112.301 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.91 74.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.995 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 8' ' ' VAL . 2.1 tm? -173.15 -66.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.043 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 7' ' ' LEU . 26.2 m -59.81 -43.34 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 8' ' ' VAL . 1.7 t -57.68 -34.75 69.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -43.95 15.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.666 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.0 tm? -47.49 -55.06 9.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.032 0.444 . . . . 0.0 111.067 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.86 HG23 ' HA ' ' A' ' 17' ' ' PRO . 86.5 m -72.77 -49.34 31.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.61 -29.61 18.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.34 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 55' ' ' ILE . 1.8 tp -63.93 -14.72 55.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.707 0.289 . . . . 0.0 111.281 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.78 12.78 8.33 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.291 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.78 ' SG ' HD11 ' A' ' 55' ' ' ILE . 3.4 m -114.18 64.84 1.36 Allowed Pre-proline 0 C--N 1.333 -0.133 0 CA-C-O 120.629 0.252 . . . . 0.0 111.052 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.86 ' HA ' HG23 ' A' ' 12' ' ' THR . 59.1 Cg_endo -71.85 -19.72 26.84 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.473 2.115 . . . . 0.0 112.361 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.95 22.3 5.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.96 -29.37 7.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.726 ' O ' HG23 ' A' ' 24' ' ' THR . 1.1 tt -49.32 -36.69 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.032 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -44.13 80.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.61 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -72.44 -36.64 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.529 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.643 ' CZ ' HD13 ' A' ' 55' ' ' ILE . 33.0 m-85 -69.63 -49.93 49.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.963 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 20' ' ' ILE . 77.0 p -49.78 -38.88 36.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.139 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -22.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.174 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HG3' ' HG ' ' A' ' 45' ' ' LEU . 7.9 mm-40 -99.55 -23.46 15.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.27 44.94 0.54 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.15 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.029 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.61 38.91 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.928 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -99.27 -26.93 14.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.159 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.47 107.09 16.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.149 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.694 HD11 HD11 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -44.65 -29.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.948 0.404 . . . . 0.0 111.175 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 83.1 m-85 -55.02 -22.36 15.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.621 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.01 -25.79 29.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.029 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -107.98 18.75 20.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.287 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.434 ' HG3' ' HA ' ' A' ' 32' ' ' TYR . 1.4 mm-40 -59.86 -44.39 94.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.088 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -103.85 -16.41 15.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.202 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.612 HD11 ' HB3' ' A' ' 41' ' ' ASP . 12.4 tp -44.39 153.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.982 0.42 . . . . 0.0 111.595 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.617 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -140.12 178.64 7.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.772 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.808 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.2 tp -61.85 -32.59 54.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.414 0.626 . . . . 0.0 109.409 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.8 -46.83 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.698 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.612 ' HB3' HD11 ' A' ' 37' ' ' LEU . 4.5 m-20 -83.41 -31.55 26.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -50.04 -49.65 50.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.336 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 52' ' ' ARG . . . -72.13 -18.11 77.72 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.403 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -61.98 -37.93 86.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.458 . . . . 0.0 110.388 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 47' ' ' ILE . 8.6 mp -50.25 -27.38 5.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 84.04 19.65 0.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.762 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.621 HD11 HD23 ' A' ' 45' ' ' LEU . 4.5 mt -85.12 137.27 37.42 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HD2' HG22 ' A' ' 47' ' ' ILE . 92.0 Cg_exo -41.75 139.31 2.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.573 2.182 . . . . 0.0 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -74.81 61.15 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -85.14 -52.33 6.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.11 36.01 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.685 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HB3' HD11 ' A' ' 39' ' ' ILE . 2.1 ttp180 -59.84 -53.14 61.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.808 ' HA ' HD13 ' A' ' 39' ' ' ILE . 1.4 ptm -60.17 -41.19 92.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -59.44 -47.14 86.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 110.582 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.78 HD11 ' SG ' ' A' ' 16' ' ' CYS . 21.3 mt -58.51 -47.8 87.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.628 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.42 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.3 t90 -55.57 -59.67 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.319 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 0.3 OUTLIER -47.22 -39.72 14.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.179 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.42 -26.87 64.69 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.999 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.809 HD11 HD12 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -78.29 -35.02 48.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 110.781 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 17.6 pt20 -70.22 -27.95 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.212 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.05 -28.64 69.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.494 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.694 HD11 HD11 ' A' ' 31' ' ' ILE . 13.2 mt -63.32 -50.12 71.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.677 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -50.11 -45.27 52.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -81.53 -27.53 34.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.4 86.1 0.46 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.607 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -106.48 29.82 6.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.76 127.47 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.747 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.849 -179.718 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.895 0.379 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.99 131.15 36.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.45 164.09 11.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.07 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -162.89 60.46 0.99 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.709 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.52 -20.5 60.59 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.575 2.183 . . . . 0.0 112.419 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 t -75.45 63.8 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.6 tm? -177.21 -60.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.809 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.671 ' N ' HD13 ' A' ' 7' ' ' LEU . 21.4 t -59.14 -43.91 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.983 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.69 -36.37 62.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -81.93 -47.03 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 20' ' ' ILE . 1.9 tm? -49.59 -33.95 16.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.616 HG23 ' HA ' ' A' ' 17' ' ' PRO . 2.2 m -83.2 -61.83 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.923 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.81 -28.72 3.93 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.874 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.707 HD11 ' HA ' ' A' ' 55' ' ' ILE . 4.1 tt -51.84 -24.49 6.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.709 177.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.93 14.2 9.52 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.738 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 87.0 m -121.16 64.31 13.25 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.689 0.28 . . . . 0.0 111.118 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.616 ' HA ' HG23 ' A' ' 12' ' ' THR . 60.5 Cg_endo -72.51 -11.26 26.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.516 2.144 . . . . 0.0 112.686 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -131.41 19.73 4.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.221 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.42 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -111.85 -27.04 8.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.89 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.7 tt -49.6 -34.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.51 -45.62 77.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.755 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -74.63 -36.3 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.418 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -66.88 -44.71 80.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 20' ' ' ILE . 56.3 p -58.53 -34.31 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.8 m -51.47 -24.17 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.162 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -100.7 -37.46 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.865 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.4 45.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.333 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.06 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.61 40.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 7' ' ' LEU . 5.8 pt20 -99.07 -28.96 13.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.981 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.05 110.67 21.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.083 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.718 HD11 HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -45.7 -28.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.937 0.399 . . . . 0.0 111.2 -178.634 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -57.93 -22.32 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.57 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -20.67 36.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.06 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.57 21.03 14.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.28 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.55 -18.94 64.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.385 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -134.28 18.17 3.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.681 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -81.54 145.82 30.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.66 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.7 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -131.7 173.69 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.485 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 8.5 tp -57.94 -35.92 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.443 0.64 . . . . 0.0 109.293 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.14 -44.8 68.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.337 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 26.7 m-20 -84.79 -34.33 22.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.729 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.681 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -50.88 -58.66 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.57 179.55 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.36 -20.0 35.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.469 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -64.06 -41.04 97.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.682 HD23 HD11 ' A' ' 47' ' ' ILE . 8.8 mp -48.16 -28.0 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.219 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 82.13 19.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.974 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HD23 ' A' ' 45' ' ' LEU . 7.3 mt -76.45 137.89 67.52 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.568 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 1.9 Cg_endo -40.66 131.79 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.964 2.442 . . . . 0.0 112.206 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.96 63.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.275 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' A' ' 48' ' ' PRO . 3.4 mm-40 -85.19 -60.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -140.32 36.29 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.751 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.916 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -49.33 -45.99 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.271 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 57' ' ' ARG . 2.3 ptp -62.14 -47.56 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 m -54.2 -40.37 67.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 52' ' ' ARG . 7.8 mt -63.29 -58.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.135 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.7 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.5 t90 -49.92 -45.6 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.396 . . . . 0.0 110.21 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.4 ' CG ' ' O ' ' A' ' 53' ' ' MET . 3.2 mmt180 -55.5 -51.56 66.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.625 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.58 -41.63 89.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.855 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 34' ' ' LEU . 1.1 tp -62.13 -32.83 73.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -70.3 -26.84 63.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.303 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -62.42 -33.38 74.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 178.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.718 HD11 HD11 ' A' ' 31' ' ' ILE . 11.8 mt -64.88 -49.74 69.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.632 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -59.18 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.753 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -23.36 67.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ASP . . . -85.6 -8.75 79.84 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.781 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -99.58 141.11 32.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.632 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.0 OUTLIER 51.15 98.39 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.004 -179.436 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.817 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 50.31 86.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.56 116.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.092 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -152.8 62.07 4.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.75 -33.01 77.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.623 2.215 . . . . 0.0 112.378 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.6 63.84 1.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.4 tm? -174.92 -64.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.775 ' N ' HD13 ' A' ' 7' ' ' LEU . 48.1 t -60.8 -43.9 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.223 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -23.56 63.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.166 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.22 -48.73 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.137 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.544 HD12 ' HB ' ' A' ' 20' ' ' ILE . 3.1 tm? -48.59 -52.16 24.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.986 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.846 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.3 m -73.6 -48.68 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.707 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.82 -30.33 28.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.37 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.6 tp -60.13 -17.69 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 111.197 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 121.01 12.6 5.8 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.551 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.85 65.72 5.25 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.085 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.846 ' HA ' HG23 ' A' ' 12' ' ' THR . 77.1 Cg_endo -77.4 -5.09 15.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -136.49 18.81 3.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.626 0.25 . . . . 0.0 111.457 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -116.63 -22.26 8.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.296 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.544 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.5 tt -51.53 -34.94 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.171 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -54.94 -46.06 74.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.703 ' HB2' HD12 ' A' ' 47' ' ' ILE . 6.1 m-85 -76.04 -31.74 58.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.703 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.503 ' CE1' HD22 ' A' ' 45' ' ' LEU . 14.6 m-85 -70.3 -43.88 69.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.236 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 20' ' ' ILE . 41.1 p -62.67 -28.81 70.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.779 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 t -51.22 -25.02 4.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -100.17 -52.25 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.74 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.7 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.001 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.59 37.34 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.422 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -99.69 -29.05 12.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.813 178.078 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.57 109.08 19.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -44.02 -29.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.955 0.407 . . . . 0.0 111.543 -178.064 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -56.36 -22.48 31.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.57 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -84.03 -20.55 32.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.001 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.33 14.83 21.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.49 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -20.53 65.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -133.41 24.36 4.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.31 . . . . 0.0 111.104 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.651 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.37 121.25 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.828 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.517 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -99.44 175.72 5.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.111 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.854 HD13 ' HA ' ' A' ' 53' ' ' MET . 5.1 tp -64.85 -32.1 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.613 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.12 -45.03 83.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.2 m-20 -83.29 -32.18 26.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.795 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.651 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -52.86 -64.38 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.359 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.429 ' HA3' ' NE ' ' A' ' 52' ' ' ARG . . . -58.3 -23.25 52.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.992 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -54.39 -37.32 64.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 110.519 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.503 HD22 ' CE1' ' A' ' 23' ' ' PHE . 8.2 mp -59.52 -15.6 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.777 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 1.6 mtmt 78.71 17.9 0.99 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 22' ' ' TYR . 6.1 mm -80.52 138.76 51.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.269 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 4.7 Cg_exo -36.34 140.32 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.224 2.616 . . . . 0.0 112.519 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -91.13 23.46 3.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.593 -178.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -67.96 -31.74 71.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.65 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.32 23.69 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.82 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -50.69 -58.38 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.99 0.424 . . . . 0.0 110.782 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.854 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -53.95 -52.05 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 m -48.17 -43.99 32.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 52' ' ' ARG . 10.3 mt -58.8 -59.09 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.516 ' CZ2' HG23 ' A' ' 38' ' ' THR . 0.1 OUTLIER -53.1 -55.31 24.93 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.856 0.36 . . . . 0.0 110.403 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 1.2 mtt180 -44.8 -40.07 5.82 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.837 0.351 . . . . 0.0 111.575 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.11 -25.14 67.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.153 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.1 mp -82.16 -35.19 28.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.763 0.316 . . . . 0.0 111.083 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.493 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.3 pt20 -71.51 -27.63 63.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -27.97 69.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.281 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.671 HD12 ' HA ' ' A' ' 59' ' ' LEU . 9.4 mt -67.22 -49.88 62.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.57 -56.87 3.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.823 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 63.4 119.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.673 0.749 . . . . 0.0 111.115 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.77 -137.16 8.22 Favored Glycine 0 C--N 1.313 -0.722 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.507 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -132.46 128.15 36.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.95 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p30 168.07 145.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.113 0.482 . . . . 0.0 110.691 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.497 179.172 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 7.2 p90 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.778 0.323 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -145.39 161.28 40.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.426 ' HB1' ' HD3' ' A' ' 5' ' ' PRO . . . -112.62 164.2 13.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 1.6 t0 -138.09 50.95 3.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.141 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 56.9 Cg_endo -70.47 68.79 2.08 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.48 2.12 . . . . 0.0 112.209 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -79.81 -14.91 58.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.609 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.629 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.6 tm? -91.34 -53.68 4.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.728 0.299 . . . . 0.0 111.132 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.544 ' N ' HD13 ' A' ' 7' ' ' LEU . 40.4 t -56.88 -57.08 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.319 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 p -55.79 -21.78 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.545 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -88.04 -53.86 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.775 0.321 . . . . 0.0 111.178 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.794 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.2 tm? -48.25 -52.0 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.109 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.836 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.0 m -71.65 -46.61 58.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.697 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.14 -33.37 30.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.358 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.6 tp -64.53 -13.42 52.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.677 0.275 . . . . 0.0 111.499 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.86 13.81 7.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.5 m -112.24 60.91 0.58 Allowed Pre-proline 0 CA--C 1.528 0.133 0 CA-C-O 120.665 0.269 . . . . 0.0 111.287 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.836 ' HA ' HG23 ' A' ' 12' ' ' THR . 56.1 Cg_endo -69.81 -30.44 22.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -124.21 19.77 9.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.798 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.9 m -109.45 -27.31 9.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.666 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' A' ' 11' ' ' LEU . 13.2 tt -52.08 -31.71 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.702 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 8.9 pt-20 -59.76 -44.55 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.507 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 59.9 m-85 -72.0 -30.89 65.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.232 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -74.13 -51.82 14.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.758 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 20' ' ' ILE . 60.4 p -49.4 -34.07 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -51.36 -24.23 4.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -99.86 -43.3 6.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 45.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.151 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.908 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.97 39.98 1.24 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.87 0.367 . . . . 0.0 111.007 -179.178 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.51 -25.07 14.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.134 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 t -111.33 108.28 17.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.548 HD11 HD11 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -48.0 -26.72 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -59.5 -21.76 60.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.563 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.68 -19.03 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.908 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.48 11.8 21.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.622 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -61.77 -21.51 64.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.301 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -132.43 21.24 4.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.534 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -77.88 146.0 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.669 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.608 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -127.99 172.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 0.0 111.589 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' A' ' 53' ' ' MET . 7.6 tp -58.94 -33.36 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.515 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.99 -49.29 76.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.625 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' HB3' HD21 ' A' ' 37' ' ' LEU . 1.7 m-20 -82.8 -15.1 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.789 HD23 HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -69.51 -56.56 7.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.882 0.372 . . . . 0.0 110.246 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.77 63.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.049 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.4 53.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.043 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 47' ' ' ILE . 4.6 mp -72.25 -3.9 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.95 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 15.4 ptpt 49.93 33.37 6.54 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 121.014 0.435 . . . . 0.0 111.427 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.546 HD11 HD23 ' A' ' 45' ' ' LEU . 36.6 mt -83.52 138.72 41.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.986 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 46.4 Cg_exo -35.39 119.37 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.008 2.472 . . . . 0.0 112.949 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.91 68.6 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.355 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -85.21 -65.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 0.0 110.665 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.68 36.64 2.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.4 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -48.63 -43.31 36.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.232 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.594 ' HA ' HD13 ' A' ' 39' ' ' ILE . 12.4 mtt -59.44 -50.54 73.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.649 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -50.77 -47.79 59.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.658 ' HA ' HD23 ' A' ' 14' ' ' LEU . 11.1 mm -55.92 -55.85 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.608 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.0 t90 -50.36 -62.94 1.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.29 -30.44 50.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.149 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -78.8 -27.36 56.88 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.839 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -75.99 -38.89 56.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 110.691 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.48 -26.01 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.327 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -27.77 68.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.673 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 31' ' ' ILE . 16.5 mt -62.5 -48.64 78.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.838 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -46.33 -51.31 14.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.241 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -131.43 -80.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.876 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.77 92.05 0.1 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.618 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.81 103.89 12.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.359 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 p30 170.19 146.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.549 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.702 179.816 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.988 0.423 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.31 160.3 19.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.963 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.5 169.13 4.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.742 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -139.01 61.85 23.45 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.1 -21.92 13.44 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.607 2.205 . . . . 0.0 112.293 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -68.05 72.36 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.842 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.3 tm? -174.91 -58.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.66 ' N ' HD13 ' A' ' 7' ' ' LEU . 29.2 m -65.28 -31.4 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -72.5 -25.16 61.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -54.52 4.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.684 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.494 HD13 HD12 ' A' ' 28' ' ' LEU . 4.9 tp -51.03 -54.23 26.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.18 0.514 . . . . 0.0 110.372 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.929 HG23 ' HA ' ' A' ' 17' ' ' PRO . 25.6 m -58.51 -50.87 72.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.497 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.36 -30.22 48.4 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.973 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.693 HD11 ' HA3' ' A' ' 58' ' ' GLY . 3.8 tp -59.5 -18.17 37.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 111.046 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.3 17.15 6.3 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.158 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.439 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 4.3 m -118.93 61.41 5.15 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.681 0.277 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.929 ' HA ' HG23 ' A' ' 12' ' ' THR . 49.2 Cg_endo -68.78 -19.8 40.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.455 2.104 . . . . 0.0 112.16 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -129.56 23.96 5.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -114.67 -24.61 8.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.823 ' O ' HG23 ' A' ' 24' ' ' THR . 13.1 tt -51.43 -46.91 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.3 mm-40 -51.42 -45.18 62.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.657 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.7 m-30 -64.84 -32.02 73.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.574 ' CE1' HD22 ' A' ' 45' ' ' LEU . 2.5 m-85 -79.28 -28.04 42.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.55 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 20' ' ' ILE . 45.2 p -70.73 -24.52 62.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.145 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.6 p -50.62 -24.81 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.24 -51.56 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.08 55.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.113 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.08 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.58 38.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.095 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -25.4 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.283 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.15 104.76 13.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.887 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.55 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.99 -27.52 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.452 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -21.25 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.71 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.6 -23.71 31.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.958 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.08 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -106.27 16.98 24.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -73.23 -20.93 60.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.268 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -128.87 20.37 5.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.324 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.621 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.12 120.6 26.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.053 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.492 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -99.79 176.75 5.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.267 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' A' ' 53' ' ' MET . 7.4 tp -65.16 -31.52 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -56.03 -42.84 77.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.266 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.507 ' HB3' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -85.09 -32.44 22.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.801 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.621 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -54.87 -52.49 62.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.456 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -71.12 -16.28 74.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.411 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -63.02 -44.81 94.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.946 0.403 . . . . 0.0 110.488 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.574 HD22 ' CE1' ' A' ' 23' ' ' PHE . 10.0 mp -44.09 -28.38 0.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.749 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.7 tttt 88.22 17.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.434 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.56 HD11 HD23 ' A' ' 45' ' ' LEU . 4.0 mt -78.24 138.15 60.28 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.9 Cg_exo -40.42 144.65 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.534 2.156 . . . . 0.0 112.419 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.53 54.08 2.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.416 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 78.7 mt-30 -84.93 -44.62 12.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.791 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 50' ' ' GLN . 4.8 m-85 -140.23 29.08 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.669 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -46.54 -61.8 1.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.106 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.733 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -55.66 -47.03 77.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.004 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 52.4 m -55.23 -38.86 69.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 52' ' ' ARG . 10.8 mt -63.96 -56.24 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.838 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.509 ' CH2' ' HB3' ' A' ' 60' ' ' GLN . 0.3 OUTLIER -56.69 -61.28 2.54 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.477 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -47.04 -32.87 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.663 0.268 . . . . 0.0 111.348 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.693 ' HA3' HD11 ' A' ' 14' ' ' LEU . . . -77.62 -27.8 58.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.681 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -79.01 -44.45 22.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.388 . . . . 0.0 110.725 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.509 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.5 pt20 -59.9 -27.02 66.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.155 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.78 -31.2 69.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.315 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 31' ' ' ILE . 12.7 mt -70.4 -50.3 40.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.687 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.09 -62.15 1.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.84 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -64.1 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.77 -170.06 26.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -117.97 -179.91 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 110.916 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.91 126.32 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.478 ' OXT' ' CG ' ' A' ' 68' ' ' TYR . 20.8 t80 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.907 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 22.9 t80 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -101.89 71.18 1.27 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.863 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.48 114.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.072 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' CB ' ' HD3' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -87.95 -53.53 0.37 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HD3' ' CB ' ' A' ' 4' ' ' ASP . 53.0 Cg_exo -54.5 -21.9 25.79 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.501 2.134 . . . . 0.0 112.235 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 t -73.69 61.47 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.731 ' CD2' HD11 ' A' ' 34' ' ' LEU . 2.8 tm? -162.25 -73.4 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.922 HG12 HD11 ' A' ' 20' ' ' ILE . 3.5 m -50.07 -42.51 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.4 -27.92 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.037 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.67 -56.25 4.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.533 HD23 ' HB ' ' A' ' 20' ' ' ILE . 7.1 tp -47.41 -55.99 7.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 0.0 110.698 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.824 HG23 ' HA ' ' A' ' 17' ' ' PRO . 63.4 m -53.15 -52.05 60.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.35 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.57 -31.05 52.04 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.028 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.8 tp -56.95 -19.88 20.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 19.02 5.29 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.332 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.5 p -134.51 66.08 69.08 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.676 0.274 . . . . 0.0 111.246 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.824 ' HA ' HG23 ' A' ' 12' ' ' THR . 11.8 Cg_exo -71.54 -9.95 25.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.754 2.303 . . . . 0.0 112.777 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -126.26 16.37 7.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.095 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -113.46 -22.91 10.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.179 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HG12 ' A' ' 8' ' ' VAL . 16.0 tt -54.18 -35.31 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.988 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.792 ' HA ' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -66.07 -41.67 90.42 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.193 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' CB ' HD13 ' A' ' 47' ' ' ILE . 62.5 m-85 -63.74 -26.97 68.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.612 ' CE1' HD22 ' A' ' 45' ' ' LEU . 2.3 m-85 -91.31 -35.95 14.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.469 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.792 HG22 ' HA ' ' A' ' 21' ' ' GLU . 4.4 t -70.72 -16.17 62.76 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.422 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -61.5 -23.0 65.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.742 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.12 -57.37 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.12 39.42 0.03 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.057 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.68 37.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.377 -179.333 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -99.86 -29.85 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.3 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -104.12 107.92 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.534 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -43.63 -30.06 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 -177.573 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.4 -21.49 25.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.674 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -85.4 -26.86 26.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -97.84 14.94 25.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -63.08 -37.78 88.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.437 0.637 . . . . 0.0 111.424 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -110.03 -14.78 14.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.268 -176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.726 HD12 HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -44.11 145.53 0.75 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -133.67 173.81 11.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.175 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.745 HD13 ' HA ' ' A' ' 53' ' ' MET . 8.8 tp -63.09 -34.6 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.638 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 2.9 pt-20 -61.98 -38.51 88.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.47 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 58.1 m-20 -84.99 -27.65 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.383 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.726 HD23 HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -56.42 -59.73 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.29 -19.81 60.1 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.118 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -56.64 -36.03 69.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.057 0.456 . . . . 0.0 110.284 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 23' ' ' PHE . 6.8 mp -60.92 -15.53 32.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.607 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 73.77 17.47 3.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 111.248 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.482 HD11 HD23 ' A' ' 45' ' ' LEU . 12.0 mt -79.46 137.87 55.43 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.3 Cg_exo -44.44 136.04 8.83 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.524 2.149 . . . . 0.0 112.299 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -68.41 62.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.234 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -85.44 -58.05 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.759 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.36 36.98 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.597 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.7 -64.74 0.77 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.745 ' HA ' HD13 ' A' ' 39' ' ' ILE . 3.3 ppp? -52.14 -42.91 63.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 52.9 m -53.13 -48.47 67.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.604 ' HA ' HD23 ' A' ' 14' ' ' LEU . 38.6 mt -62.94 -44.03 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.4 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 9.5 t90 -56.72 -55.23 36.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.438 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.3 ptm180 -59.46 -30.67 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.989 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -79.2 -26.33 57.87 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.822 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -81.08 -41.42 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.807 0.337 . . . . 0.0 110.485 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.77 -27.67 69.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.364 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -63.17 -30.71 71.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.527 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.523 HD11 HD11 ' A' ' 31' ' ' ILE . 10.3 mt -66.2 -51.27 59.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.652 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -55.84 -45.73 78.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.117 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -46.84 -44.88 19.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.46 -20.95 9.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.525 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 138.04 38.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.995 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 174.32 132.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.473 ' O ' ' CD1' ' A' ' 68' ' ' TYR . 23.8 t80 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.871 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.818 0.342 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 69.78 -174.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.93 136.58 37.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.444 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -65.42 -51.43 52.11 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 84.3 Cg_endo -83.4 59.05 6.32 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.71 2.274 . . . . 0.0 112.393 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 t -79.96 -28.97 39.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -90.06 -60.89 1.81 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.065 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 m -43.0 -36.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.794 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -58.06 -51.52 69.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.104 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.54 -38.54 48.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.312 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.785 HD21 HD12 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -46.82 -57.25 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.05 0.452 . . . . 0.0 111.119 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.883 HG23 ' HA ' ' A' ' 17' ' ' PRO . 22.0 m -71.55 -50.52 30.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.804 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.2 -30.07 16.82 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.266 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.7 tp -58.15 -18.78 27.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.132 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 15.63 6.53 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.357 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 m -122.92 72.26 43.68 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.683 0.278 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.883 ' HA ' HG23 ' A' ' 12' ' ' THR . 83.3 Cg_endo -83.33 6.49 5.77 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.67 2.247 . . . . 0.0 113.064 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -145.3 17.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.604 0.24 . . . . 0.0 111.534 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -118.23 -21.05 8.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.396 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 24' ' ' THR . 6.6 tt -50.26 -38.55 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.989 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.35 -46.25 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.54 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.345 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.682 ' HZ ' HD13 ' A' ' 55' ' ' ILE . 29.3 m-85 -63.12 -54.71 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 20' ' ' ILE . 80.7 p -51.72 -30.49 22.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.963 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 p -50.66 -25.79 4.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -101.24 -45.88 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.04 45.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.183 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.46 44.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 110.927 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.643 ' C ' HD12 ' A' ' 7' ' ' LEU . 2.8 pt20 -107.98 -19.4 13.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.453 177.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.562 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -121.57 103.16 8.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.606 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.843 HD11 HD11 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -40.76 -31.64 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.137 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -56.09 -21.3 21.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.21 -24.66 27.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.978 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -103.21 16.52 26.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.105 0.479 . . . . 0.0 111.003 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -59.68 -39.82 85.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -107.34 -20.06 13.39 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.647 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -46.04 150.63 0.56 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.356 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.774 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -140.32 177.35 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.213 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.49 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 9.5 tp -59.1 -34.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.37 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -59.15 -39.2 81.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.227 178.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -85.53 -33.57 21.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.542 178.765 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.595 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -53.52 -50.19 65.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.479 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -22.16 68.95 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.029 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -62.86 -27.28 69.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.0 mp -62.53 -14.77 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.494 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 5.0 mttm 72.53 16.72 4.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.804 0.335 . . . . 0.0 111.366 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 9.0 mt -85.39 138.7 36.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.4 Cg_exo -44.95 130.74 10.42 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.232 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -68.01 64.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -85.04 -52.27 6.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.655 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -140.15 25.61 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.798 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -49.04 -48.2 44.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.194 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.483 ' HA ' HD13 ' A' ' 39' ' ' ILE . 35.8 mtm -57.36 -56.57 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -49.79 -44.26 48.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 52' ' ' ARG . 14.3 mt -57.11 -55.36 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.774 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.2 t90 -52.45 -50.4 62.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -52.79 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.92 -39.99 80.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 34' ' ' LEU . 2.6 mp -66.19 -29.17 69.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.486 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -74.43 -28.03 60.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.391 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -67.17 -26.57 66.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.77 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.843 HD11 HD11 ' A' ' 31' ' ' ILE . 14.0 mt -78.7 -47.29 17.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.002 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -62.89 -43.3 99.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.118 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -65.28 -41.87 93.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.08 167.5 35.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.76 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.26 159.61 19.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.837 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p30 174.64 129.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 68' ' ' TYR . 55.2 t80 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.956 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.827 0.346 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -60.99 137.55 58.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.031 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.03 165.2 25.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -133.57 64.2 67.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.48 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 47.1 Cg_exo -55.76 -21.55 32.95 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.565 2.176 . . . . 0.0 112.303 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.17 -40.02 22.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.388 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.784 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.5 tm? -75.05 -64.97 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.258 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.784 ' N ' HD13 ' A' ' 7' ' ' LEU . 2.9 m -53.28 -34.35 22.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.381 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 4.8 t -63.55 -33.15 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.381 . . . . 0.0 111.27 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.42 -48.47 7.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.645 HD11 HD12 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -47.58 -53.14 15.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.783 HG23 ' HA ' ' A' ' 17' ' ' PRO . 50.9 m -74.45 -48.0 30.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.731 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.18 -29.86 30.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.055 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.715 HD21 ' HA3' ' A' ' 58' ' ' GLY . 4.0 tp -59.31 -17.94 33.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.669 0.271 . . . . 0.0 111.274 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.26 19.36 5.9 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.181 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 85.0 m -126.87 73.74 76.0 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.709 0.29 . . . . 0.0 110.992 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.783 ' HA ' HG23 ' A' ' 12' ' ' THR . 7.7 Cg_endo -84.74 -0.26 9.23 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.068 2.512 . . . . 0.0 112.918 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.8 13.58 3.4 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 1.3 m -117.53 -20.19 9.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.601 0.239 . . . . 0.0 111.419 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.525 ' CG1' HD22 ' A' ' 11' ' ' LEU . 13.9 tt -51.67 -28.96 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.926 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.506 ' HA ' HG22 ' A' ' 24' ' ' THR . 4.8 mm-40 -68.64 -43.38 76.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.256 0.551 . . . . 0.0 110.388 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.5 m-30 -68.33 -24.76 64.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.249 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.8 -32.38 15.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 21' ' ' GLU . 2.6 t -69.32 -10.37 57.54 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.993 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -19.35 62.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.714 ' CD ' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.3 -20.74 11.73 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.362 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 33' ' ' HIS . . . 131.82 51.39 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.435 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.067 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -109.45 37.68 2.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.889 0.376 . . . . 0.0 111.129 179.005 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -99.36 -30.43 12.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.92 109.48 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.706 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.732 HD11 HD11 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -44.38 -27.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 111.657 -177.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -20.63 59.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.762 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.468 ' CG ' ' O ' ' A' ' 27' ' ' GLY . 46.5 t-80 -85.06 -19.11 32.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.997 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.067 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.16 14.0 21.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.528 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.21 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.053 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -125.06 16.95 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.33 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.563 HD13 HD21 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -85.11 140.44 30.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.386 . . . . 0.0 110.684 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.637 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -128.81 -179.84 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.047 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.801 HD13 ' HA ' ' A' ' 53' ' ' MET . 3.8 tp -58.25 -34.26 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -52.19 -43.26 64.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.274 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.444 ' HB3' ' CD2' ' A' ' 37' ' ' LEU . 4.3 m-20 -83.99 -30.07 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.588 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -67.41 -36.98 82.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.794 178.313 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.459 ' HA2' ' CZ ' ' A' ' 52' ' ' ARG . . . -79.88 2.23 75.45 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.75 -41.13 16.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.714 HD11 ' CD ' ' A' ' 26' ' ' GLN . 3.7 mt -62.69 -12.31 22.82 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.069 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 71.31 15.23 6.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 111.264 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 48' ' ' PRO . 25.1 mm -61.17 138.58 94.44 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.474 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 47' ' ' ILE . 4.3 Cg_exo -37.02 153.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.581 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 11.1 tt0 -92.69 23.12 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.429 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -85.07 -33.22 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.54 ' O ' HD12 ' A' ' 55' ' ' ILE . 7.5 m-85 -135.16 12.32 3.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' CZ ' ' HA2' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -54.09 -68.29 0.19 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 179.475 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.801 ' HA ' HD13 ' A' ' 39' ' ' ILE . 2.9 mtm -53.33 -42.26 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.871 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -51.4 -50.75 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.581 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.664 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.2 mt -56.65 -56.96 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.637 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.2 t90 -49.85 -54.89 16.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 6.6 mmt180 -51.37 -32.32 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.715 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -78.53 -25.25 61.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.797 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.967 HD11 HD12 ' A' ' 34' ' ' LEU . 1.2 tp -80.94 -40.58 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.494 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 4.4 pt20 -63.15 -27.76 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.071 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -55.34 -37.75 67.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.11 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.732 HD11 HD11 ' A' ' 31' ' ' ILE . 10.2 mt -61.14 -45.87 92.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.392 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.16 37.61 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.79 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -51.32 -39.74 57.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.077 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.42 -90.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -137.31 128.84 28.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 111.015 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.42 -161.26 1.15 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.17 0.51 . . . . 0.0 110.612 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.1 t80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.595 -179.001 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 16.8 t80 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.803 0.335 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.93 179.31 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.89 172.22 12.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.91 67.95 18.15 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.7 -20.18 23.29 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.596 2.198 . . . . 0.0 112.343 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 t -68.55 65.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.053 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.1 tm? -177.17 -58.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' N ' HD13 ' A' ' 7' ' ' LEU . 35.3 m -66.12 -37.31 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.168 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 p -63.19 -26.48 68.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -95.7 -46.78 6.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.17 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tm? -49.58 -52.7 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.862 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 17' ' ' PRO . 91.5 m -77.6 -46.74 21.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.472 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.11 -26.98 6.64 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.362 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.809 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -54.52 -22.5 13.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.774 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.64 16.91 5.76 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.353 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.425 ' HB3' ' CG ' ' A' ' 51' ' ' TYR . 4.6 p -130.12 80.54 70.7 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.772 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.747 ' HA ' HG23 ' A' ' 12' ' ' THR . 71.6 Cg_endo -78.61 6.1 5.09 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.714 2.276 . . . . 0.0 112.996 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -135.56 22.47 3.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.674 0.273 . . . . 0.0 111.143 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 4.8 t -114.27 -28.62 7.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.967 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 24' ' ' THR . 1.6 tt -50.87 -45.59 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.916 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.511 ' N ' HG23 ' A' ' 20' ' ' ILE . 2.1 pt-20 -49.66 -44.45 47.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' HB2' HD13 ' A' ' 47' ' ' ILE . 70.5 m-85 -69.84 -35.46 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.692 ' CE1' HD12 ' A' ' 47' ' ' ILE . 3.2 m-85 -70.68 -49.6 45.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.73 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 20' ' ' ILE . 71.7 p -55.28 -24.34 27.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -49.15 -30.37 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.244 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -99.99 -53.56 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.1 48.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.99 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.105 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -99.51 40.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.047 -179.083 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -99.1 -27.45 13.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.867 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.1 104.39 12.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.598 HD11 HD11 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -43.81 -29.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.99 0.424 . . . . 0.0 111.278 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -55.23 -23.63 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.668 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.45 -21.16 35.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.955 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.105 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.06 22.04 14.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -32.41 71.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.55 -18.36 11.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.716 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.466 HD23 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -44.45 140.86 2.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.344 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.645 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -128.69 179.18 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.118 -179.424 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.848 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.6 tp -57.3 -33.65 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.482 0.658 . . . . 0.0 109.276 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.75 -47.49 79.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.539 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.1 m-20 -80.18 -27.52 38.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.673 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -55.18 -52.48 63.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.177 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -15.18 62.89 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.324 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -66.06 -40.31 90.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.561 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 47' ' ' ILE . 8.9 mp -47.3 -27.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.347 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 5.9 ttmm 86.66 16.09 0.1 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.633 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.692 HD12 ' CE1' ' A' ' 23' ' ' PHE . 2.8 mt -86.21 137.69 34.83 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.816 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 3.0 Cg_endo -45.26 158.87 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.675 2.25 . . . . 0.0 112.023 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.45 57.8 4.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.177 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.47 -58.12 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.58 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.425 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 1.5 m-85 -137.15 33.48 2.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.616 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.1 ttp180 -56.52 -66.66 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.01 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.848 ' HA ' HD13 ' A' ' 39' ' ' ILE . 59.4 mtt -54.84 -34.81 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.68 ' CG2' HD12 ' A' ' 14' ' ' LEU . 55.2 m -58.14 -49.98 75.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.729 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.618 HD13 ' CE2' ' A' ' 23' ' ' PHE . 60.0 mt -66.13 -35.72 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.602 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.645 ' NE1' HG22 ' A' ' 38' ' ' THR . 10.6 t90 -59.48 -55.82 29.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.941 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.433 ' NH1' ' HB3' ' A' ' 53' ' ' MET . 0.0 OUTLIER -53.34 -39.48 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.621 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.809 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -67.96 -40.98 88.75 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.91 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 34' ' ' LEU . 1.1 tp -64.26 -38.67 91.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.332 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -63.82 -31.15 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.199 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -33.62 66.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.216 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.598 HD11 HD11 ' A' ' 31' ' ' ILE . 11.5 mt -61.93 -42.02 98.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.431 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.15 38.55 1.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.658 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -132.41 -44.47 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.22 -88.07 0.77 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.379 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 -177.02 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.807 0.337 . . . . 0.0 110.912 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.71 128.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.963 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.616 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.9 tm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.829 0.347 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 7' ' ' LEU . 46.4 t -67.85 -50.87 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.166 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -25.01 65.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.116 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -50.9 6.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.029 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.795 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.2 tm? -48.9 -53.03 21.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.015 0.436 . . . . 0.0 110.859 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.838 HG23 ' HA ' ' A' ' 17' ' ' PRO . 55.8 m -74.69 -46.88 34.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.46 -29.82 17.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.286 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.8 tp -62.38 -15.05 46.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.642 0.258 . . . . 0.0 111.277 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.59 12.78 8.48 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.419 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 55' ' ' ILE . 34.1 m -116.12 67.21 3.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.684 0.278 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.838 ' HA ' HG23 ' A' ' 12' ' ' THR . 59.5 Cg_endo -72.55 -17.5 26.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.526 2.151 . . . . 0.0 112.521 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -130.04 21.36 5.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.028 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -28.07 8.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.795 ' HB ' HD12 ' A' ' 11' ' ' LEU . 2.4 tt -52.2 -34.76 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.817 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.96 -44.05 86.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.667 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -71.98 -33.57 68.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.482 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.534 ' CE1' HD22 ' A' ' 45' ' ' LEU . 10.2 m-85 -73.76 -45.19 53.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.58 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' ILE . 65.9 p -55.73 -32.08 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.79 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -49.52 -25.92 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.996 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -99.9 -48.07 4.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.44 47.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.469 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.137 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.24 39.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.126 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -30.24 12.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.039 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.52 110.47 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.075 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.537 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -46.44 -27.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.004 0.431 . . . . 0.0 111.279 -178.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -21.82 49.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.63 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -21.52 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.214 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.137 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.3 19.25 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -28.61 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.329 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.75 -20.44 10.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.513 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -44.94 148.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.633 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.668 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -140.39 178.63 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.121 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.6 tp -59.65 -33.33 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.48 0.657 . . . . 0.0 109.23 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.18 -50.94 71.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -78.04 -24.27 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.9 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.509 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.63 -6.9 60.09 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.734 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -77.38 -43.63 32.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.964 0.412 . . . . 0.0 110.432 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.681 HD23 HD11 ' A' ' 47' ' ' ILE . 9.3 mp -47.35 -29.11 2.35 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.174 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER 82.44 21.37 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.681 HD11 HD23 ' A' ' 45' ' ' LEU . 4.5 mt -81.35 138.0 48.52 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.305 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.0 Cg_exo -39.66 136.76 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.527 2.151 . . . . 0.0 112.294 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -78.73 55.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.399 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.53 -43.16 13.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -140.36 30.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -50.71 -59.31 4.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.572 ' HA ' HD13 ' A' ' 39' ' ' ILE . 5.9 ptm -59.37 -44.49 92.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.408 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 54.9 m -51.7 -50.19 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.456 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.69 ' HA ' HD23 ' A' ' 14' ' ' LEU . 17.6 mt -59.74 -46.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.668 ' NE1' HG22 ' A' ' 38' ' ' THR . 13.2 t90 -57.64 -61.65 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.56 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.8 ptm180 -51.78 -31.16 25.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.684 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -74.7 -36.58 47.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.714 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 34' ' ' LEU . 2.6 tp -67.46 -42.08 83.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.253 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.523 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 37.3 mt-30 -61.02 -27.69 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.279 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.292 178.916 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.643 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.836 0.351 . . . . 0.0 110.72 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.585 ' N ' HD13 ' A' ' 7' ' ' LEU . 7.8 p -66.1 -33.84 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.02 64.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -85.7 -47.5 9.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -52.93 -48.45 67.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.363 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.7 m -81.06 -40.83 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.097 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.25 -30.83 11.56 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.195 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -57.1 -20.46 25.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 178.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.94 19.06 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.185 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 78.85 35.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.638 0.256 . . . . 0.0 110.974 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 12' ' ' THR . 87.7 Cg_endo -84.74 13.85 2.64 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.656 2.237 . . . . 0.0 112.93 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -143.0 25.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 111.022 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.18 -34.34 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.294 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.683 ' O ' HG22 ' A' ' 24' ' ' THR . 0.5 OUTLIER -46.95 -28.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -59.8 -46.6 88.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.095 0.474 . . . . 0.0 110.625 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.43 ' HB2' HD13 ' A' ' 47' ' ' ILE . 38.7 m-85 -78.72 -28.65 45.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -77.46 -43.85 30.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.841 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 20' ' ' ILE . 14.8 t -67.49 -28.74 68.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.754 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m -54.12 -22.42 11.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.968 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.406 ' HG3' ' HG ' ' A' ' 45' ' ' LEU . 1.1 mm-40 -99.78 -56.72 2.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.33 43.51 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.213 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.035 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.2 40.78 1.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.833 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -99.46 -27.53 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.09 109.95 18.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.116 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.526 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -46.48 -27.52 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 111.095 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -58.04 -22.22 49.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -84.18 -19.19 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.03 4.45 15.7 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.83 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -53.31 -36.48 61.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.724 0.297 . . . . 0.0 111.186 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -112.81 19.41 17.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' ' 41' ' ' ASP . 12.8 tp -84.79 155.98 21.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.641 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -139.27 177.38 7.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.877 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.5 tp -58.29 -34.16 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.419 0.628 . . . . 0.0 109.42 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.89 -47.33 77.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.715 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.75 ' HB3' HD11 ' A' ' 37' ' ' LEU . 21.0 m-20 -80.93 -31.0 35.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.551 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -51.3 -51.39 54.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.28 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.09 -20.33 77.87 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.324 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -58.04 -44.17 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.14 0.495 . . . . 0.0 110.202 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.639 HD23 HD11 ' A' ' 47' ' ' ILE . 8.1 mp -48.52 -29.46 4.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.318 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttpt 86.63 19.43 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.315 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.639 HD11 HD23 ' A' ' 45' ' ' LEU . 3.8 mt -83.98 138.62 39.96 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.242 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.463 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 61.7 Cg_exo -36.81 151.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.703 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 1.9 pt-20 -91.65 22.47 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 33.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HB3' HD11 ' A' ' 39' ' ' ILE . 1.4 ttp180 -62.16 -51.14 69.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.376 . . . . 0.0 111.009 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.877 ' HA ' HD13 ' A' ' 39' ' ' ILE . 2.3 ttp -66.22 -32.32 73.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.121 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 14' ' ' LEU . 56.2 m -59.63 -50.36 74.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . 45.1 mt -62.7 -41.42 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.805 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.613 ' NE1' HG22 ' A' ' 38' ' ' THR . 9.4 t90 -57.19 -51.52 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.101 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -50.8 -46.85 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.441 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.675 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -65.97 -37.95 93.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.585 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.86 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -61.61 -36.47 80.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 178.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.512 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 56.5 mt-30 -66.53 -28.6 68.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.203 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.585 179.169 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.5 tm? . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.755 0.312 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.64 ' N ' HD13 ' A' ' 7' ' ' LEU . 14.5 t -59.01 -45.05 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.433 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -59.38 -30.5 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -88.11 -51.87 5.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.336 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.63 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.5 tm? -45.66 -53.21 9.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 111.151 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.857 HG23 ' HA ' ' A' ' 17' ' ' PRO . 51.3 m -74.36 -47.69 32.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.37 -24.35 22.62 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.478 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.618 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.8 tp -61.38 -18.17 57.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.742 0.306 . . . . 0.0 111.327 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.98 18.68 5.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.299 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -134.33 74.6 66.48 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.858 0.361 . . . . 0.0 110.759 179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.857 ' HA ' HG23 ' A' ' 12' ' ' THR . 71.6 Cg_endo -84.63 10.06 3.88 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.809 2.34 . . . . 0.0 112.821 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.3 16.04 2.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 111.221 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -115.28 -22.24 9.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.63 ' HB ' HD12 ' A' ' 11' ' ' LEU . 3.2 tt -50.18 -36.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 110.974 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.501 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 12.2 pt-20 -57.63 -43.84 85.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.501 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 64.3 m-85 -70.71 -32.63 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 22.3 m-85 -73.91 -52.81 11.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.536 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 20' ' ' ILE . 40.3 p -50.67 -29.18 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 0.5 OUTLIER -50.57 -27.64 7.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.231 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.17 -42.43 6.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.87 45.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.182 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.035 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.5 40.01 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -99.22 -27.58 13.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.992 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.48 107.44 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.025 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.526 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -45.75 -27.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.059 0.457 . . . . 0.0 111.348 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -21.01 34.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 -22.35 29.04 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -107.01 18.78 21.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 0.0 111.508 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -19.23 64.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.258 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -125.39 -8.69 6.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -61.14 153.88 24.63 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.828 0.347 . . . . 0.0 110.984 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.709 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -140.15 178.31 7.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.063 0.459 . . . . 0.0 111.478 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.487 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 7.4 tp -60.42 -34.0 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.52 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -39.87 78.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.416 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.65 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.4 m-20 -86.05 -34.69 20.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.642 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -48.38 -59.01 3.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.879 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.48 -19.12 32.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.388 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -67.21 -31.02 71.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.4 mp -62.85 -17.52 61.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.488 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 2.3 mtmt 74.19 17.45 3.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 111.369 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.449 HG13 ' CB ' ' A' ' 45' ' ' LEU . 7.4 mt -80.95 137.82 49.94 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.678 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 59.6 Cg_exo -37.66 112.81 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.83 2.354 . . . . 0.0 112.787 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -68.15 63.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.112 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -85.11 -50.33 7.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.558 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.06 28.64 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.433 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -46.7 -30.54 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.283 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -50.03 48.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.2 m -54.62 -40.0 68.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.369 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.618 ' HA ' HD23 ' A' ' 14' ' ' LEU . 6.8 mm -61.7 -55.65 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.895 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.709 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.5 t90 -52.05 -45.58 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.243 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -51.24 -53.77 32.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.611 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.2 -41.78 54.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 34' ' ' LEU . 3.3 mp -65.37 -28.18 69.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 110.355 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.516 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 47.6 mt-30 -75.07 -28.49 60.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.478 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.573 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.8 tm? . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.809 0.338 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.65 ' N ' HD13 ' A' ' 7' ' ' LEU . 42.3 t -53.78 -59.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.056 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.1 -6.75 30.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.769 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.43 -59.61 1.97 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.974 HD13 ' N ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.04 -26.35 68.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.507 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.974 ' N ' HD13 ' A' ' 11' ' ' LEU . 33.1 m -81.11 -50.43 9.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.282 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.23 -25.7 60.47 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.421 ' CD2' ' HA3' ' A' ' 58' ' ' GLY . 5.1 tp -49.63 -24.78 2.38 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.025 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.65 10.45 4.91 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.282 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 73.52 72.82 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 116.958 0.379 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.873 ' HA ' HG23 ' A' ' 12' ' ' THR . 3.1 Cg_exo -77.67 4.03 6.38 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.897 2.398 . . . . 0.0 112.901 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -132.43 19.67 4.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.638 0.256 . . . . 0.0 111.264 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -114.01 -24.23 9.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.046 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.79 HD13 ' HG ' ' A' ' 11' ' ' LEU . 8.5 tp -49.89 -36.65 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.74 -40.67 92.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.548 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.1 m-30 -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.458 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.526 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 6.9 m-85 -80.89 -42.44 21.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 20' ' ' ILE . 11.9 p -52.88 -29.64 29.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -27.12 3.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.259 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -99.94 -58.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.957 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.44 46.86 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.446 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.055 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.4 39.89 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -99.66 -28.95 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.105 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -116.21 115.57 26.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.166 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.535 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -47.85 -26.74 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 111.049 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 19.8 m-85 -59.91 -19.39 51.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -85.33 -30.22 23.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.864 0.364 . . . . 0.0 110.55 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.055 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -98.67 23.52 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.492 . . . . 0.0 110.757 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 32' ' ' TYR . 1.3 mm-40 -68.1 -37.91 81.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.607 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.54 -18.17 12.47 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.661 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.797 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -44.78 148.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.303 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.575 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -140.26 173.71 11.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.108 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.496 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 6.9 tp -57.14 -33.77 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.392 0.615 . . . . 0.0 109.384 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.79 -45.35 78.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.332 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -84.62 -31.66 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.797 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -54.49 -45.57 73.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.418 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.445 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -67.66 -10.27 57.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -78.58 -27.76 45.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.116 0.484 . . . . 0.0 110.403 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.526 ' CD2' ' CD2' ' A' ' 23' ' ' PHE . 8.1 mp -62.39 -11.74 17.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.146 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt 77.09 20.18 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 45' ' ' LEU . 7.1 mm -82.35 131.74 54.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.66 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HG2' ' HG3' ' A' ' 50' ' ' GLN . 7.6 Cg_endo -49.7 176.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.667 2.245 . . . . 0.0 112.396 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.59 40.65 1.04 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.96 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.4 ' HG3' ' HG2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -82.5 -51.97 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.811 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -140.24 25.64 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.289 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -51.83 -57.72 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.7 mmm -59.98 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.915 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.0 m -50.36 -48.16 55.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.654 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 52' ' ' ARG . 8.3 mt -55.53 -56.96 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.755 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.575 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.5 t90 -51.47 -52.44 46.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.855 0.359 . . . . 0.0 110.456 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -47.01 -59.6 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.018 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' A' ' 14' ' ' LEU . . . -51.67 -34.05 35.33 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.704 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.8 mp -69.81 -31.25 69.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.427 . . . . 0.0 110.102 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.525 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 56.2 mt-30 -68.48 -28.9 67.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.941 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.375 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.623 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.7 tm? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.924 0.392 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.612 ' N ' HD13 ' A' ' 7' ' ' LEU . 60.4 t -67.96 -42.35 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.042 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -24.94 37.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.53 -44.72 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.796 HD11 HD12 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -46.01 -54.18 8.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.97 0.414 . . . . 0.0 111.138 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.697 HG23 ' HA ' ' A' ' 17' ' ' PRO . 23.8 m -76.89 -49.79 14.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.91 -24.87 8.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.192 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.5 tp -58.46 -18.8 31.55 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.779 0.323 . . . . 0.0 111.113 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.4 19.49 7.05 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.069 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.7 m -134.23 77.69 60.17 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 111.113 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.697 ' HA ' HG23 ' A' ' 12' ' ' THR . 90.4 Cg_endo -87.47 19.43 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.892 2.394 . . . . 0.0 112.833 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.47 20.34 1.87 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.472 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 p -120.36 -30.98 4.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.69 0.281 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.727 ' O ' HG23 ' A' ' 24' ' ' THR . 12.2 tt -46.75 -30.8 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.567 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.46 -44.19 88.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 110.349 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.498 ' CB ' HD12 ' A' ' 47' ' ' ILE . 40.3 m-85 -75.15 -29.0 60.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.818 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' CE1' HD22 ' A' ' 45' ' ' LEU . 25.3 m-85 -78.17 -30.36 49.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.94 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 20' ' ' ILE . 7.1 p -69.39 -32.94 72.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -24.56 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.95 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -99.89 -49.25 4.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.18 51.38 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.328 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.97 ' CD1' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.69 39.28 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.0 110.948 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.7 pt20 -99.39 -28.55 13.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.128 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.98 112.9 23.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.022 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.512 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -45.37 -28.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.975 0.416 . . . . 0.0 111.116 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 m-85 -57.15 -21.01 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.753 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 -31.2 25.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.961 0.41 . . . . 0.0 110.613 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.97 HD22 ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.94 25.35 8.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.875 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.445 ' HG3' ' HA ' ' A' ' 32' ' ' TYR . 3.7 mm-40 -67.76 -42.99 80.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.612 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.61 -21.33 13.75 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.503 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -46.31 144.91 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.119 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.715 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -135.02 178.67 6.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.131 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.589 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.2 tp -59.25 -32.99 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.363 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.07 -48.05 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.704 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 6.5 m-20 -80.34 -25.97 38.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -55.62 -49.21 73.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.83 -9.16 58.87 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.775 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -76.54 -43.69 38.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.058 0.456 . . . . 0.0 110.433 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.513 HD22 ' CE1' ' A' ' 23' ' ' PHE . 10.0 mp -46.15 -27.57 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.9 ttmm 86.17 19.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.237 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.498 HD12 ' CB ' ' A' ' 22' ' ' TYR . 4.9 mm -78.13 138.42 60.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.692 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 47' ' ' ILE . 81.4 Cg_exo -41.05 149.42 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.515 2.143 . . . . 0.0 112.389 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -89.01 47.21 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -85.19 -53.71 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.77 31.88 2.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.065 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.0 ttp180 -54.89 -48.28 73.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.589 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -60.57 -45.21 94.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.7 m -51.95 -45.93 64.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 14' ' ' LEU . 17.9 mt -61.16 -42.97 95.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.766 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 11.3 t90 -59.73 -50.29 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -47.13 -56.69 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.734 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.52 -42.29 65.7 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.661 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 34' ' ' LEU . 3.5 mp -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.518 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 39.6 mt-30 -71.53 -17.25 62.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.604 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.848 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.814 0.34 . . . . 0.0 111.147 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 m -43.95 -37.05 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.714 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -30.48 70.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.98 -47.28 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.36 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 7' ' ' LEU . 1.8 tm? -48.69 -54.45 14.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.0 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.634 HG23 ' HA ' ' A' ' 17' ' ' PRO . 87.8 m -79.17 -44.25 22.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.261 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 -28.46 12.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.248 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.898 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -55.09 -22.02 14.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.015 0.436 . . . . 0.0 110.844 178.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 20.95 5.75 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.086 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.7 p -134.96 83.6 39.8 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.634 ' HA ' HG23 ' A' ' 12' ' ' THR . 96.8 Cg_endo -87.28 21.48 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.785 2.323 . . . . 0.0 113.02 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -138.17 17.61 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.385 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.9 p -115.72 -26.73 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.2 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.679 HG13 HG23 ' A' ' 24' ' ' THR . 1.0 OUTLIER -48.85 -42.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -55.83 -42.29 75.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -74.16 -30.52 62.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.652 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CE1' HD12 ' A' ' 47' ' ' ILE . 33.2 m-85 -76.83 -51.59 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.752 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.679 HG23 HG13 ' A' ' 20' ' ' ILE . 53.3 p -50.43 -27.61 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.153 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.3 t -53.23 -24.12 10.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -103.89 -38.72 6.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.058 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.68 47.08 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.9 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.988 HD13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -99.19 44.62 1.02 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.309 0.576 . . . . 0.0 110.647 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.468 ' C ' HD12 ' A' ' 7' ' ' LEU . 5.6 pt20 -107.39 -13.98 14.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.314 177.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.645 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -127.16 103.68 7.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.467 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -43.04 -29.12 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 111.761 -177.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -56.76 -22.61 36.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -85.23 -11.47 54.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.496 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.993 HD12 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -122.37 14.81 10.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.404 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -24.28 62.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.21 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -115.38 -18.37 11.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.486 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.88 143.24 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.674 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -137.31 176.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.25 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.479 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 3.7 tp -55.84 -33.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.437 0.637 . . . . 0.0 109.46 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.02 -43.41 81.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.681 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.6 m-20 -84.81 -28.62 26.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.762 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -52.45 -46.35 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.43 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.32 62.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.775 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -80.67 -44.94 18.0 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 47' ' ' ILE . 9.4 mp -49.02 -28.14 3.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.249 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.6 tptt 83.34 21.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.317 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 45' ' ' LEU . 6.1 mt -83.68 137.93 41.13 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.479 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.454 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 69.7 Cg_exo -38.07 153.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.783 2.322 . . . . 0.0 112.596 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 10.3 pm0 -91.84 21.18 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.403 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -58.58 -44.27 89.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.809 0.338 . . . . 0.0 110.828 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 16' ' ' CYS . 12.4 m-85 -140.69 31.96 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.359 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -55.19 -61.15 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.381 . . . . 0.0 110.773 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtm -56.54 -42.97 79.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.777 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.629 ' CG2' HD12 ' A' ' 14' ' ' LEU . 85.9 m -51.01 -50.47 58.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.498 HD13 ' CZ ' ' A' ' 23' ' ' PHE . 6.6 mt -62.66 -37.66 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.674 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.0 t90 -61.63 -54.58 40.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.404 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 5.5 mtm180 -54.67 -36.75 64.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.853 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.898 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -74.35 -31.58 59.0 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.114 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.993 HD11 HD12 ' A' ' 34' ' ' LEU . 3.6 tp -73.91 -36.34 64.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.801 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 5.0 pt20 -69.1 -26.91 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.243 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.84 HD23 HD12 ' A' ' 31' ' ' ILE . 1.2 tm? . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.943 0.402 . . . . 0.0 110.636 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' N ' HD13 ' A' ' 7' ' ' LEU . 39.0 t -68.82 -39.11 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.129 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 p -59.41 -34.35 72.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.87 -43.73 12.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.513 HD12 ' HB ' ' A' ' 20' ' ' ILE . 1.7 tm? -48.24 -52.8 19.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.818 HG23 ' HA ' ' A' ' 17' ' ' PRO . 55.4 m -75.68 -50.44 15.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.2 -23.61 12.96 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.328 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.6 tp -58.59 -18.49 30.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 0.0 111.18 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.59 12.14 6.85 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.588 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 3.4 m -132.16 77.85 70.15 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.818 ' HA ' HG23 ' A' ' 12' ' ' THR . 90.6 Cg_endo -79.97 4.7 6.52 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.7 2.267 . . . . 0.0 112.939 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.21 20.49 3.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.687 0.28 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 8.3 m -114.19 -28.25 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.976 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.606 HG13 HG23 ' A' ' 24' ' ' THR . 1.7 tt -47.7 -44.15 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.07 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.478 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.4 mm-40 -49.97 -44.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.802 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.63 -32.79 62.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.556 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HE2' HG21 ' A' ' 55' ' ' ILE . 4.0 m-85 -69.29 -51.08 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.606 HG23 HG13 ' A' ' 20' ' ' ILE . 80.4 p -58.16 -28.02 64.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.7 t -47.29 -27.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.239 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -101.61 -56.28 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.753 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.14 46.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.092 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.979 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -99.4 38.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 111.14 -179.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.08 -27.83 13.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.785 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 108.04 17.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.852 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.84 HD12 HD23 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -43.23 -33.71 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.988 0.423 . . . . 0.0 111.548 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -55.92 -20.63 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.985 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.81 -15.77 47.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.675 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.112 HD12 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -113.28 9.84 18.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -36.38 65.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -99.88 -22.3 15.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 41' ' ' ASP . 5.0 tp -47.79 135.2 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.701 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -132.67 178.55 6.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.009 0.433 . . . . 0.0 111.304 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 53' ' ' MET . 5.5 tp -58.97 -32.44 47.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.552 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -57.11 -45.37 83.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.833 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.4 m-20 -85.01 -27.11 26.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.701 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -49.26 -53.31 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.855 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.441 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . -68.15 -8.83 55.77 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.733 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -75.13 -42.37 56.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 110.426 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 47' ' ' ILE . 9.5 mp -47.87 -28.01 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.45 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.2 tttm 87.17 17.22 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.586 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.598 HD12 ' CE1' ' A' ' 23' ' ' PHE . 4.0 mt -85.91 138.49 35.13 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.595 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 2.7 Cg_endo -40.46 146.35 0.3 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.965 2.444 . . . . 0.0 112.108 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -90.21 42.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.76 -43.67 71.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.762 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -140.26 30.4 1.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.665 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 9.6 ttp180 -48.36 -50.75 29.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.825 ' HA ' HD13 ' A' ' 39' ' ' ILE . 4.9 mtt -61.2 -54.1 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.263 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -47.41 -48.93 26.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 0.0 111.034 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.667 HG21 ' HE2' ' A' ' 23' ' ' PHE . 6.6 mt -59.06 -41.51 83.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.743 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.603 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.9 t90 -62.43 -46.67 87.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.261 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.07 -60.03 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.43 -30.62 61.97 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.67 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.112 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -70.99 -25.96 62.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -69.24 -12.62 61.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.728 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.2 tm? . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.728 ' N ' HD13 ' A' ' 7' ' ' LEU . 34.9 m -57.21 -35.8 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.6 p -64.38 -24.29 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.073 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.76 -48.74 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.571 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.5 tm? -48.26 -53.22 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.133 0.492 . . . . 0.0 110.876 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.849 HG23 ' HA ' ' A' ' 17' ' ' PRO . 93.0 m -70.67 -49.59 45.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.37 -32.7 22.93 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.9 tp -60.17 -17.14 38.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.81 11.23 6.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.611 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.847 ' SG ' HD11 ' A' ' 55' ' ' ILE . 1.3 m -114.91 72.41 2.86 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-O 120.739 0.304 . . . . 0.0 111.146 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.849 ' HA ' HG23 ' A' ' 12' ' ' THR . 85.2 Cg_endo -80.64 -13.1 12.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.256 . . . . 0.0 112.943 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.87 22.08 4.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.112 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 87.6 m -114.83 -28.21 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.072 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 24' ' ' THR . 2.5 tt -48.52 -32.83 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.95 -44.82 96.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.533 ' HB2' HD12 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -77.69 -27.95 50.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.463 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE1' HD22 ' A' ' 45' ' ' LEU . 20.1 m-85 -76.54 -46.36 26.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 20' ' ' ILE . 37.9 p -56.34 -30.75 63.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 p -55.79 -23.64 31.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.262 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.84 -34.98 9.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.75 41.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.304 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.037 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.79 39.53 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.024 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.22 -29.6 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.914 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.59 109.38 19.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.83 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.554 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -44.43 -28.34 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 111.526 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -58.64 -22.46 56.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.677 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -84.23 -19.9 33.16 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.037 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.56 13.38 22.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.679 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -17.46 64.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.408 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -128.36 17.86 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -84.88 147.41 26.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.29 . . . . 0.0 110.654 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.747 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -131.02 172.72 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.012 0.434 . . . . 0.0 111.523 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.44 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 7.5 tp -56.98 -34.3 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.676 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -59.09 -38.85 80.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.624 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 32.5 m-20 -85.47 -26.81 26.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.591 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -54.77 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.662 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -55.15 -20.44 20.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.369 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -61.73 -37.83 85.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 0.0 110.358 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.493 HD22 ' CE1' ' A' ' 23' ' ' PHE . 6.8 mp -61.26 -15.41 34.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.485 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 74.81 19.3 2.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.93 0.395 . . . . 0.0 111.073 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 22' ' ' TYR . 7.4 mm -79.23 138.17 56.21 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.513 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 87.7 Cg_exo -43.05 157.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.407 2.072 . . . . 0.0 112.136 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -85.56 -46.14 11.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -140.31 21.81 2.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.412 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -51.01 -57.34 8.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.438 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -60.36 -41.86 94.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.628 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.414 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 53.4 m -54.4 -47.59 72.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.604 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.847 HD11 ' SG ' ' A' ' 16' ' ' CYS . 6.8 mt -62.31 -36.77 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.619 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.4 t90 -64.23 -51.27 64.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 5.4 ptp180 -60.69 -33.14 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.623 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -77.54 -25.73 62.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.126 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 34' ' ' LEU . 1.2 mp -78.46 -34.28 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.642 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -73.16 -30.46 63.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.38 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.569 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.761 HD23 HD12 ' A' ' 31' ' ' ILE . 1.8 tm? . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.691 0.282 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.483 ' N ' HD13 ' A' ' 7' ' ' LEU . 46.6 t -53.71 -59.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.548 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -55.6 -19.61 10.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.13 -57.04 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 111.391 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 11' ' ' LEU . 1.9 tm? -46.16 -45.07 16.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.86 HG23 ' HA ' ' A' ' 17' ' ' PRO . 33.7 m -83.34 -49.11 9.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.635 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.58 -27.19 25.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.245 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' A' ' 55' ' ' ILE . 6.4 tp -60.74 -17.19 47.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.737 0.304 . . . . 0.0 111.047 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.57 16.87 6.79 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.309 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -127.79 71.86 78.28 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.672 0.272 . . . . 0.0 111.174 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.86 ' HA ' HG23 ' A' ' 12' ' ' THR . 87.6 Cg_endo -84.0 12.0 3.15 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.67 2.247 . . . . 0.0 112.854 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -138.73 16.21 2.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.674 0.273 . . . . 0.0 111.557 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -116.45 -23.05 8.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.765 0.317 . . . . 0.0 111.233 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.612 ' O ' HG23 ' A' ' 24' ' ' THR . 1.4 tt -48.58 -43.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.26 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.3 pt-20 -56.01 -41.64 75.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.482 ' CB ' HG23 ' A' ' 47' ' ' ILE . 52.3 m-85 -74.31 -33.63 63.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.685 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.516 ' CE1' HD22 ' A' ' 45' ' ' LEU . 9.1 m-85 -74.16 -51.26 16.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.865 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 20' ' ' ILE . 64.9 p -48.87 -34.41 12.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.328 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -47.98 -26.56 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.564 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -101.45 -29.71 11.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.74 45.55 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.097 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.033 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.11 40.15 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.995 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 7' ' ' LEU . 2.9 mt-30 -99.34 -30.08 12.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.784 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.27 109.05 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.917 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.761 HD12 HD23 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -43.62 -28.51 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 111.637 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.07 -23.91 62.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.766 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -80.27 -14.6 58.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.726 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -115.39 -1.5 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.81 -35.28 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.61 0.243 . . . . 0.0 111.508 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -108.6 15.66 23.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.783 ' HB3' HD23 ' A' ' 59' ' ' LEU . 14.7 tp -85.35 156.17 21.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.343 . . . . 0.0 110.792 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -140.14 174.35 10.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.488 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 5.0 tp -57.64 -35.25 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -39.22 80.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.701 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.58 ' HB3' HD11 ' A' ' 37' ' ' LEU . 14.0 m-20 -85.73 -32.8 21.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -52.35 -45.25 65.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.334 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HD2' ' A' ' 52' ' ' ARG . . . -77.54 -0.26 72.44 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.644 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -85.17 -33.57 22.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.062 0.458 . . . . 0.0 110.252 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.516 HD22 ' CE1' ' A' ' 23' ' ' PHE . 7.3 mp -61.11 -14.88 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.656 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.27 17.66 2.0 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.096 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.482 HG23 ' CB ' ' A' ' 22' ' ' TYR . 6.2 mt -85.09 138.18 37.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 68.4 Cg_exo -38.63 138.94 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.705 2.27 . . . . 0.0 112.555 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.89 22.45 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.445 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -55.58 -36.32 66.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.964 0.412 . . . . 0.0 110.51 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.17 28.77 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.6 ttp180 -48.95 -58.2 5.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -46.37 79.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -50.99 -50.66 57.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.71 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.568 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.8 mt -57.06 -52.16 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.488 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 7.5 t90 -52.25 -47.74 65.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 60' ' ' GLN . 7.1 mmt180 -49.94 -42.54 48.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.615 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -77.53 -21.9 71.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.798 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.016 HD11 HD12 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -85.24 -24.64 27.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.985 0.421 . . . . 0.0 111.023 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 7.7 pt20 -73.57 -11.61 60.49 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 8' ' ' VAL . 2.1 tm? . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.745 0.307 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 7' ' ' LEU . 26.2 m -59.81 -43.34 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 8' ' ' VAL . 1.7 t -57.68 -34.75 69.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -43.95 15.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.666 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.0 tm? -47.49 -55.06 9.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.032 0.444 . . . . 0.0 111.067 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.86 HG23 ' HA ' ' A' ' 17' ' ' PRO . 86.5 m -72.77 -49.34 31.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.61 -29.61 18.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.34 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 55' ' ' ILE . 1.8 tp -63.93 -14.72 55.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.707 0.289 . . . . 0.0 111.281 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.78 12.78 8.33 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.291 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.78 ' SG ' HD11 ' A' ' 55' ' ' ILE . 3.4 m -114.18 64.84 1.36 Allowed Pre-proline 0 C--N 1.333 -0.133 0 CA-C-O 120.629 0.252 . . . . 0.0 111.052 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.86 ' HA ' HG23 ' A' ' 12' ' ' THR . 59.1 Cg_endo -71.85 -19.72 26.84 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.473 2.115 . . . . 0.0 112.361 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.95 22.3 5.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.96 -29.37 7.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.726 ' O ' HG23 ' A' ' 24' ' ' THR . 1.1 tt -49.32 -36.69 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.032 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -44.13 80.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.61 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -72.44 -36.64 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.529 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.643 ' CZ ' HD13 ' A' ' 55' ' ' ILE . 33.0 m-85 -69.63 -49.93 49.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.963 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 20' ' ' ILE . 77.0 p -49.78 -38.88 36.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.139 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -22.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.174 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HG3' ' HG ' ' A' ' 45' ' ' LEU . 7.9 mm-40 -99.55 -23.46 15.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.27 44.94 0.54 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.15 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.029 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.61 38.91 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.928 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -99.27 -26.93 14.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.159 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.47 107.09 16.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.149 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.518 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.65 -29.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.948 0.404 . . . . 0.0 111.175 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 83.1 m-85 -55.02 -22.36 15.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.621 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.01 -25.79 29.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.029 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -107.98 18.75 20.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.287 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.434 ' HG3' ' HA ' ' A' ' 32' ' ' TYR . 1.4 mm-40 -59.86 -44.39 94.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.088 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.85 -16.41 15.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.202 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.612 HD11 ' HB3' ' A' ' 41' ' ' ASP . 12.4 tp -44.39 153.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.982 0.42 . . . . 0.0 111.595 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.617 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -140.12 178.64 7.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.772 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.808 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.2 tp -61.85 -32.59 54.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.414 0.626 . . . . 0.0 109.409 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.8 -46.83 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.698 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.612 ' HB3' HD11 ' A' ' 37' ' ' LEU . 4.5 m-20 -83.41 -31.55 26.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -50.04 -49.65 50.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.336 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 52' ' ' ARG . . . -72.13 -18.11 77.72 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.403 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -61.98 -37.93 86.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.458 . . . . 0.0 110.388 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 47' ' ' ILE . 8.6 mp -50.25 -27.38 5.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 84.04 19.65 0.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.762 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.621 HD11 HD23 ' A' ' 45' ' ' LEU . 4.5 mt -85.12 137.27 37.42 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HD2' HG22 ' A' ' 47' ' ' ILE . 92.0 Cg_exo -41.75 139.31 2.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.573 2.182 . . . . 0.0 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -74.81 61.15 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -85.14 -52.33 6.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.11 36.01 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.685 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HB3' HD11 ' A' ' 39' ' ' ILE . 2.1 ttp180 -59.84 -53.14 61.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.808 ' HA ' HD13 ' A' ' 39' ' ' ILE . 1.4 ptm -60.17 -41.19 92.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -59.44 -47.14 86.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 110.582 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.78 HD11 ' SG ' ' A' ' 16' ' ' CYS . 21.3 mt -58.51 -47.8 87.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.628 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.42 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.3 t90 -55.57 -59.67 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.319 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 0.3 OUTLIER -47.22 -39.72 14.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.179 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.42 -26.87 64.69 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.999 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.809 HD11 HD12 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -78.29 -35.02 48.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 110.781 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 7.2 pt20 -70.22 -27.95 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.212 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.494 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.6 tm? . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.76 0.314 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.671 ' N ' HD13 ' A' ' 7' ' ' LEU . 21.4 t -59.14 -43.91 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.983 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.69 -36.37 62.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -81.93 -47.03 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 20' ' ' ILE . 1.9 tm? -49.59 -33.95 16.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.616 HG23 ' HA ' ' A' ' 17' ' ' PRO . 2.2 m -83.2 -61.83 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.923 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.81 -28.72 3.93 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.874 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.707 HD11 ' HA ' ' A' ' 55' ' ' ILE . 4.1 tt -51.84 -24.49 6.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.709 177.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.93 14.2 9.52 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.738 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 87.0 m -121.16 64.31 13.25 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.689 0.28 . . . . 0.0 111.118 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.616 ' HA ' HG23 ' A' ' 12' ' ' THR . 60.5 Cg_endo -72.51 -11.26 26.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.516 2.144 . . . . 0.0 112.686 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -131.41 19.73 4.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.221 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.42 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -111.85 -27.04 8.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.89 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.7 tt -49.6 -34.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.51 -45.62 77.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.755 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -74.63 -36.3 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.418 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -66.88 -44.71 80.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 20' ' ' ILE . 56.3 p -58.53 -34.31 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.8 m -51.47 -24.17 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.162 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -100.7 -37.46 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.865 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.4 45.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.333 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.06 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.61 40.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 7' ' ' LEU . 5.8 pt20 -99.07 -28.96 13.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.981 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.05 110.67 21.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.083 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.565 ' HB ' HD23 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -45.7 -28.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.937 0.399 . . . . 0.0 111.2 -178.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -57.93 -22.32 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.57 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -20.67 36.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.06 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.57 21.03 14.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.28 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.55 -18.94 64.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.385 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -134.28 18.17 3.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.681 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -81.54 145.82 30.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.66 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.7 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -131.7 173.69 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.485 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 8.5 tp -57.94 -35.92 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.443 0.64 . . . . 0.0 109.293 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.14 -44.8 68.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.337 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 26.7 m-20 -84.79 -34.33 22.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.729 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.681 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -50.88 -58.66 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.57 179.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.36 -20.0 35.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.469 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -64.06 -41.04 97.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.682 HD23 HD11 ' A' ' 47' ' ' ILE . 8.8 mp -48.16 -28.0 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.219 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 82.13 19.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.974 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HD23 ' A' ' 45' ' ' LEU . 7.3 mt -76.45 137.89 67.52 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.568 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 1.9 Cg_endo -40.66 131.79 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.964 2.442 . . . . 0.0 112.206 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.96 63.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.275 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' A' ' 48' ' ' PRO . 3.4 mm-40 -85.19 -60.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -140.32 36.29 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.751 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.916 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -49.33 -45.99 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.271 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 57' ' ' ARG . 2.3 ptp -62.14 -47.56 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 m -54.2 -40.37 67.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 52' ' ' ARG . 7.8 mt -63.29 -58.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.135 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.7 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.5 t90 -49.92 -45.6 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.396 . . . . 0.0 110.21 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.4 ' CG ' ' O ' ' A' ' 53' ' ' MET . 3.2 mmt180 -55.5 -51.56 66.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.625 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.58 -41.63 89.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.855 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 34' ' ' LEU . 1.1 tp -62.13 -32.83 73.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.507 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 50.8 mt-30 -70.3 -26.84 63.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.303 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.4 tm? . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.754 0.311 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.775 ' N ' HD13 ' A' ' 7' ' ' LEU . 48.1 t -60.8 -43.9 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.223 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -23.56 63.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.166 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.22 -48.73 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.137 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.544 HD12 ' HB ' ' A' ' 20' ' ' ILE . 3.1 tm? -48.59 -52.16 24.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.986 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.846 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.3 m -73.6 -48.68 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.707 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.82 -30.33 28.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.37 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.6 tp -60.13 -17.69 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 111.197 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 121.01 12.6 5.8 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.551 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.85 65.72 5.25 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.085 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.846 ' HA ' HG23 ' A' ' 12' ' ' THR . 77.1 Cg_endo -77.4 -5.09 15.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -136.49 18.81 3.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.626 0.25 . . . . 0.0 111.457 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -116.63 -22.26 8.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.296 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.544 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.5 tt -51.53 -34.94 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.171 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -54.94 -46.06 74.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.703 ' HB2' HD12 ' A' ' 47' ' ' ILE . 6.1 m-85 -76.04 -31.74 58.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.703 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.503 ' CE1' HD22 ' A' ' 45' ' ' LEU . 14.6 m-85 -70.3 -43.88 69.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.236 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 20' ' ' ILE . 41.1 p -62.67 -28.81 70.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.779 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 t -51.22 -25.02 4.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -100.17 -52.25 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.74 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.7 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.001 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.59 37.34 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.422 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -99.69 -29.05 12.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.813 178.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.57 109.08 19.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.521 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -44.02 -29.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.955 0.407 . . . . 0.0 111.543 -178.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -56.36 -22.48 31.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.57 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -84.03 -20.55 32.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.001 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.33 14.83 21.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.49 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -20.53 65.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -133.41 24.36 4.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.31 . . . . 0.0 111.104 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.651 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.37 121.25 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.828 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.517 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -99.44 175.72 5.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.111 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.854 HD13 ' HA ' ' A' ' 53' ' ' MET . 5.1 tp -64.85 -32.1 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.613 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.12 -45.03 83.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.2 m-20 -83.29 -32.18 26.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.795 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.651 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -52.86 -64.38 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.359 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.429 ' HA3' ' NE ' ' A' ' 52' ' ' ARG . . . -58.3 -23.25 52.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.992 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -54.39 -37.32 64.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 110.519 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.503 HD22 ' CE1' ' A' ' 23' ' ' PHE . 8.2 mp -59.52 -15.6 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.777 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 1.6 mtmt 78.71 17.9 0.99 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 22' ' ' TYR . 6.1 mm -80.52 138.76 51.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.269 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 4.7 Cg_exo -36.34 140.32 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.224 2.616 . . . . 0.0 112.519 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -91.13 23.46 3.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.593 -178.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -67.96 -31.74 71.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.65 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.32 23.69 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.82 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -50.69 -58.38 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.99 0.424 . . . . 0.0 110.782 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.854 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -53.95 -52.05 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 m -48.17 -43.99 32.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 52' ' ' ARG . 10.3 mt -58.8 -59.09 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.516 ' CZ2' HG23 ' A' ' 38' ' ' THR . 0.1 OUTLIER -53.1 -55.31 24.93 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.856 0.36 . . . . 0.0 110.403 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 1.2 mtt180 -44.8 -40.07 5.82 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.837 0.351 . . . . 0.0 111.575 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.11 -25.14 67.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.153 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 34' ' ' LEU . 1.1 mp -82.16 -35.19 28.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.763 0.316 . . . . 0.0 111.083 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.493 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.3 pt20 -71.51 -27.63 63.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.281 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.629 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.6 tm? . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.728 0.299 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.544 ' N ' HD13 ' A' ' 7' ' ' LEU . 40.4 t -56.88 -57.08 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.319 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 p -55.79 -21.78 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.545 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -88.04 -53.86 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.775 0.321 . . . . 0.0 111.178 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.794 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.2 tm? -48.25 -52.0 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.109 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.836 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.0 m -71.65 -46.61 58.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.697 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.14 -33.37 30.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.358 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.6 tp -64.53 -13.42 52.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.677 0.275 . . . . 0.0 111.499 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.86 13.81 7.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.5 m -112.24 60.91 0.58 Allowed Pre-proline 0 CA--C 1.528 0.133 0 CA-C-O 120.665 0.269 . . . . 0.0 111.287 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.836 ' HA ' HG23 ' A' ' 12' ' ' THR . 56.1 Cg_endo -69.81 -30.44 22.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -124.21 19.77 9.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.798 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.9 m -109.45 -27.31 9.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.666 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' A' ' 11' ' ' LEU . 13.2 tt -52.08 -31.71 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.702 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 8.9 pt-20 -59.76 -44.55 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.507 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 59.9 m-85 -72.0 -30.89 65.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.232 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -74.13 -51.82 14.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.758 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 20' ' ' ILE . 60.4 p -49.4 -34.07 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -51.36 -24.23 4.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -99.86 -43.3 6.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 45.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.151 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.908 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.97 39.98 1.24 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.87 0.367 . . . . 0.0 111.007 -179.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.51 -25.07 14.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.134 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 t -111.33 108.28 17.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.527 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -48.0 -26.72 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -59.5 -21.76 60.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.563 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.68 -19.03 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.908 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.48 11.8 21.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.622 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -61.77 -21.51 64.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.301 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -132.43 21.24 4.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.534 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -77.88 146.0 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.669 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.608 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -127.99 172.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 0.0 111.589 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' A' ' 53' ' ' MET . 7.6 tp -58.94 -33.36 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.515 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.99 -49.29 76.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.625 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' HB3' HD21 ' A' ' 37' ' ' LEU . 1.7 m-20 -82.8 -15.1 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.789 HD23 HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -69.51 -56.56 7.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.882 0.372 . . . . 0.0 110.246 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.77 63.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.049 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.4 53.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.043 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 47' ' ' ILE . 4.6 mp -72.25 -3.9 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.95 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 15.4 ptpt 49.93 33.37 6.54 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 121.014 0.435 . . . . 0.0 111.427 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.546 HD11 HD23 ' A' ' 45' ' ' LEU . 36.6 mt -83.52 138.72 41.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.986 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 46.4 Cg_exo -35.39 119.37 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.008 2.472 . . . . 0.0 112.949 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.91 68.6 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.355 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -85.21 -65.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 0.0 110.665 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.68 36.64 2.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.4 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -48.63 -43.31 36.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.232 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.594 ' HA ' HD13 ' A' ' 39' ' ' ILE . 12.4 mtt -59.44 -50.54 73.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.649 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -50.77 -47.79 59.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.658 ' HA ' HD23 ' A' ' 14' ' ' LEU . 11.1 mm -55.92 -55.85 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.608 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.0 t90 -50.36 -62.94 1.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.29 -30.44 50.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.149 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -78.8 -27.36 56.88 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.839 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -75.99 -38.89 56.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 110.691 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.48 -26.01 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.327 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.673 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.3 tm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.66 ' N ' HD13 ' A' ' 7' ' ' LEU . 29.2 m -65.28 -31.4 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -72.5 -25.16 61.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -54.52 4.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.684 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.494 HD13 HD12 ' A' ' 28' ' ' LEU . 4.9 tp -51.03 -54.23 26.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.18 0.514 . . . . 0.0 110.372 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.929 HG23 ' HA ' ' A' ' 17' ' ' PRO . 25.6 m -58.51 -50.87 72.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.497 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.36 -30.22 48.4 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.973 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.693 HD11 ' HA3' ' A' ' 58' ' ' GLY . 3.8 tp -59.5 -18.17 37.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 111.046 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.3 17.15 6.3 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.158 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.439 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 4.3 m -118.93 61.41 5.15 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.681 0.277 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.929 ' HA ' HG23 ' A' ' 12' ' ' THR . 49.2 Cg_endo -68.78 -19.8 40.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.455 2.104 . . . . 0.0 112.16 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -129.56 23.96 5.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -114.67 -24.61 8.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.823 ' O ' HG23 ' A' ' 24' ' ' THR . 13.1 tt -51.43 -46.91 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.3 mm-40 -51.42 -45.18 62.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.657 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.7 m-30 -64.84 -32.02 73.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.574 ' CE1' HD22 ' A' ' 45' ' ' LEU . 2.5 m-85 -79.28 -28.04 42.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.55 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 20' ' ' ILE . 45.2 p -70.73 -24.52 62.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.145 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.4 ' OG ' ' NE2' ' A' ' 26' ' ' GLN . 93.6 p -50.62 -24.81 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.4 ' NE2' ' OG ' ' A' ' 25' ' ' SER . 4.3 mm-40 -104.24 -51.56 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.08 55.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.113 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.08 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.58 38.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.095 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -25.4 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.283 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.15 104.76 13.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.887 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.55 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.99 -27.52 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.452 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -21.25 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.71 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.6 -23.71 31.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.958 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.08 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -106.27 16.98 24.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -73.23 -20.93 60.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.268 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -128.87 20.37 5.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.324 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.621 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.12 120.6 26.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.053 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.492 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -99.79 176.75 5.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.267 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' A' ' 53' ' ' MET . 7.4 tp -65.16 -31.52 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -56.03 -42.84 77.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.266 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.507 ' HB3' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -85.09 -32.44 22.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.801 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.621 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -54.87 -52.49 62.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.456 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -71.12 -16.28 74.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.411 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -63.02 -44.81 94.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.946 0.403 . . . . 0.0 110.488 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.574 HD22 ' CE1' ' A' ' 23' ' ' PHE . 10.0 mp -44.09 -28.38 0.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.749 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.7 tttt 88.22 17.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.434 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.56 HD11 HD23 ' A' ' 45' ' ' LEU . 4.0 mt -78.24 138.15 60.28 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.9 Cg_exo -40.42 144.65 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.534 2.156 . . . . 0.0 112.419 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.53 54.08 2.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.416 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 78.7 mt-30 -84.93 -44.62 12.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.791 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 50' ' ' GLN . 4.8 m-85 -140.23 29.08 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.669 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -46.54 -61.8 1.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.106 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.733 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -55.66 -47.03 77.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.004 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 52.4 m -55.23 -38.86 69.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 52' ' ' ARG . 10.8 mt -63.96 -56.24 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.838 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.509 ' CH2' ' HB3' ' A' ' 60' ' ' GLN . 0.3 OUTLIER -56.69 -61.28 2.54 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.477 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -47.04 -32.87 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.663 0.268 . . . . 0.0 111.348 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.693 ' HA3' HD11 ' A' ' 14' ' ' LEU . . . -77.62 -27.8 58.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.681 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -79.01 -44.45 22.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.388 . . . . 0.0 110.725 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.509 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.5 pt20 -59.9 -27.02 66.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.155 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.315 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.731 ' CD2' HD11 ' A' ' 34' ' ' LEU . 2.8 tm? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.697 0.284 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.922 HG12 HD11 ' A' ' 20' ' ' ILE . 3.5 m -50.07 -42.51 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.4 -27.92 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.037 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.67 -56.25 4.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.533 HD23 ' HB ' ' A' ' 20' ' ' ILE . 7.1 tp -47.41 -55.99 7.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 0.0 110.698 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.824 HG23 ' HA ' ' A' ' 17' ' ' PRO . 63.4 m -53.15 -52.05 60.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.35 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.57 -31.05 52.04 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.028 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.8 tp -56.95 -19.88 20.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 19.02 5.29 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.332 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.5 p -134.51 66.08 69.08 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.676 0.274 . . . . 0.0 111.246 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.824 ' HA ' HG23 ' A' ' 12' ' ' THR . 11.8 Cg_exo -71.54 -9.95 25.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.754 2.303 . . . . 0.0 112.777 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -126.26 16.37 7.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.095 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -113.46 -22.91 10.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.179 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HG12 ' A' ' 8' ' ' VAL . 16.0 tt -54.18 -35.31 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.988 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.792 ' HA ' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -66.07 -41.67 90.42 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.193 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.462 ' CB ' HD13 ' A' ' 47' ' ' ILE . 62.5 m-85 -63.74 -26.97 68.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.612 ' CE1' HD22 ' A' ' 45' ' ' LEU . 2.3 m-85 -91.31 -35.95 14.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.469 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.792 HG22 ' HA ' ' A' ' 21' ' ' GLU . 4.4 t -70.72 -16.17 62.76 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.422 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -61.5 -23.0 65.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.742 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.12 -57.37 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.12 39.42 0.03 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.057 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.68 37.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.377 -179.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -99.86 -29.85 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.3 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -104.12 107.92 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.534 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -43.63 -30.06 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 -177.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.4 -21.49 25.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.674 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -85.4 -26.86 26.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -97.84 14.94 25.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -63.08 -37.78 88.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.437 0.637 . . . . 0.0 111.424 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.03 -14.78 14.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.268 -176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.726 HD12 HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -44.11 145.53 0.75 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -133.67 173.81 11.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.175 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.745 HD13 ' HA ' ' A' ' 53' ' ' MET . 8.8 tp -63.09 -34.6 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.638 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 2.9 pt-20 -61.98 -38.51 88.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.47 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 58.1 m-20 -84.99 -27.65 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.383 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.726 HD23 HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -56.42 -59.73 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.29 -19.81 60.1 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.118 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -56.64 -36.03 69.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.057 0.456 . . . . 0.0 110.284 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 23' ' ' PHE . 6.8 mp -60.92 -15.53 32.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.607 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 73.77 17.47 3.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 111.248 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.482 HD11 HD23 ' A' ' 45' ' ' LEU . 12.0 mt -79.46 137.87 55.43 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.3 Cg_exo -44.44 136.04 8.83 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.524 2.149 . . . . 0.0 112.299 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -68.41 62.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.234 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -85.44 -58.05 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.759 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.36 36.98 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.597 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.7 -64.74 0.77 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.745 ' HA ' HD13 ' A' ' 39' ' ' ILE . 3.3 ppp? -52.14 -42.91 63.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 52.9 m -53.13 -48.47 67.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.604 ' HA ' HD23 ' A' ' 14' ' ' LEU . 38.6 mt -62.94 -44.03 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.4 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 9.5 t90 -56.72 -55.23 36.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.438 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.3 ptm180 -59.46 -30.67 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.989 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -79.2 -26.33 57.87 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.822 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -81.08 -41.42 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.807 0.337 . . . . 0.0 110.485 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.77 -27.67 69.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.364 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.527 179.015 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.735 0.302 . . . . 0.0 111.065 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 m -43.0 -36.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.794 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -58.06 -51.52 69.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.104 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.54 -38.54 48.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.312 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.785 HD21 HD12 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -46.82 -57.25 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.05 0.452 . . . . 0.0 111.119 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.883 HG23 ' HA ' ' A' ' 17' ' ' PRO . 22.0 m -71.55 -50.52 30.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.804 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.2 -30.07 16.82 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.266 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.7 tp -58.15 -18.78 27.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.132 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 15.63 6.53 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.357 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 m -122.92 72.26 43.68 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.683 0.278 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.883 ' HA ' HG23 ' A' ' 12' ' ' THR . 83.3 Cg_endo -83.33 6.49 5.77 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.67 2.247 . . . . 0.0 113.064 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -145.3 17.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.604 0.24 . . . . 0.0 111.534 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -118.23 -21.05 8.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.396 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 24' ' ' THR . 6.6 tt -50.26 -38.55 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.989 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.35 -46.25 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.54 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.345 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.682 ' HZ ' HD13 ' A' ' 55' ' ' ILE . 29.3 m-85 -63.12 -54.71 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 20' ' ' ILE . 80.7 p -51.72 -30.49 22.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.963 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 p -50.66 -25.79 4.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -101.24 -45.88 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.04 45.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.183 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.46 44.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 110.927 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.643 ' C ' HD12 ' A' ' 7' ' ' LEU . 2.8 pt20 -107.98 -19.4 13.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.453 177.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.562 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -121.57 103.16 8.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.606 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.524 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -40.76 -31.64 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.137 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -56.09 -21.3 21.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.21 -24.66 27.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.978 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -103.21 16.52 26.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.105 0.479 . . . . 0.0 111.003 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -59.68 -39.82 85.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.34 -20.06 13.39 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.647 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -46.04 150.63 0.56 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.356 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.774 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -140.32 177.35 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.213 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.49 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 9.5 tp -59.1 -34.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.37 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -59.15 -39.2 81.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.227 178.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -85.53 -33.57 21.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.542 178.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.595 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -53.52 -50.19 65.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.479 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -22.16 68.95 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.029 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -62.86 -27.28 69.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.0 mp -62.53 -14.77 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.494 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 5.0 mttm 72.53 16.72 4.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.804 0.335 . . . . 0.0 111.366 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 9.0 mt -85.39 138.7 36.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.4 Cg_exo -44.95 130.74 10.42 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.232 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -68.01 64.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -85.04 -52.27 6.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.655 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -140.15 25.61 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.798 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -49.04 -48.2 44.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.194 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.483 ' HA ' HD13 ' A' ' 39' ' ' ILE . 35.8 mtm -57.36 -56.57 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -49.79 -44.26 48.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 52' ' ' ARG . 14.3 mt -57.11 -55.36 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.774 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.2 t90 -52.45 -50.4 62.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -52.79 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.92 -39.99 80.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 34' ' ' LEU . 2.6 mp -66.19 -29.17 69.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.486 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.52 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 35.3 mt-30 -74.43 -28.03 60.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.391 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.77 179.385 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.784 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.5 tm? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.685 0.279 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.784 ' N ' HD13 ' A' ' 7' ' ' LEU . 2.9 m -53.28 -34.35 22.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.381 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 t -63.55 -33.15 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.381 . . . . 0.0 111.27 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.42 -48.47 7.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.645 HD11 HD12 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -47.58 -53.14 15.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.783 HG23 ' HA ' ' A' ' 17' ' ' PRO . 50.9 m -74.45 -48.0 30.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.731 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.18 -29.86 30.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.055 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.715 HD21 ' HA3' ' A' ' 58' ' ' GLY . 4.0 tp -59.31 -17.94 33.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.669 0.271 . . . . 0.0 111.274 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.26 19.36 5.9 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.181 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 85.0 m -126.87 73.74 76.0 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.709 0.29 . . . . 0.0 110.992 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.783 ' HA ' HG23 ' A' ' 12' ' ' THR . 7.7 Cg_endo -84.74 -0.26 9.23 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.068 2.512 . . . . 0.0 112.918 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.8 13.58 3.4 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 1.3 m -117.53 -20.19 9.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.601 0.239 . . . . 0.0 111.419 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.525 ' CG1' HD22 ' A' ' 11' ' ' LEU . 13.9 tt -51.67 -28.96 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.926 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.506 ' HA ' HG22 ' A' ' 24' ' ' THR . 4.8 mm-40 -68.64 -43.38 76.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.256 0.551 . . . . 0.0 110.388 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.5 m-30 -68.33 -24.76 64.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.249 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.8 -32.38 15.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 21' ' ' GLU . 2.6 t -69.32 -10.37 57.54 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.993 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -19.35 62.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.714 ' CD ' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.3 -20.74 11.73 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.362 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 33' ' ' HIS . . . 131.82 51.39 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.435 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.067 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -109.45 37.68 2.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.889 0.376 . . . . 0.0 111.129 179.005 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -99.36 -30.43 12.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.92 109.48 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.706 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.547 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -44.38 -27.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 111.657 -177.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -20.63 59.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.762 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.468 ' CG ' ' O ' ' A' ' 27' ' ' GLY . 46.5 t-80 -85.06 -19.11 32.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.997 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.067 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.16 14.0 21.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.528 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.21 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.053 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -125.06 16.95 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.33 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.563 HD13 HD21 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -85.11 140.44 30.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.386 . . . . 0.0 110.684 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.637 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -128.81 -179.84 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.047 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.801 HD13 ' HA ' ' A' ' 53' ' ' MET . 3.8 tp -58.25 -34.26 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -52.19 -43.26 64.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.274 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.444 ' HB3' ' CD2' ' A' ' 37' ' ' LEU . 4.3 m-20 -83.99 -30.07 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.588 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -67.41 -36.98 82.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.794 178.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.459 ' HA2' ' CZ ' ' A' ' 52' ' ' ARG . . . -79.88 2.23 75.45 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.75 -41.13 16.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.714 HD11 ' CD ' ' A' ' 26' ' ' GLN . 3.7 mt -62.69 -12.31 22.82 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.069 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 71.31 15.23 6.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 111.264 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 48' ' ' PRO . 25.1 mm -61.17 138.58 94.44 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.474 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 47' ' ' ILE . 4.3 Cg_exo -37.02 153.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.581 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 11.1 tt0 -92.69 23.12 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.429 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -85.07 -33.22 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.54 ' O ' HD12 ' A' ' 55' ' ' ILE . 7.5 m-85 -135.16 12.32 3.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.459 ' CZ ' ' HA2' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -54.09 -68.29 0.19 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 179.475 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.801 ' HA ' HD13 ' A' ' 39' ' ' ILE . 2.9 mtm -53.33 -42.26 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.871 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -51.4 -50.75 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.581 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.664 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.2 mt -56.65 -56.96 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.637 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.2 t90 -49.85 -54.89 16.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 6.6 mmt180 -51.37 -32.32 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.715 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -78.53 -25.25 61.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.797 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.967 HD11 HD12 ' A' ' 34' ' ' LEU . 1.2 tp -80.94 -40.58 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.494 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 4.4 pt20 -63.15 -27.76 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.071 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.11 178.403 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.1 tm? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.789 0.328 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' N ' HD13 ' A' ' 7' ' ' LEU . 35.3 m -66.12 -37.31 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.168 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 p -63.19 -26.48 68.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -95.7 -46.78 6.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.17 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tm? -49.58 -52.7 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.862 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 17' ' ' PRO . 91.5 m -77.6 -46.74 21.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.472 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.11 -26.98 6.64 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.362 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.809 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -54.52 -22.5 13.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.774 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.64 16.91 5.76 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.353 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.425 ' HB3' ' CG ' ' A' ' 51' ' ' TYR . 4.6 p -130.12 80.54 70.7 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.772 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.747 ' HA ' HG23 ' A' ' 12' ' ' THR . 71.6 Cg_endo -78.61 6.1 5.09 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.714 2.276 . . . . 0.0 112.996 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -135.56 22.47 3.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.674 0.273 . . . . 0.0 111.143 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 4.8 t -114.27 -28.62 7.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.967 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 24' ' ' THR . 1.6 tt -50.87 -45.59 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.916 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.511 ' N ' HG23 ' A' ' 20' ' ' ILE . 2.1 pt-20 -49.66 -44.45 47.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.427 ' HB2' HD13 ' A' ' 47' ' ' ILE . 70.5 m-85 -69.84 -35.46 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.692 ' CE1' HD12 ' A' ' 47' ' ' ILE . 3.2 m-85 -70.68 -49.6 45.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.73 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 20' ' ' ILE . 71.7 p -55.28 -24.34 27.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -49.15 -30.37 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.244 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -99.99 -53.56 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.1 48.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.99 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.105 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -99.51 40.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.047 -179.083 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -99.1 -27.45 13.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.867 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.1 104.39 12.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.527 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -43.81 -29.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.99 0.424 . . . . 0.0 111.278 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -55.23 -23.63 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.668 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.45 -21.16 35.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.955 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.105 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.06 22.04 14.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -32.41 71.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.55 -18.36 11.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.716 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.466 HD23 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -44.45 140.86 2.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.344 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.645 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -128.69 179.18 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.118 -179.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.848 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.6 tp -57.3 -33.65 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.482 0.658 . . . . 0.0 109.276 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.75 -47.49 79.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.539 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.1 m-20 -80.18 -27.52 38.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.673 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -55.18 -52.48 63.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.177 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -15.18 62.89 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.324 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -66.06 -40.31 90.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.561 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 47' ' ' ILE . 8.9 mp -47.3 -27.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.347 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 5.9 ttmm 86.66 16.09 0.1 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.633 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.692 HD12 ' CE1' ' A' ' 23' ' ' PHE . 2.8 mt -86.21 137.69 34.83 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.816 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 3.0 Cg_endo -45.26 158.87 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.675 2.25 . . . . 0.0 112.023 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.45 57.8 4.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.177 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.47 -58.12 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.58 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.425 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 1.5 m-85 -137.15 33.48 2.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.616 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.1 ttp180 -56.52 -66.66 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.01 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.848 ' HA ' HD13 ' A' ' 39' ' ' ILE . 59.4 mtt -54.84 -34.81 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.68 ' CG2' HD12 ' A' ' 14' ' ' LEU . 55.2 m -58.14 -49.98 75.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.729 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.618 HD13 ' CE2' ' A' ' 23' ' ' PHE . 60.0 mt -66.13 -35.72 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.602 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.645 ' NE1' HG22 ' A' ' 38' ' ' THR . 10.6 t90 -59.48 -55.82 29.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.941 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.433 ' NH1' ' HB3' ' A' ' 53' ' ' MET . 0.0 OUTLIER -53.34 -39.48 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.621 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.809 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -67.96 -40.98 88.75 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.91 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 34' ' ' LEU . 1.1 tp -64.26 -38.67 91.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.332 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.47 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 36.7 mt-30 -63.82 -31.15 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.199 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.216 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.688 0.28 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 31.5 m170 50.41 94.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 2' ' ' HIS . . . 67.32 148.36 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.114 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -140.4 75.71 26.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 7' ' ' LEU . 35.5 Cg_exo -59.83 -37.45 86.31 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.571 2.181 . . . . 0.0 112.286 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -64.91 73.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.056 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.616 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.9 tm? 177.3 -50.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' N ' HD13 ' A' ' 7' ' ' LEU . 46.4 t -67.85 -50.87 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.166 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -25.01 65.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.116 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -50.9 6.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.029 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.795 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.2 tm? -48.9 -53.03 21.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.015 0.436 . . . . 0.0 110.859 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.838 HG23 ' HA ' ' A' ' 17' ' ' PRO . 55.8 m -74.69 -46.88 34.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.46 -29.82 17.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.286 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.8 tp -62.38 -15.05 46.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.642 0.258 . . . . 0.0 111.277 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.59 12.78 8.48 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.419 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 55' ' ' ILE . 34.1 m -116.12 67.21 3.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.684 0.278 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.838 ' HA ' HG23 ' A' ' 12' ' ' THR . 59.5 Cg_endo -72.55 -17.5 26.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.526 2.151 . . . . 0.0 112.521 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -130.04 21.36 5.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.028 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -28.07 8.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.795 ' HB ' HD12 ' A' ' 11' ' ' LEU . 2.4 tt -52.2 -34.76 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.817 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.96 -44.05 86.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.667 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -71.98 -33.57 68.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.482 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.534 ' CE1' HD22 ' A' ' 45' ' ' LEU . 10.2 m-85 -73.76 -45.19 53.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.58 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' ILE . 65.9 p -55.73 -32.08 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.79 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -49.52 -25.92 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.996 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -99.9 -48.07 4.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.44 47.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.469 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.137 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.24 39.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.126 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.56 -30.24 12.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.039 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.52 110.47 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.075 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.537 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -46.44 -27.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.004 0.431 . . . . 0.0 111.279 -178.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -21.82 49.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.63 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -21.52 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.214 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.137 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.3 19.25 19.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -28.61 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.329 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.75 -20.44 10.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.513 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -44.94 148.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.633 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.668 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -140.39 178.63 7.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.121 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.6 tp -59.65 -33.33 51.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.48 0.657 . . . . 0.0 109.23 176.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.18 -50.94 71.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -78.04 -24.27 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.9 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -59.71 -48.82 80.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.509 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.63 -6.9 60.09 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.734 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -77.38 -43.63 32.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.964 0.412 . . . . 0.0 110.432 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.681 HD23 HD11 ' A' ' 47' ' ' ILE . 9.3 mp -47.35 -29.11 2.35 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.174 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER 82.44 21.37 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.681 HD11 HD23 ' A' ' 45' ' ' LEU . 4.5 mt -81.35 138.0 48.52 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.305 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.0 Cg_exo -39.66 136.76 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.527 2.151 . . . . 0.0 112.294 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -78.73 55.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.399 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.53 -43.16 13.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -140.36 30.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -50.71 -59.31 4.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.572 ' HA ' HD13 ' A' ' 39' ' ' ILE . 5.9 ptm -59.37 -44.49 92.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.408 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 54.9 m -51.7 -50.19 60.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.456 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.69 ' HA ' HD23 ' A' ' 14' ' ' LEU . 17.6 mt -59.74 -46.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.668 ' NE1' HG22 ' A' ' 38' ' ' THR . 13.2 t90 -57.64 -61.65 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.56 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.8 ptm180 -51.78 -31.16 25.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.684 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -74.7 -36.58 47.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.714 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 34' ' ' LEU . 2.6 tp -67.46 -42.08 83.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.253 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.523 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 37.3 mt-30 -61.02 -27.69 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.279 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -57.56 -40.24 78.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.292 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.22 -52.07 67.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.48 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -37.61 81.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.738 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -60.98 -80.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.734 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.86 140.06 8.27 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.674 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -120.39 102.69 8.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.742 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.42 120.46 6.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.938 -179.871 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -90.54 74.63 6.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.01 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.36 171.79 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -135.67 68.63 66.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.776 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.31 -28.81 27.92 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.542 2.161 . . . . 0.0 112.295 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.19 61.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.643 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -179.17 -50.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.72 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.585 ' N ' HD13 ' A' ' 7' ' ' LEU . 7.8 p -66.1 -33.84 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -28.02 64.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.712 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -85.7 -47.5 9.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -52.93 -48.45 67.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.363 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.7 m -81.06 -40.83 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.097 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.25 -30.83 11.56 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.195 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -57.1 -20.46 25.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 178.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.94 19.06 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.185 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 78.85 35.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.638 0.256 . . . . 0.0 110.974 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 12' ' ' THR . 87.7 Cg_endo -84.74 13.85 2.64 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.656 2.237 . . . . 0.0 112.93 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -143.0 25.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 111.022 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.18 -34.34 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.294 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.683 ' O ' HG22 ' A' ' 24' ' ' THR . 0.5 OUTLIER -46.95 -28.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -59.8 -46.6 88.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.095 0.474 . . . . 0.0 110.625 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.43 ' HB2' HD13 ' A' ' 47' ' ' ILE . 38.7 m-85 -78.72 -28.65 45.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -77.46 -43.85 30.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.841 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 20' ' ' ILE . 14.8 t -67.49 -28.74 68.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.754 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 m -54.12 -22.42 11.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.968 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.406 ' HG3' ' HG ' ' A' ' 45' ' ' LEU . 1.1 mm-40 -99.78 -56.72 2.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.33 43.51 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.213 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.035 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.2 40.78 1.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.833 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -99.46 -27.53 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.965 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.09 109.95 18.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.116 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -46.48 -27.52 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 111.095 -178.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -58.04 -22.22 49.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -84.18 -19.19 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.03 4.45 15.7 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.83 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -53.31 -36.48 61.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.724 0.297 . . . . 0.0 111.186 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -112.81 19.41 17.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' ' 41' ' ' ASP . 12.8 tp -84.79 155.98 21.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.641 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -139.27 177.38 7.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.308 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.877 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.5 tp -58.29 -34.16 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.419 0.628 . . . . 0.0 109.42 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.89 -47.33 77.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.715 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.75 ' HB3' HD11 ' A' ' 37' ' ' LEU . 21.0 m-20 -80.93 -31.0 35.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.551 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -51.3 -51.39 54.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.28 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.09 -20.33 77.87 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.324 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -58.04 -44.17 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.14 0.495 . . . . 0.0 110.202 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.639 HD23 HD11 ' A' ' 47' ' ' ILE . 8.1 mp -48.52 -29.46 4.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.318 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.8 ttpt 86.63 19.43 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.315 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.639 HD11 HD23 ' A' ' 45' ' ' LEU . 3.8 mt -83.98 138.62 39.96 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.242 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.463 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 61.7 Cg_exo -36.81 151.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.83 2.353 . . . . 0.0 112.703 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 1.9 pt-20 -91.65 22.47 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 33.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HB3' HD11 ' A' ' 39' ' ' ILE . 1.4 ttp180 -62.16 -51.14 69.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.891 0.376 . . . . 0.0 111.009 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.877 ' HA ' HD13 ' A' ' 39' ' ' ILE . 2.3 ttp -66.22 -32.32 73.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.121 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 14' ' ' LEU . 56.2 m -59.63 -50.36 74.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . 45.1 mt -62.7 -41.42 92.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.805 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.613 ' NE1' HG22 ' A' ' 38' ' ' THR . 9.4 t90 -57.19 -51.52 69.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.101 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -50.8 -46.85 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.441 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.675 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -65.97 -37.95 93.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.585 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.86 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -61.61 -36.47 80.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 178.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.512 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 56.5 mt-30 -66.53 -28.6 68.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.203 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -64.24 -32.26 73.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.585 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.574 ' CD1' HD11 ' A' ' 31' ' ' ILE . 8.0 mt -69.2 -46.11 68.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.842 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -53.17 59.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.961 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.12 -41.63 94.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.038 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.05 144.37 16.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.568 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -127.17 170.24 12.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.857 0.361 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -178.85 128.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.965 179.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.956 0.408 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -75.98 67.41 2.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -111.06 119.46 39.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.033 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -159.31 64.43 2.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.32 -20.47 61.87 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.595 2.196 . . . . 0.0 112.281 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 m -53.05 -22.93 6.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.5 tm? -66.6 -58.22 5.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.254 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.64 ' N ' HD13 ' A' ' 7' ' ' LEU . 14.5 t -59.01 -45.05 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.433 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -59.38 -30.5 68.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -88.11 -51.87 5.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.336 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.63 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.5 tm? -45.66 -53.21 9.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 111.151 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.857 HG23 ' HA ' ' A' ' 17' ' ' PRO . 51.3 m -74.36 -47.69 32.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.37 -24.35 22.62 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.478 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.618 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.8 tp -61.38 -18.17 57.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.742 0.306 . . . . 0.0 111.327 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.98 18.68 5.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.299 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -134.33 74.6 66.48 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.858 0.361 . . . . 0.0 110.759 179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.857 ' HA ' HG23 ' A' ' 12' ' ' THR . 71.6 Cg_endo -84.63 10.06 3.88 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.809 2.34 . . . . 0.0 112.821 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.3 16.04 2.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 111.221 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -115.28 -22.24 9.5 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.114 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.63 ' HB ' HD12 ' A' ' 11' ' ' LEU . 3.2 tt -50.18 -36.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 110.974 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.501 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 12.2 pt-20 -57.63 -43.84 85.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.501 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 64.3 m-85 -70.71 -32.63 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 22.3 m-85 -73.91 -52.81 11.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.536 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 20' ' ' ILE . 40.3 p -50.67 -29.18 10.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 0.5 OUTLIER -50.57 -27.64 7.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.231 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.17 -42.43 6.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.87 45.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.182 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.035 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.5 40.01 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.892 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -99.22 -27.58 13.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.992 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.48 107.44 16.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.025 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.773 HD11 HD11 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -45.75 -27.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.059 0.457 . . . . 0.0 111.348 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -21.01 34.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.675 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 -22.35 29.04 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -107.01 18.78 21.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 0.0 111.508 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -19.23 64.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.258 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -125.39 -8.69 6.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -61.14 153.88 24.63 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.828 0.347 . . . . 0.0 110.984 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.709 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -140.15 178.31 7.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.063 0.459 . . . . 0.0 111.478 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.487 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 7.4 tp -60.42 -34.0 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.52 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -39.87 78.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.416 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.65 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.4 m-20 -86.05 -34.69 20.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.642 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -48.38 -59.01 3.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.879 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.48 -19.12 32.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.388 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -67.21 -31.02 71.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.4 mp -62.85 -17.52 61.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.488 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 2.3 mtmt 74.19 17.45 3.29 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 111.369 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.449 HG13 ' CB ' ' A' ' 45' ' ' LEU . 7.4 mt -80.95 137.82 49.94 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.678 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 59.6 Cg_exo -37.66 112.81 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.83 2.354 . . . . 0.0 112.787 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -68.15 63.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.112 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -85.11 -50.33 7.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.558 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.06 28.64 2.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.433 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -46.7 -30.54 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.283 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -50.03 48.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.2 m -54.62 -40.0 68.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.369 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.618 ' HA ' HD23 ' A' ' 14' ' ' LEU . 6.8 mm -61.7 -55.65 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.895 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.709 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.5 t90 -52.05 -45.58 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.243 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -51.24 -53.77 32.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.611 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.2 -41.78 54.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 34' ' ' LEU . 3.3 mp -65.37 -28.18 69.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 110.355 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.516 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 47.6 mt-30 -75.07 -28.49 60.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.478 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -67.09 -29.5 69.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.573 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.773 HD11 HD11 ' A' ' 31' ' ' ILE . 15.3 mt -68.13 -49.26 62.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.7 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.05 -67.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.894 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 49.53 30.09 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.43 0.634 . . . . 0.0 111.292 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.75 64.65 0.85 Allowed Glycine 0 C--N 1.315 -0.624 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.477 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -102.67 149.07 24.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.341 . . . . 0.0 110.94 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 p30 176.3 132.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.798 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.92 -179.893 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.854 0.359 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -52.82 153.68 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.02 162.04 13.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.989 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 64.77 50.39 0.9 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 43.0 Cg_endo -67.3 -31.28 35.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.555 2.17 . . . . 0.0 112.238 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.3 m -84.93 54.33 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.014 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.8 tm? -147.91 -61.77 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.65 ' N ' HD13 ' A' ' 7' ' ' LEU . 42.3 t -53.78 -59.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.056 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.1 -6.75 30.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.769 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.43 -59.61 1.97 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.859 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.974 HD13 ' N ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.04 -26.35 68.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.507 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.974 ' N ' HD13 ' A' ' 11' ' ' LEU . 33.1 m -81.11 -50.43 9.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.282 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.23 -25.7 60.47 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.421 ' CD2' ' HA3' ' A' ' 58' ' ' GLY . 5.1 tp -49.63 -24.78 2.38 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.025 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.65 10.45 4.91 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.282 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 73.52 72.82 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 116.958 0.379 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.873 ' HA ' HG23 ' A' ' 12' ' ' THR . 3.1 Cg_exo -77.67 4.03 6.38 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.897 2.398 . . . . 0.0 112.901 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -132.43 19.67 4.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.638 0.256 . . . . 0.0 111.264 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -114.01 -24.23 9.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.046 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.79 HD13 ' HG ' ' A' ' 11' ' ' LEU . 8.5 tp -49.89 -36.65 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.74 -40.67 92.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.548 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.1 m-30 -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.458 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.526 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 6.9 m-85 -80.89 -42.44 21.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 20' ' ' ILE . 11.9 p -52.88 -29.64 29.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -27.12 3.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.259 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -99.94 -58.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.957 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.44 46.86 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.446 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.055 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.4 39.89 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -99.66 -28.95 12.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.105 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -116.21 115.57 26.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.166 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.535 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -47.85 -26.74 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 111.049 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 19.8 m-85 -59.91 -19.39 51.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -85.33 -30.22 23.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.864 0.364 . . . . 0.0 110.55 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.055 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -98.67 23.52 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.492 . . . . 0.0 110.757 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 32' ' ' TYR . 1.3 mm-40 -68.1 -37.91 81.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.607 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.54 -18.17 12.47 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.661 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.797 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -44.78 148.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.303 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.575 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -140.26 173.71 11.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.108 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.496 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 6.9 tp -57.14 -33.77 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.392 0.615 . . . . 0.0 109.384 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.79 -45.35 78.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.332 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -84.62 -31.66 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.797 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -54.49 -45.57 73.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.418 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.445 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -67.66 -10.27 57.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -78.58 -27.76 45.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.116 0.484 . . . . 0.0 110.403 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.526 ' CD2' ' CD2' ' A' ' 23' ' ' PHE . 8.1 mp -62.39 -11.74 17.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.146 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt 77.09 20.18 1.25 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 45' ' ' LEU . 7.1 mm -82.35 131.74 54.9 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.66 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HG2' ' HG3' ' A' ' 50' ' ' GLN . 7.6 Cg_endo -49.7 176.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.667 2.245 . . . . 0.0 112.396 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.59 40.65 1.04 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.96 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.4 ' HG3' ' HG2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -82.5 -51.97 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.811 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -140.24 25.64 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.289 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -51.83 -57.72 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 35.7 mmm -59.98 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.915 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.0 m -50.36 -48.16 55.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.654 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 52' ' ' ARG . 8.3 mt -55.53 -56.96 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.755 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.575 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.5 t90 -51.47 -52.44 46.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.855 0.359 . . . . 0.0 110.456 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -47.01 -59.6 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.018 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' A' ' 14' ' ' LEU . . . -51.67 -34.05 35.33 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.704 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 1.8 mp -69.81 -31.25 69.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.427 . . . . 0.0 110.102 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.525 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 56.2 mt-30 -68.48 -28.9 67.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.941 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -30.41 69.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.375 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.431 HD11 HD11 ' A' ' 31' ' ' ILE . 9.2 mt -75.91 -46.24 31.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.604 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.11 -45.97 61.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.8 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -57.03 -78.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.03 -168.96 16.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.446 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -113.1 129.17 56.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.373 . . . . 0.0 110.94 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.4 -161.24 1.16 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.145 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.962 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.2 t80 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.0 OUTLIER 51.86 48.06 23.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 2' ' ' HIS . . . 70.54 156.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.185 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.63 76.66 0.32 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.991 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.44 -25.7 21.1 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.532 2.155 . . . . 0.0 112.199 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -78.32 59.71 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.623 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.7 tm? -167.04 -59.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.612 ' N ' HD13 ' A' ' 7' ' ' LEU . 60.4 t -67.96 -42.35 85.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.042 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -24.94 37.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.53 -44.72 6.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.114 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.796 HD11 HD12 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -46.01 -54.18 8.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.97 0.414 . . . . 0.0 111.138 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.697 HG23 ' HA ' ' A' ' 17' ' ' PRO . 23.8 m -76.89 -49.79 14.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.595 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.91 -24.87 8.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.192 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.5 tp -58.46 -18.8 31.55 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.779 0.323 . . . . 0.0 111.113 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.4 19.49 7.05 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.069 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.7 m -134.23 77.69 60.17 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 111.113 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.697 ' HA ' HG23 ' A' ' 12' ' ' THR . 90.4 Cg_endo -87.47 19.43 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.892 2.394 . . . . 0.0 112.833 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.47 20.34 1.87 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.472 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 p -120.36 -30.98 4.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.69 0.281 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.727 ' O ' HG23 ' A' ' 24' ' ' THR . 12.2 tt -46.75 -30.8 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.567 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.46 -44.19 88.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 110.349 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.498 ' CB ' HD12 ' A' ' 47' ' ' ILE . 40.3 m-85 -75.15 -29.0 60.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.818 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' CE1' HD22 ' A' ' 45' ' ' LEU . 25.3 m-85 -78.17 -30.36 49.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.94 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 20' ' ' ILE . 7.1 p -69.39 -32.94 72.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -24.56 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.95 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -99.89 -49.25 4.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.18 51.38 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.328 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.97 ' CD1' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.69 39.28 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.0 110.948 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.7 pt20 -99.39 -28.55 13.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.128 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.98 112.9 23.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.022 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.512 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -45.37 -28.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.975 0.416 . . . . 0.0 111.116 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 m-85 -57.15 -21.01 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.753 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 -31.2 25.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.961 0.41 . . . . 0.0 110.613 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.97 HD22 ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -101.94 25.35 8.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.875 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.646 ' NE2' HD13 ' A' ' 62' ' ' LEU . 3.7 mm-40 -67.76 -42.99 80.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.612 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.61 -21.33 13.75 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.503 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -46.31 144.91 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.119 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.715 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -135.02 178.67 6.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.131 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.589 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.2 tp -59.25 -32.99 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.363 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.07 -48.05 76.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.704 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 6.5 m-20 -80.34 -25.97 38.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -55.62 -49.21 73.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.83 -9.16 58.87 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.775 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -76.54 -43.69 38.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.058 0.456 . . . . 0.0 110.433 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.513 HD22 ' CE1' ' A' ' 23' ' ' PHE . 10.0 mp -46.15 -27.57 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.9 ttmm 86.17 19.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.237 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.498 HD12 ' CB ' ' A' ' 22' ' ' TYR . 4.9 mm -78.13 138.42 60.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.692 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 47' ' ' ILE . 81.4 Cg_exo -41.05 149.42 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.515 2.143 . . . . 0.0 112.389 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -89.01 47.21 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -85.19 -53.71 5.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.77 31.88 2.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.065 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.0 ttp180 -54.89 -48.28 73.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.763 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.589 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -60.57 -45.21 94.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.7 m -51.95 -45.93 64.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 14' ' ' LEU . 17.9 mt -61.16 -42.97 95.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.766 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CE2' ' NE2' ' A' ' 60' ' ' GLN . 11.3 t90 -59.73 -50.29 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -47.13 -56.69 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.734 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.52 -42.29 65.7 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.661 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.612 ' HA ' HD23 ' A' ' 62' ' ' LEU . 3.5 mp -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.518 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 39.6 mt-30 -71.53 -17.25 62.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.604 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.69 -27.79 28.78 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.848 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.646 HD13 ' NE2' ' A' ' 35' ' ' GLN . 0.8 OUTLIER -70.76 -40.72 72.51 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.855 0.836 . . . . 0.0 109.878 178.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD2' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -95.53 37.5 1.19 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.84 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -70.59 -30.24 66.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.842 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.74 -122.94 6.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.373 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -120.47 101.88 8.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -152.29 24.15 0.63 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.416 0.627 . . . . 0.0 111.979 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.309 -1.188 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.251 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.845 0.355 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -101.61 173.89 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.7 155.24 34.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.055 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -81.18 -50.26 0.97 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 6.3 Cg_exo -75.19 55.6 4.09 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.953 2.435 . . . . 0.0 112.249 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.3 t -85.35 -32.76 22.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.07 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -73.55 -65.34 0.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.147 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 m -43.95 -37.05 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.714 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -30.48 70.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.98 -47.28 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.36 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 7' ' ' LEU . 1.8 tm? -48.69 -54.45 14.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.0 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.634 HG23 ' HA ' ' A' ' 17' ' ' PRO . 87.8 m -79.17 -44.25 22.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.261 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 -28.46 12.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.248 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.898 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -55.09 -22.02 14.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.015 0.436 . . . . 0.0 110.844 178.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 20.95 5.75 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.086 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.7 p -134.96 83.6 39.8 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.634 ' HA ' HG23 ' A' ' 12' ' ' THR . 96.8 Cg_endo -87.28 21.48 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.785 2.323 . . . . 0.0 113.02 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -138.17 17.61 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.632 0.253 . . . . 0.0 111.385 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.9 p -115.72 -26.73 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.2 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.679 HG13 HG23 ' A' ' 24' ' ' THR . 1.0 OUTLIER -48.85 -42.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -55.83 -42.29 75.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -74.16 -30.52 62.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.652 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CE1' HD12 ' A' ' 47' ' ' ILE . 33.2 m-85 -76.83 -51.59 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.752 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.679 HG23 HG13 ' A' ' 20' ' ' ILE . 53.3 p -50.43 -27.61 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.153 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.3 t -53.23 -24.12 10.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -103.89 -38.72 6.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.058 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.68 47.08 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.9 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.988 HD13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -99.19 44.62 1.02 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.309 0.576 . . . . 0.0 110.647 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.468 ' C ' HD12 ' A' ' 7' ' ' LEU . 5.6 pt20 -107.39 -13.98 14.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.314 177.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.645 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -127.16 103.68 7.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.735 HD11 HD11 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -43.04 -29.12 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 111.761 -177.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -56.76 -22.61 36.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.656 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -85.23 -11.47 54.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.496 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.993 HD12 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -122.37 14.81 10.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.404 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -24.28 62.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.21 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -115.38 -18.37 11.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.486 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.88 143.24 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.674 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -137.31 176.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.25 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.479 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 3.7 tp -55.84 -33.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.437 0.637 . . . . 0.0 109.46 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.02 -43.41 81.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.681 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.6 m-20 -84.81 -28.62 26.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.762 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -52.45 -46.35 66.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.43 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -5.32 62.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.775 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -80.67 -44.94 18.0 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 47' ' ' ILE . 9.4 mp -49.02 -28.14 3.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.249 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 2.6 tptt 83.34 21.98 0.17 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.317 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 45' ' ' LEU . 6.1 mt -83.68 137.93 41.13 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.479 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.454 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 69.7 Cg_exo -38.07 153.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.783 2.322 . . . . 0.0 112.596 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 10.3 pm0 -91.84 21.18 5.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.403 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -58.58 -44.27 89.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.809 0.338 . . . . 0.0 110.828 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 16' ' ' CYS . 12.4 m-85 -140.69 31.96 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.359 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -55.19 -61.15 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.381 . . . . 0.0 110.773 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtm -56.54 -42.97 79.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.777 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.629 ' CG2' HD12 ' A' ' 14' ' ' LEU . 85.9 m -51.01 -50.47 58.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.498 HD13 ' CZ ' ' A' ' 23' ' ' PHE . 6.6 mt -62.66 -37.66 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.674 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.0 t90 -61.63 -54.58 40.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.404 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 5.5 mtm180 -54.67 -36.75 64.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.853 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.898 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -74.35 -31.58 59.0 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.114 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.993 HD11 HD12 ' A' ' 34' ' ' LEU . 3.6 tp -73.91 -36.34 64.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 0.0 110.801 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 5.0 pt20 -69.1 -26.91 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.243 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.28 -28.73 69.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.735 HD11 HD11 ' A' ' 31' ' ' ILE . 6.3 mt -66.9 -35.45 80.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.416 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.92 32.66 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.214 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -53.55 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.872 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.66 87.87 0.42 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.463 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -130.57 134.31 46.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 111.018 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.1 t70 179.78 141.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.234 0.54 . . . . 0.0 110.739 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.412 ' OXT' ' CG ' ' A' ' 68' ' ' TYR . 2.4 t80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.615 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.91 0.386 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m170 63.57 167.93 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.003 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.47 121.49 5.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.073 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -173.89 -64.08 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 4' ' ' ASP . 48.1 Cg_endo -69.16 -20.28 37.88 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.532 2.155 . . . . 0.0 112.234 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.81 57.24 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 110.905 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.84 HD23 HD12 ' A' ' 31' ' ' ILE . 1.2 tm? -168.0 -51.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.636 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' N ' HD13 ' A' ' 7' ' ' LEU . 39.0 t -68.82 -39.11 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.129 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 p -59.41 -34.35 72.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.87 -43.73 12.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.513 HD12 ' HB ' ' A' ' 20' ' ' ILE . 1.7 tm? -48.24 -52.8 19.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.818 HG23 ' HA ' ' A' ' 17' ' ' PRO . 55.4 m -75.68 -50.44 15.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.2 -23.61 12.96 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.328 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.6 tp -58.59 -18.49 30.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 0.0 111.18 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.59 12.14 6.85 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.588 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 3.4 m -132.16 77.85 70.15 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.818 ' HA ' HG23 ' A' ' 12' ' ' THR . 90.6 Cg_endo -79.97 4.7 6.52 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.7 2.267 . . . . 0.0 112.939 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.21 20.49 3.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.687 0.28 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 8.3 m -114.19 -28.25 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.976 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.606 HG13 HG23 ' A' ' 24' ' ' THR . 1.7 tt -47.7 -44.15 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.07 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.4 mm-40 -49.97 -44.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.802 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.63 -32.79 62.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.556 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HE2' HG21 ' A' ' 55' ' ' ILE . 4.0 m-85 -69.29 -51.08 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.585 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.606 HG23 HG13 ' A' ' 20' ' ' ILE . 80.4 p -58.16 -28.02 64.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.7 t -47.29 -27.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.239 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -101.61 -56.28 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.753 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.14 46.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.092 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.979 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -99.4 38.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.013 0.435 . . . . 0.0 111.14 -179.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.08 -27.83 13.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.785 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 108.04 17.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.852 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.84 HD12 HD23 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -43.23 -33.71 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.988 0.423 . . . . 0.0 111.548 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -55.92 -20.63 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.985 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.81 -15.77 47.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.675 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.112 HD12 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -113.28 9.84 18.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.417 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -54.87 -36.38 65.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -99.88 -22.3 15.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 41' ' ' ASP . 5.0 tp -47.79 135.2 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.701 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -132.67 178.55 6.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.009 0.433 . . . . 0.0 111.304 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 53' ' ' MET . 5.5 tp -58.97 -32.44 47.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.552 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -57.11 -45.37 83.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.833 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.4 m-20 -85.01 -27.11 26.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.701 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -49.26 -53.31 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.855 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.441 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . -68.15 -8.83 55.77 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.733 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -75.13 -42.37 56.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 110.426 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 47' ' ' ILE . 9.5 mp -47.87 -28.01 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.45 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.2 tttm 87.17 17.22 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.586 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.598 HD12 ' CE1' ' A' ' 23' ' ' PHE . 4.0 mt -85.91 138.49 35.13 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.595 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 2.7 Cg_endo -40.46 146.35 0.3 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.965 2.444 . . . . 0.0 112.108 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -90.21 42.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.388 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -69.76 -43.67 71.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.762 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -140.26 30.4 1.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.665 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 9.6 ttp180 -48.36 -50.75 29.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.825 ' HA ' HD13 ' A' ' 39' ' ' ILE . 4.9 mtt -61.2 -54.1 48.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.263 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -47.41 -48.93 26.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 0.0 111.034 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.667 HG21 ' HE2' ' A' ' 23' ' ' PHE . 6.6 mt -59.06 -41.51 83.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.743 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.603 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.9 t90 -62.43 -46.67 87.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.261 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.07 -60.03 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.43 -30.62 61.97 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.67 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.112 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -70.99 -25.96 62.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -69.24 -12.62 61.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.23 -37.39 26.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.84 HD13 HG13 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -52.86 -36.02 58.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 110.163 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -62.89 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.242 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -42.04 -56.12 2.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.612 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.69 98.3 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.552 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -121.24 92.71 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.829 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 170.01 143.47 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.632 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.717 179.199 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.875 0.369 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -93.74 83.21 4.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.986 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.32 146.47 46.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.825 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER 173.65 -63.92 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 4' ' ' ASP . 11.9 Cg_endo -55.13 -21.33 27.38 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.678 2.252 . . . . 0.0 112.346 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -84.17 7.75 17.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.672 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.728 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.2 tm? -121.14 -60.82 1.61 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.797 0.332 . . . . 0.0 110.69 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.728 ' N ' HD13 ' A' ' 7' ' ' LEU . 34.9 m -57.21 -35.8 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.6 p -64.38 -24.29 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.073 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.76 -48.74 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.571 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.5 tm? -48.26 -53.22 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.133 0.492 . . . . 0.0 110.876 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.849 HG23 ' HA ' ' A' ' 17' ' ' PRO . 93.0 m -70.67 -49.59 45.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.37 -32.7 22.93 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.26 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.9 tp -60.17 -17.14 38.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.81 11.23 6.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.611 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.847 ' SG ' HD11 ' A' ' 55' ' ' ILE . 1.3 m -114.91 72.41 2.86 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-O 120.739 0.304 . . . . 0.0 111.146 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.849 ' HA ' HG23 ' A' ' 12' ' ' THR . 85.2 Cg_endo -80.64 -13.1 12.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.256 . . . . 0.0 112.943 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.87 22.08 4.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.112 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 87.6 m -114.83 -28.21 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.072 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 24' ' ' THR . 2.5 tt -48.52 -32.83 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.081 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.95 -44.82 96.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.533 ' HB2' HD12 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -77.69 -27.95 50.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.463 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE1' HD22 ' A' ' 45' ' ' LEU . 20.1 m-85 -76.54 -46.36 26.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 20' ' ' ILE . 37.9 p -56.34 -30.75 63.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 p -55.79 -23.64 31.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.262 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -99.84 -34.98 9.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.75 41.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.304 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.037 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.79 39.53 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.024 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.22 -29.6 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.914 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.59 109.38 19.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.83 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.554 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -44.43 -28.34 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 111.526 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -58.64 -22.46 56.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.677 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -84.23 -19.9 33.16 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.037 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -110.56 13.38 22.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.679 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -17.46 64.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.408 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -128.36 17.86 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -84.88 147.41 26.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.29 . . . . 0.0 110.654 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.747 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -131.02 172.72 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.012 0.434 . . . . 0.0 111.523 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.44 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 7.5 tp -56.98 -34.3 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.676 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -59.09 -38.85 80.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.624 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 32.5 m-20 -85.47 -26.81 26.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.591 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -54.77 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.662 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -55.15 -20.44 20.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.369 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -61.73 -37.83 85.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 0.0 110.358 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.493 HD22 ' CE1' ' A' ' 23' ' ' PHE . 6.8 mp -61.26 -15.41 34.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.485 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 mttt 74.81 19.3 2.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.93 0.395 . . . . 0.0 111.073 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 22' ' ' TYR . 7.4 mm -79.23 138.17 56.21 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.513 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 87.7 Cg_exo -43.05 157.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.407 2.072 . . . . 0.0 112.136 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -85.56 -46.14 11.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -140.31 21.81 2.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.412 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -51.01 -57.34 8.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.438 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -60.36 -41.86 94.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.628 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.414 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 53.4 m -54.4 -47.59 72.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.604 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.847 HD11 ' SG ' ' A' ' 16' ' ' CYS . 6.8 mt -62.31 -36.77 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.619 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.4 t90 -64.23 -51.27 64.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 5.4 ptp180 -60.69 -33.14 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.623 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -77.54 -25.73 62.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.126 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.816 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.2 mp -78.46 -34.28 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.642 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -73.16 -30.46 63.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.38 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.34 -32.73 74.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.569 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 59' ' ' LEU . 10.2 mt -60.33 -52.22 66.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.685 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -51.13 -53.79 31.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.802 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -54.94 -73.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.96 -74.11 0.29 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.348 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.93 132.87 53.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.744 0.307 . . . . 0.0 110.89 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 68' ' ' TYR . 17.4 t0 -179.73 142.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.235 0.541 . . . . 0.0 110.775 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.415 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 1.8 m-30 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.941 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 4.7 t80 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.893 0.378 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -132.44 49.01 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 6' ' ' SER . . . -64.12 -175.38 0.15 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 t70 57.65 65.98 3.14 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.65 140.81 38.01 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.915 5.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.631 ' HB3' ' HB1' ' A' ' 3' ' ' ALA . 92.1 p -85.48 -24.14 27.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.012 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.761 HD23 HD12 ' A' ' 31' ' ' ILE . 1.8 tm? -95.43 -51.77 4.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.327 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.483 ' N ' HD13 ' A' ' 7' ' ' LEU . 46.6 t -53.71 -59.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.548 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -55.6 -19.61 10.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.13 -57.04 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.778 0.323 . . . . 0.0 111.391 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 11' ' ' LEU . 1.9 tm? -46.16 -45.07 16.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.86 HG23 ' HA ' ' A' ' 17' ' ' PRO . 33.7 m -83.34 -49.11 9.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.635 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.58 -27.19 25.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.245 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' A' ' 55' ' ' ILE . 6.4 tp -60.74 -17.19 47.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.737 0.304 . . . . 0.0 111.047 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.57 16.87 6.79 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.309 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -127.79 71.86 78.28 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.672 0.272 . . . . 0.0 111.174 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.86 ' HA ' HG23 ' A' ' 12' ' ' THR . 87.6 Cg_endo -84.0 12.0 3.15 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.67 2.247 . . . . 0.0 112.854 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -138.73 16.21 2.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.674 0.273 . . . . 0.0 111.557 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -116.45 -23.05 8.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.765 0.317 . . . . 0.0 111.233 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.612 ' O ' HG23 ' A' ' 24' ' ' THR . 1.4 tt -48.58 -43.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.26 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.3 pt-20 -56.01 -41.64 75.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.482 ' CB ' HG23 ' A' ' 47' ' ' ILE . 52.3 m-85 -74.31 -33.63 63.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.685 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.516 ' CE1' HD22 ' A' ' 45' ' ' LEU . 9.1 m-85 -74.16 -51.26 16.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.865 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 20' ' ' ILE . 64.9 p -48.87 -34.41 12.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.328 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -47.98 -26.56 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.564 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -101.45 -29.71 11.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.74 45.55 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.097 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.033 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.11 40.15 1.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.995 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 7' ' ' LEU . 2.9 mt-30 -99.34 -30.08 12.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.784 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.27 109.05 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.917 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.761 HD12 HD23 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -43.62 -28.51 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 111.637 -177.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.07 -23.91 62.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.766 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -80.27 -14.6 58.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.726 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -115.39 -1.5 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.466 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -49.81 -35.28 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.61 0.243 . . . . 0.0 111.508 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -108.6 15.66 23.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.783 ' HB3' HD23 ' A' ' 59' ' ' LEU . 14.7 tp -85.35 156.17 21.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.343 . . . . 0.0 110.792 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -140.14 174.35 10.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.488 ' HB ' ' CD2' ' A' ' 56' ' ' TRP . 5.0 tp -57.64 -35.25 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.564 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -39.22 80.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.701 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.58 ' HB3' HD11 ' A' ' 37' ' ' LEU . 14.0 m-20 -85.73 -32.8 21.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -52.35 -45.25 65.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.334 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HD2' ' A' ' 52' ' ' ARG . . . -77.54 -0.26 72.44 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.644 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -85.17 -33.57 22.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.062 0.458 . . . . 0.0 110.252 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.516 HD22 ' CE1' ' A' ' 23' ' ' PHE . 7.3 mp -61.11 -14.88 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.656 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.27 17.66 2.0 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.096 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.482 HG23 ' CB ' ' A' ' 22' ' ' TYR . 6.2 mt -85.09 138.18 37.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 68.4 Cg_exo -38.63 138.94 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.705 2.27 . . . . 0.0 112.555 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.89 22.45 4.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.445 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -55.58 -36.32 66.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.964 0.412 . . . . 0.0 110.51 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.17 28.77 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' A' ' 55' ' ' ILE . 4.6 ttp180 -48.95 -58.2 5.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.072 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -46.37 79.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -50.99 -50.66 57.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.71 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.568 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.8 mt -57.06 -52.16 59.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.488 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 7.5 t90 -52.25 -47.74 65.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.166 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 60' ' ' GLN . 7.1 mmt180 -49.94 -42.54 48.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.615 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -77.53 -21.9 71.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.798 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.016 HD11 HD12 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -85.24 -24.64 27.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.985 0.421 . . . . 0.0 111.023 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 7.7 pt20 -73.57 -11.61 60.49 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -80.2 -38.33 31.4 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.346 177.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.584 HD13 HG13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -52.31 -29.36 23.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.128 0.49 . . . . 0.0 109.86 178.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 -69.29 0.73 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.589 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.45 33.18 2.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.315 0.578 . . . . 0.0 111.632 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' ASP . . . -126.93 -1.0 6.98 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.068 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -139.9 125.02 18.69 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.923 0.361 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 169.78 146.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.543 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.769 179.692 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 2' ' ' HIS . 1.6 p80 -170.82 126.53 0.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.953 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.26 174.37 5.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -127.16 68.49 72.48 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.83 -33.73 72.47 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.487 2.125 . . . . 0.0 112.301 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.91 74.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.995 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 8' ' ' VAL . 2.1 tm? -173.15 -66.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.043 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 7' ' ' LEU . 26.2 m -59.81 -43.34 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 8' ' ' VAL . 1.7 t -57.68 -34.75 69.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -43.95 15.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.666 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.0 tm? -47.49 -55.06 9.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.032 0.444 . . . . 0.0 111.067 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.86 HG23 ' HA ' ' A' ' 17' ' ' PRO . 86.5 m -72.77 -49.34 31.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.61 -29.61 18.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.34 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 55' ' ' ILE . 1.8 tp -63.93 -14.72 55.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.707 0.289 . . . . 0.0 111.281 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.78 12.78 8.33 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.291 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.78 ' SG ' HD11 ' A' ' 55' ' ' ILE . 3.4 m -114.18 64.84 1.36 Allowed Pre-proline 0 C--N 1.333 -0.133 0 CA-C-O 120.629 0.252 . . . . 0.0 111.052 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.86 ' HA ' HG23 ' A' ' 12' ' ' THR . 59.1 Cg_endo -71.85 -19.72 26.84 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.473 2.115 . . . . 0.0 112.361 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.95 22.3 5.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.96 -29.37 7.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.726 ' O ' HG23 ' A' ' 24' ' ' THR . 1.1 tt -49.32 -36.69 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.032 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -44.13 80.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.61 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -72.44 -36.64 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.529 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.643 ' CZ ' HD13 ' A' ' 55' ' ' ILE . 33.0 m-85 -69.63 -49.93 49.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.963 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 20' ' ' ILE . 77.0 p -49.78 -38.88 36.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.139 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -22.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.174 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HG3' ' HG ' ' A' ' 45' ' ' LEU . 7.9 mm-40 -99.55 -23.46 15.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.27 44.94 0.54 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.15 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.029 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.61 38.91 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.928 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -99.27 -26.93 14.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.159 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.47 107.09 16.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.149 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.694 HD11 HD11 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -44.65 -29.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.948 0.404 . . . . 0.0 111.175 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 35' ' ' GLN . 83.1 m-85 -55.02 -22.36 15.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.621 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.01 -25.79 29.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.029 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -107.98 18.75 20.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.287 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.434 ' HG3' ' HA ' ' A' ' 32' ' ' TYR . 1.4 mm-40 -59.86 -44.39 94.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.47 0.652 . . . . 0.0 111.088 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.85 -16.41 15.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.202 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.612 HD11 ' HB3' ' A' ' 41' ' ' ASP . 12.4 tp -44.39 153.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.982 0.42 . . . . 0.0 111.595 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.617 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -140.12 178.64 7.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.772 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.808 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.2 tp -61.85 -32.59 54.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.414 0.626 . . . . 0.0 109.409 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.8 -46.83 81.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.698 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.612 ' HB3' HD11 ' A' ' 37' ' ' LEU . 4.5 m-20 -83.41 -31.55 26.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.794 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -50.04 -49.65 50.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.336 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 52' ' ' ARG . . . -72.13 -18.11 77.72 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.403 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -61.98 -37.93 86.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.458 . . . . 0.0 110.388 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 47' ' ' ILE . 8.6 mp -50.25 -27.38 5.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 84.04 19.65 0.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.762 -178.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.621 HD11 HD23 ' A' ' 45' ' ' LEU . 4.5 mt -85.12 137.27 37.42 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HD2' HG22 ' A' ' 47' ' ' ILE . 92.0 Cg_exo -41.75 139.31 2.25 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.573 2.182 . . . . 0.0 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -74.81 61.15 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -85.14 -52.33 6.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.11 36.01 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.685 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HB3' HD11 ' A' ' 39' ' ' ILE . 2.1 ttp180 -59.84 -53.14 61.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.808 ' HA ' HD13 ' A' ' 39' ' ' ILE . 1.4 ptm -60.17 -41.19 92.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -59.44 -47.14 86.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 110.582 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.78 HD11 ' SG ' ' A' ' 16' ' ' CYS . 21.3 mt -58.51 -47.8 87.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.628 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.42 ' NE1' HG22 ' A' ' 38' ' ' THR . 11.3 t90 -55.57 -59.67 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.319 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 0.3 OUTLIER -47.22 -39.72 14.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.179 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.42 -26.87 64.69 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.999 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.809 HD11 HD12 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -78.29 -35.02 48.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 110.781 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 7.2 pt20 -70.22 -27.95 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.212 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.05 -28.64 69.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.494 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.694 HD11 HD11 ' A' ' 31' ' ' ILE . 13.2 mt -63.32 -50.12 71.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.677 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -50.11 -45.27 52.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -81.53 -27.53 34.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.4 86.1 0.46 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.607 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -106.48 29.82 6.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.76 127.47 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.747 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.849 -179.718 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.895 0.379 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.99 131.15 36.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.45 164.09 11.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.07 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -162.89 60.46 0.99 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.709 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.52 -20.5 60.59 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.575 2.183 . . . . 0.0 112.419 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 t -75.45 63.8 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.6 tm? -177.21 -60.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.809 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.671 ' N ' HD13 ' A' ' 7' ' ' LEU . 21.4 t -59.14 -43.91 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.983 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.69 -36.37 62.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -81.93 -47.03 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 20' ' ' ILE . 1.9 tm? -49.59 -33.95 16.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.616 HG23 ' HA ' ' A' ' 17' ' ' PRO . 2.2 m -83.2 -61.83 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.923 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -46.81 -28.72 3.93 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.874 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.707 HD11 ' HA ' ' A' ' 55' ' ' ILE . 4.1 tt -51.84 -24.49 6.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.709 177.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.93 14.2 9.52 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.738 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 87.0 m -121.16 64.31 13.25 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.689 0.28 . . . . 0.0 111.118 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.616 ' HA ' HG23 ' A' ' 12' ' ' THR . 60.5 Cg_endo -72.51 -11.26 26.23 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.516 2.144 . . . . 0.0 112.686 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -131.41 19.73 4.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.221 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.42 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -111.85 -27.04 8.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.89 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.7 tt -49.6 -34.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.51 -45.62 77.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.755 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -74.63 -36.3 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.418 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -66.88 -44.71 80.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 20' ' ' ILE . 56.3 p -58.53 -34.31 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.8 m -51.47 -24.17 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.162 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -100.7 -37.46 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.865 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.4 45.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.333 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.06 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.61 40.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 7' ' ' LEU . 5.8 pt20 -99.07 -28.96 13.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.981 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.05 110.67 21.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.083 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.718 HD11 HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -45.7 -28.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.937 0.399 . . . . 0.0 111.2 -178.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -57.93 -22.32 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.57 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -20.67 36.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.06 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.57 21.03 14.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.28 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.55 -18.94 64.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.385 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -134.28 18.17 3.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.681 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -81.54 145.82 30.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.66 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.7 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -131.7 173.69 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.485 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 8.5 tp -57.94 -35.92 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.443 0.64 . . . . 0.0 109.293 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.14 -44.8 68.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.337 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 26.7 m-20 -84.79 -34.33 22.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.729 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.681 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -50.88 -58.66 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.57 179.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.36 -20.0 35.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.469 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -64.06 -41.04 97.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.682 HD23 HD11 ' A' ' 47' ' ' ILE . 8.8 mp -48.16 -28.0 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.219 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 82.13 19.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.974 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HD23 ' A' ' 45' ' ' LEU . 7.3 mt -76.45 137.89 67.52 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.568 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 1.9 Cg_endo -40.66 131.79 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.964 2.442 . . . . 0.0 112.206 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.96 63.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.275 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' A' ' 48' ' ' PRO . 3.4 mm-40 -85.19 -60.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.703 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -140.32 36.29 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.751 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.916 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -49.33 -45.99 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.271 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 57' ' ' ARG . 2.3 ptp -62.14 -47.56 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 m -54.2 -40.37 67.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.471 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 52' ' ' ARG . 7.8 mt -63.29 -58.54 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.135 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.7 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.5 t90 -49.92 -45.6 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.396 . . . . 0.0 110.21 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.4 ' CG ' ' O ' ' A' ' 53' ' ' MET . 3.2 mmt180 -55.5 -51.56 66.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.625 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.58 -41.63 89.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.855 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 34' ' ' LEU . 1.1 tp -62.13 -32.83 73.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 0.0 110.252 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.507 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 50.8 mt-30 -70.3 -26.84 63.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.303 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -62.42 -33.38 74.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 178.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.718 HD11 HD11 ' A' ' 31' ' ' ILE . 11.8 mt -64.88 -49.74 69.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.632 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -59.18 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.753 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -23.36 67.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ASP . . . -85.6 -8.75 79.84 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.781 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -99.58 141.11 32.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.632 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.0 OUTLIER 51.15 98.39 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.004 -179.436 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.817 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 50.31 86.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.56 116.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.092 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -152.8 62.07 4.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.75 -33.01 77.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.623 2.215 . . . . 0.0 112.378 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.6 63.84 1.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.4 tm? -174.92 -64.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.775 ' N ' HD13 ' A' ' 7' ' ' LEU . 48.1 t -60.8 -43.9 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.223 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -23.56 63.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.166 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.22 -48.73 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.137 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.544 HD12 ' HB ' ' A' ' 20' ' ' ILE . 3.1 tm? -48.59 -52.16 24.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.986 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.846 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.3 m -73.6 -48.68 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.707 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.82 -30.33 28.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.37 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.6 tp -60.13 -17.69 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 111.197 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 121.01 12.6 5.8 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.551 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.85 65.72 5.25 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.085 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.846 ' HA ' HG23 ' A' ' 12' ' ' THR . 77.1 Cg_endo -77.4 -5.09 15.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -136.49 18.81 3.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.626 0.25 . . . . 0.0 111.457 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -116.63 -22.26 8.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.296 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.544 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.5 tt -51.53 -34.94 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.171 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -54.94 -46.06 74.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.703 ' HB2' HD12 ' A' ' 47' ' ' ILE . 6.1 m-85 -76.04 -31.74 58.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.703 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.503 ' CE1' HD22 ' A' ' 45' ' ' LEU . 14.6 m-85 -70.3 -43.88 69.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.236 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 20' ' ' ILE . 41.1 p -62.67 -28.81 70.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.779 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 t -51.22 -25.02 4.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -100.17 -52.25 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.74 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.7 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.001 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.59 37.34 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.422 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -99.69 -29.05 12.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.813 178.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.57 109.08 19.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -44.02 -29.58 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.955 0.407 . . . . 0.0 111.543 -178.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -56.36 -22.48 31.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.57 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -84.03 -20.55 32.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.001 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.33 14.83 21.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.49 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -20.53 65.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -133.41 24.36 4.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.31 . . . . 0.0 111.104 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.651 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.37 121.25 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.828 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.517 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -99.44 175.72 5.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.111 -179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.854 HD13 ' HA ' ' A' ' 53' ' ' MET . 5.1 tp -64.85 -32.1 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.613 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.12 -45.03 83.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.2 m-20 -83.29 -32.18 26.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.795 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.651 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -52.86 -64.38 0.84 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.359 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.429 ' HA3' ' NE ' ' A' ' 52' ' ' ARG . . . -58.3 -23.25 52.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.992 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -54.39 -37.32 64.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 110.519 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.503 HD22 ' CE1' ' A' ' 23' ' ' PHE . 8.2 mp -59.52 -15.6 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.777 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 1.6 mtmt 78.71 17.9 0.99 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 22' ' ' TYR . 6.1 mm -80.52 138.76 51.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.269 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 4.7 Cg_exo -36.34 140.32 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.224 2.616 . . . . 0.0 112.519 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -91.13 23.46 3.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.593 -178.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -67.96 -31.74 71.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 110.65 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.32 23.69 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.82 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -50.69 -58.38 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.99 0.424 . . . . 0.0 110.782 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.854 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -53.95 -52.05 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 m -48.17 -43.99 32.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 52' ' ' ARG . 10.3 mt -58.8 -59.09 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.516 ' CZ2' HG23 ' A' ' 38' ' ' THR . 0.1 OUTLIER -53.1 -55.31 24.93 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.856 0.36 . . . . 0.0 110.403 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 1.2 mtt180 -44.8 -40.07 5.82 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.837 0.351 . . . . 0.0 111.575 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.11 -25.14 67.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.153 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.1 mp -82.16 -35.19 28.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.763 0.316 . . . . 0.0 111.083 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.493 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.3 pt20 -71.51 -27.63 63.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 110.261 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -27.97 69.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.281 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.671 HD12 ' HA ' ' A' ' 59' ' ' LEU . 9.4 mt -67.22 -49.88 62.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.57 -56.87 3.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.823 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 63.4 119.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.673 0.749 . . . . 0.0 111.115 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.77 -137.16 8.22 Favored Glycine 0 C--N 1.313 -0.722 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.507 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -132.46 128.15 36.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.95 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p30 168.07 145.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.113 0.482 . . . . 0.0 110.691 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.497 179.172 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 7.2 p90 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.778 0.323 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -145.39 161.28 40.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.426 ' HB1' ' HD3' ' A' ' 5' ' ' PRO . . . -112.62 164.2 13.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 1.6 t0 -138.09 50.95 3.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.141 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 56.9 Cg_endo -70.47 68.79 2.08 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.48 2.12 . . . . 0.0 112.209 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -79.81 -14.91 58.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.609 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.629 ' C ' HD13 ' A' ' 7' ' ' LEU . 1.6 tm? -91.34 -53.68 4.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.728 0.299 . . . . 0.0 111.132 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.544 ' N ' HD13 ' A' ' 7' ' ' LEU . 40.4 t -56.88 -57.08 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.319 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 p -55.79 -21.78 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.545 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -88.04 -53.86 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.775 0.321 . . . . 0.0 111.178 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.794 HD12 ' HB ' ' A' ' 20' ' ' ILE . 2.2 tm? -48.25 -52.0 23.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 111.109 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.836 HG23 ' HA ' ' A' ' 17' ' ' PRO . 54.0 m -71.65 -46.61 58.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.697 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.14 -33.37 30.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.358 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 55' ' ' ILE . 2.6 tp -64.53 -13.42 52.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.677 0.275 . . . . 0.0 111.499 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.86 13.81 7.03 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.5 m -112.24 60.91 0.58 Allowed Pre-proline 0 CA--C 1.528 0.133 0 CA-C-O 120.665 0.269 . . . . 0.0 111.287 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.836 ' HA ' HG23 ' A' ' 12' ' ' THR . 56.1 Cg_endo -69.81 -30.44 22.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -124.21 19.77 9.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.798 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.9 m -109.45 -27.31 9.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.666 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' A' ' 11' ' ' LEU . 13.2 tt -52.08 -31.71 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.702 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG3' ' CD1' ' A' ' 22' ' ' TYR . 8.9 pt-20 -59.76 -44.55 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.507 ' CD1' ' HG3' ' A' ' 21' ' ' GLU . 59.9 m-85 -72.0 -30.89 65.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.232 178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE1' ' CD2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -74.13 -51.82 14.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.758 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 20' ' ' ILE . 60.4 p -49.4 -34.07 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -51.36 -24.23 4.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -99.86 -43.3 6.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 45.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.151 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.908 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.97 39.98 1.24 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.87 0.367 . . . . 0.0 111.007 -179.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.51 -25.07 14.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.134 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 t -111.33 108.28 17.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.548 HD11 HD11 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -48.0 -26.72 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 111.031 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -59.5 -21.76 60.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.563 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.68 -19.03 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.908 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.48 11.8 21.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.622 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -61.77 -21.51 64.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.301 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -132.43 21.24 4.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.534 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -77.88 146.0 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.669 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.608 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -127.99 172.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 0.0 111.589 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' A' ' 53' ' ' MET . 7.6 tp -58.94 -33.36 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.515 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.99 -49.29 76.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.625 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' HB3' HD21 ' A' ' 37' ' ' LEU . 1.7 m-20 -82.8 -15.1 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.288 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.789 HD23 HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -69.51 -56.56 7.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.882 0.372 . . . . 0.0 110.246 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.77 63.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.049 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.54 -30.4 53.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.043 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 47' ' ' ILE . 4.6 mp -72.25 -3.9 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.95 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 15.4 ptpt 49.93 33.37 6.54 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 121.014 0.435 . . . . 0.0 111.427 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.546 HD11 HD23 ' A' ' 45' ' ' LEU . 36.6 mt -83.52 138.72 41.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.986 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 46.4 Cg_exo -35.39 119.37 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.008 2.472 . . . . 0.0 112.949 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -65.91 68.6 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.355 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -85.21 -65.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 0.0 110.665 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.68 36.64 2.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.4 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.455 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -48.63 -43.31 36.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.232 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.594 ' HA ' HD13 ' A' ' 39' ' ' ILE . 12.4 mtt -59.44 -50.54 73.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.649 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -50.77 -47.79 59.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.658 ' HA ' HD23 ' A' ' 14' ' ' LEU . 11.1 mm -55.92 -55.85 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.608 ' NE1' HG22 ' A' ' 38' ' ' THR . 6.0 t90 -50.36 -62.94 1.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -54.29 -30.44 50.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.149 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -78.8 -27.36 56.88 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.839 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -75.99 -38.89 56.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 110.691 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.48 -26.01 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.327 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -27.77 68.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.673 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 31' ' ' ILE . 16.5 mt -62.5 -48.64 78.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.838 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -46.33 -51.31 14.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.241 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -131.43 -80.58 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.876 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.77 92.05 0.1 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.618 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.485 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 2.0 m-70 -111.81 103.89 12.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.359 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 p30 170.19 146.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.549 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.702 179.816 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.988 0.423 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.31 160.3 19.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.963 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.5 169.13 4.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.742 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -139.01 61.85 23.45 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.1 -21.92 13.44 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.607 2.205 . . . . 0.0 112.293 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -68.05 72.36 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.842 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.3 tm? -174.91 -58.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.66 ' N ' HD13 ' A' ' 7' ' ' LEU . 29.2 m -65.28 -31.4 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -72.5 -25.16 61.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -54.52 4.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.684 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.494 HD13 HD12 ' A' ' 28' ' ' LEU . 4.9 tp -51.03 -54.23 26.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.18 0.514 . . . . 0.0 110.372 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.929 HG23 ' HA ' ' A' ' 17' ' ' PRO . 25.6 m -58.51 -50.87 72.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.497 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.36 -30.22 48.4 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.973 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.693 HD11 ' HA3' ' A' ' 58' ' ' GLY . 3.8 tp -59.5 -18.17 37.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 111.046 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.3 17.15 6.3 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.158 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.439 ' CB ' ' HB2' ' A' ' 19' ' ' CYS . 4.3 m -118.93 61.41 5.15 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.681 0.277 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.929 ' HA ' HG23 ' A' ' 12' ' ' THR . 49.2 Cg_endo -68.78 -19.8 40.57 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.455 2.104 . . . . 0.0 112.16 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -129.56 23.96 5.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -114.67 -24.61 8.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.823 ' O ' HG23 ' A' ' 24' ' ' THR . 13.1 tt -51.43 -46.91 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.815 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 20' ' ' ILE . 1.3 mm-40 -51.42 -45.18 62.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.657 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.7 m-30 -64.84 -32.02 73.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.574 ' CE1' HD22 ' A' ' 45' ' ' LEU . 2.5 m-85 -79.28 -28.04 42.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.55 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 20' ' ' ILE . 45.2 p -70.73 -24.52 62.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.145 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.4 ' OG ' ' NE2' ' A' ' 26' ' ' GLN . 93.6 p -50.62 -24.81 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.4 ' NE2' ' OG ' ' A' ' 25' ' ' SER . 4.3 mm-40 -104.24 -51.56 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.08 55.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.113 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.08 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -99.58 38.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.095 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -25.4 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.283 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.15 104.76 13.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.887 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.55 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.99 -27.52 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.452 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -21.25 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.71 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.6 -23.71 31.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.958 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.08 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -106.27 16.98 24.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -73.23 -20.93 60.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.268 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -128.87 20.37 5.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.324 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.621 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.12 120.6 26.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.053 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.492 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -99.79 176.75 5.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.267 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' A' ' 53' ' ' MET . 7.4 tp -65.16 -31.52 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -56.03 -42.84 77.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.266 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.507 ' HB3' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -85.09 -32.44 22.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.801 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.621 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -54.87 -52.49 62.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.42 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.456 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . -71.12 -16.28 74.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.411 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -63.02 -44.81 94.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.946 0.403 . . . . 0.0 110.488 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.574 HD22 ' CE1' ' A' ' 23' ' ' PHE . 10.0 mp -44.09 -28.38 0.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.749 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 7.7 tttt 88.22 17.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.434 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.56 HD11 HD23 ' A' ' 45' ' ' LEU . 4.0 mt -78.24 138.15 60.28 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.9 Cg_exo -40.42 144.65 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.534 2.156 . . . . 0.0 112.419 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.53 54.08 2.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.416 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 78.7 mt-30 -84.93 -44.62 12.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.791 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 50' ' ' GLN . 4.8 m-85 -140.23 29.08 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.669 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -46.54 -61.8 1.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.106 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.733 ' HA ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -55.66 -47.03 77.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.004 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 52.4 m -55.23 -38.86 69.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 52' ' ' ARG . 10.8 mt -63.96 -56.24 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.838 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.509 ' CH2' ' HB3' ' A' ' 60' ' ' GLN . 0.3 OUTLIER -56.69 -61.28 2.54 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.477 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -47.04 -32.87 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.663 0.268 . . . . 0.0 111.348 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.693 ' HA3' HD11 ' A' ' 14' ' ' LEU . . . -77.62 -27.8 58.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.681 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -79.01 -44.45 22.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.388 . . . . 0.0 110.725 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.509 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 3.5 pt20 -59.9 -27.02 66.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.155 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.78 -31.2 69.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.315 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 31' ' ' ILE . 12.7 mt -70.4 -50.3 40.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.687 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.09 -62.15 1.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.84 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -64.1 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.77 -170.06 26.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -117.97 -179.91 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 110.916 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.91 126.32 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.478 ' OXT' ' CG ' ' A' ' 68' ' ' TYR . 20.8 t80 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.907 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 22.9 t80 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -101.89 71.18 1.27 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.863 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.48 114.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.072 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' CB ' ' HD3' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -87.95 -53.53 0.37 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HD3' ' CB ' ' A' ' 4' ' ' ASP . 53.0 Cg_exo -54.5 -21.9 25.79 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.501 2.134 . . . . 0.0 112.235 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 t -73.69 61.47 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.731 ' CD2' HD11 ' A' ' 34' ' ' LEU . 2.8 tm? -162.25 -73.4 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.922 HG12 HD11 ' A' ' 20' ' ' ILE . 3.5 m -50.07 -42.51 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.4 -27.92 67.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.037 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.67 -56.25 4.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.825 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.533 HD23 ' HB ' ' A' ' 20' ' ' ILE . 7.1 tp -47.41 -55.99 7.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 0.0 110.698 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.824 HG23 ' HA ' ' A' ' 17' ' ' PRO . 63.4 m -53.15 -52.05 60.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.35 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.57 -31.05 52.04 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.028 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.8 tp -56.95 -19.88 20.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 19.02 5.29 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.332 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.5 p -134.51 66.08 69.08 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.676 0.274 . . . . 0.0 111.246 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.824 ' HA ' HG23 ' A' ' 12' ' ' THR . 11.8 Cg_exo -71.54 -9.95 25.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.754 2.303 . . . . 0.0 112.777 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -126.26 16.37 7.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.095 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -113.46 -22.91 10.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.179 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HG12 ' A' ' 8' ' ' VAL . 16.0 tt -54.18 -35.31 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.988 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.792 ' HA ' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -66.07 -41.67 90.42 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.193 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' CB ' HD13 ' A' ' 47' ' ' ILE . 62.5 m-85 -63.74 -26.97 68.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.612 ' CE1' HD22 ' A' ' 45' ' ' LEU . 2.3 m-85 -91.31 -35.95 14.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.469 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.792 HG22 ' HA ' ' A' ' 21' ' ' GLU . 4.4 t -70.72 -16.17 62.76 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.422 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -61.5 -23.0 65.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.742 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -100.12 -57.37 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.12 39.42 0.03 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.057 HD13 HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.68 37.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.377 -179.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -99.86 -29.85 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.968 0.413 . . . . 0.0 110.3 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -104.12 107.92 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.534 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -43.63 -30.06 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 -177.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.4 -21.49 25.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.674 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -85.4 -26.86 26.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -97.84 14.94 25.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -63.08 -37.78 88.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.437 0.637 . . . . 0.0 111.424 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.03 -14.78 14.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.268 -176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.726 HD12 HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -44.11 145.53 0.75 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.355 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -133.67 173.81 11.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.175 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.745 HD13 ' HA ' ' A' ' 53' ' ' MET . 8.8 tp -63.09 -34.6 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.638 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 2.9 pt-20 -61.98 -38.51 88.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.47 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 58.1 m-20 -84.99 -27.65 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.383 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.726 HD23 HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -56.42 -59.73 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.29 -19.81 60.1 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.118 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -56.64 -36.03 69.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.057 0.456 . . . . 0.0 110.284 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 23' ' ' PHE . 6.8 mp -60.92 -15.53 32.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.607 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 73.77 17.47 3.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 111.248 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.482 HD11 HD23 ' A' ' 45' ' ' LEU . 12.0 mt -79.46 137.87 55.43 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.709 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.3 Cg_exo -44.44 136.04 8.83 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.524 2.149 . . . . 0.0 112.299 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -68.41 62.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.234 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -85.44 -58.05 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.759 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.36 36.98 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.597 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -56.7 -64.74 0.77 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.745 ' HA ' HD13 ' A' ' 39' ' ' ILE . 3.3 ppp? -52.14 -42.91 63.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 52.9 m -53.13 -48.47 67.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.604 ' HA ' HD23 ' A' ' 14' ' ' LEU . 38.6 mt -62.94 -44.03 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.4 ' CD2' ' HB ' ' A' ' 39' ' ' ILE . 9.5 t90 -56.72 -55.23 36.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.438 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HG3' ' N ' ' A' ' 58' ' ' GLY . 4.3 ptm180 -59.46 -30.67 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.989 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -79.2 -26.33 57.87 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.822 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -81.08 -41.42 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.807 0.337 . . . . 0.0 110.485 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.77 -27.67 69.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.364 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -63.17 -30.71 71.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.527 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.523 HD11 HD11 ' A' ' 31' ' ' ILE . 10.3 mt -66.2 -51.27 59.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.652 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -55.84 -45.73 78.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.117 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -46.84 -44.88 19.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.46 -20.95 9.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.525 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 138.04 38.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.995 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 174.32 132.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.473 ' O ' ' CD1' ' A' ' 68' ' ' TYR . 23.8 t80 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.871 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.818 0.342 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 69.78 -174.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.93 136.58 37.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.444 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -65.42 -51.43 52.11 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 4' ' ' ASP . 84.3 Cg_endo -83.4 59.05 6.32 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.71 2.274 . . . . 0.0 112.393 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 t -79.96 -28.97 39.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -90.06 -60.89 1.81 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.065 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 m -43.0 -36.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.794 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -58.06 -51.52 69.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.104 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.54 -38.54 48.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.312 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.785 HD21 HD12 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -46.82 -57.25 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.05 0.452 . . . . 0.0 111.119 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.883 HG23 ' HA ' ' A' ' 17' ' ' PRO . 22.0 m -71.55 -50.52 30.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.804 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.2 -30.07 16.82 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.266 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 55' ' ' ILE . 3.7 tp -58.15 -18.78 27.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.132 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.13 15.63 6.53 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.357 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 m -122.92 72.26 43.68 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.683 0.278 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.883 ' HA ' HG23 ' A' ' 12' ' ' THR . 83.3 Cg_endo -83.33 6.49 5.77 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.67 2.247 . . . . 0.0 113.064 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -145.3 17.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.604 0.24 . . . . 0.0 111.534 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -118.23 -21.05 8.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.396 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 24' ' ' THR . 6.6 tt -50.26 -38.55 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.989 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.35 -46.25 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.54 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.345 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.682 ' HZ ' HD13 ' A' ' 55' ' ' ILE . 29.3 m-85 -63.12 -54.71 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 20' ' ' ILE . 80.7 p -51.72 -30.49 22.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.963 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 p -50.66 -25.79 4.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -101.24 -45.88 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.04 45.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.183 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.978 HD13 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.46 44.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.244 0.545 . . . . 0.0 110.927 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.643 ' C ' HD12 ' A' ' 7' ' ' LEU . 2.8 pt20 -107.98 -19.4 13.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.453 177.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.562 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -121.57 103.16 8.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.606 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.843 HD11 HD11 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -40.76 -31.64 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -177.137 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -56.09 -21.3 21.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.21 -24.66 27.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.978 HD22 HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -103.21 16.52 26.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.105 0.479 . . . . 0.0 111.003 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -59.68 -39.82 85.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.34 -20.06 13.39 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.647 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -46.04 150.63 0.56 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.356 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.774 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -140.32 177.35 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.213 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.49 ' HB ' ' CE3' ' A' ' 56' ' ' TRP . 9.5 tp -59.1 -34.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.37 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -59.15 -39.2 81.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.227 178.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -85.53 -33.57 21.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.542 178.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.595 ' CD2' HD22 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -53.52 -50.19 65.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.479 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -22.16 68.95 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.029 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -62.86 -27.28 69.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.0 mp -62.53 -14.77 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.494 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 5.0 mttm 72.53 16.72 4.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.804 0.335 . . . . 0.0 111.366 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG2' ' HD2' ' A' ' 48' ' ' PRO . 9.0 mt -85.39 138.7 36.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 84.4 Cg_exo -44.95 130.74 10.42 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.232 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -68.01 64.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -85.04 -52.27 6.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.655 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -140.15 25.61 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.798 ' HA ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -49.04 -48.2 44.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.194 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.483 ' HA ' HD13 ' A' ' 39' ' ' ILE . 35.8 mtm -57.36 -56.57 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.0 m -49.79 -44.26 48.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.797 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 52' ' ' ARG . 14.3 mt -57.11 -55.36 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.774 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.2 t90 -52.45 -50.4 62.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -52.79 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.92 -39.99 80.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.062 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 34' ' ' LEU . 2.6 mp -66.19 -29.17 69.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.486 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.52 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 35.3 mt-30 -74.43 -28.03 60.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.391 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -67.17 -26.57 66.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.77 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.843 HD11 HD11 ' A' ' 31' ' ' ILE . 14.0 mt -78.7 -47.29 17.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.002 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -62.89 -43.3 99.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.118 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -65.28 -41.87 93.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.08 167.5 35.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.76 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.26 159.61 19.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.837 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 p30 174.64 129.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 68' ' ' TYR . 55.2 t80 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.956 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.827 0.346 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -60.99 137.55 58.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.031 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.03 165.2 25.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -133.57 64.2 67.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.48 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 47.1 Cg_exo -55.76 -21.55 32.95 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.565 2.176 . . . . 0.0 112.303 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.17 -40.02 22.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.388 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.784 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.5 tm? -75.05 -64.97 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.258 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.784 ' N ' HD13 ' A' ' 7' ' ' LEU . 2.9 m -53.28 -34.35 22.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.381 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 4.8 t -63.55 -33.15 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.381 . . . . 0.0 111.27 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.42 -48.47 7.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.645 HD11 HD12 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -47.58 -53.14 15.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.783 HG23 ' HA ' ' A' ' 17' ' ' PRO . 50.9 m -74.45 -48.0 30.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.731 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.18 -29.86 30.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.055 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.715 HD21 ' HA3' ' A' ' 58' ' ' GLY . 4.0 tp -59.31 -17.94 33.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.669 0.271 . . . . 0.0 111.274 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.26 19.36 5.9 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.181 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 85.0 m -126.87 73.74 76.0 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.709 0.29 . . . . 0.0 110.992 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.783 ' HA ' HG23 ' A' ' 12' ' ' THR . 7.7 Cg_endo -84.74 -0.26 9.23 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.068 2.512 . . . . 0.0 112.918 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -135.8 13.58 3.4 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 1.3 m -117.53 -20.19 9.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.601 0.239 . . . . 0.0 111.419 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.525 ' CG1' HD22 ' A' ' 11' ' ' LEU . 13.9 tt -51.67 -28.96 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 110.926 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.506 ' HA ' HG22 ' A' ' 24' ' ' THR . 4.8 mm-40 -68.64 -43.38 76.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.256 0.551 . . . . 0.0 110.388 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 1.5 m-30 -68.33 -24.76 64.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.249 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -91.8 -32.38 15.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 21' ' ' GLU . 2.6 t -69.32 -10.37 57.54 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.993 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -19.35 62.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.714 ' CD ' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -112.3 -20.74 11.73 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.362 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 33' ' ' HIS . . . 131.82 51.39 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.435 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.067 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -109.45 37.68 2.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.889 0.376 . . . . 0.0 111.129 179.005 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -99.36 -30.43 12.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.92 109.48 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.706 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.732 HD11 HD11 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -44.38 -27.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 111.657 -177.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -20.63 59.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.762 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.468 ' CG ' ' O ' ' A' ' 27' ' ' GLY . 46.5 t-80 -85.06 -19.11 32.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.997 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.067 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -111.16 14.0 21.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.528 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.21 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.053 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -125.06 16.95 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.33 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.563 HD13 HD21 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -85.11 140.44 30.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.386 . . . . 0.0 110.684 179.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.637 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -128.81 -179.84 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.047 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.801 HD13 ' HA ' ' A' ' 53' ' ' MET . 3.8 tp -58.25 -34.26 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -52.19 -43.26 64.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.274 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.444 ' HB3' ' CD2' ' A' ' 37' ' ' LEU . 4.3 m-20 -83.99 -30.07 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.588 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -67.41 -36.98 82.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.794 178.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.459 ' HA2' ' CZ ' ' A' ' 52' ' ' ARG . . . -79.88 2.23 75.45 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.75 -41.13 16.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.714 HD11 ' CD ' ' A' ' 26' ' ' GLN . 3.7 mt -62.69 -12.31 22.82 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.069 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 71.31 15.23 6.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 111.264 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 48' ' ' PRO . 25.1 mm -61.17 138.58 94.44 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.474 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 47' ' ' ILE . 4.3 Cg_exo -37.02 153.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.581 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 52' ' ' ARG . 11.1 tt0 -92.69 23.12 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.429 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -85.07 -33.22 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.54 ' O ' HD12 ' A' ' 55' ' ' ILE . 7.5 m-85 -135.16 12.32 3.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' CZ ' ' HA2' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -54.09 -68.29 0.19 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 179.475 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.801 ' HA ' HD13 ' A' ' 39' ' ' ILE . 2.9 mtm -53.33 -42.26 66.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.871 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.4 m -51.4 -50.75 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.581 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.664 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.2 mt -56.65 -56.96 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.637 ' NE1' HG22 ' A' ' 38' ' ' THR . 7.2 t90 -49.85 -54.89 16.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 6.6 mmt180 -51.37 -32.32 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.803 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.715 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -78.53 -25.25 61.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.797 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.967 HD11 HD12 ' A' ' 34' ' ' LEU . 1.2 tp -80.94 -40.58 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.494 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 4.4 pt20 -63.15 -27.76 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.071 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -55.34 -37.75 67.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.11 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.732 HD11 HD11 ' A' ' 31' ' ' ILE . 10.2 mt -61.14 -45.87 92.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.392 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.16 37.61 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.79 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -51.32 -39.74 57.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.077 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.42 -90.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -137.31 128.84 28.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 111.015 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.42 -161.26 1.15 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.17 0.51 . . . . 0.0 110.612 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.1 t80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.595 -179.001 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 16.8 t80 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.803 0.335 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.93 179.31 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.89 172.22 12.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.91 67.95 18.15 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.7 -20.18 23.29 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.596 2.198 . . . . 0.0 112.343 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 t -68.55 65.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.053 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 7' ' ' LEU . 2.1 tm? -177.17 -58.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' N ' HD13 ' A' ' 7' ' ' LEU . 35.3 m -66.12 -37.31 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.168 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 p -63.19 -26.48 68.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -95.7 -46.78 6.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.17 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tm? -49.58 -52.7 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.862 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 17' ' ' PRO . 91.5 m -77.6 -46.74 21.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.472 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.11 -26.98 6.64 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.362 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.809 HD21 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -54.52 -22.5 13.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.774 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.64 16.91 5.76 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.353 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.425 ' HB3' ' CG ' ' A' ' 51' ' ' TYR . 4.6 p -130.12 80.54 70.7 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.772 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.747 ' HA ' HG23 ' A' ' 12' ' ' THR . 71.6 Cg_endo -78.61 6.1 5.09 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.714 2.276 . . . . 0.0 112.996 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -135.56 22.47 3.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.674 0.273 . . . . 0.0 111.143 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 4.8 t -114.27 -28.62 7.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.967 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 24' ' ' THR . 1.6 tt -50.87 -45.59 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.916 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.511 ' N ' HG23 ' A' ' 20' ' ' ILE . 2.1 pt-20 -49.66 -44.45 47.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' HB2' HD13 ' A' ' 47' ' ' ILE . 70.5 m-85 -69.84 -35.46 74.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.418 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.692 ' CE1' HD12 ' A' ' 47' ' ' ILE . 3.2 m-85 -70.68 -49.6 45.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.73 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 20' ' ' ILE . 71.7 p -55.28 -24.34 27.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -49.15 -30.37 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.244 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -99.99 -53.56 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.1 48.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.99 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.105 HD13 HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -99.51 40.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.047 -179.083 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -99.1 -27.45 13.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.867 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.1 104.39 12.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.598 HD11 HD11 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -43.81 -29.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.99 0.424 . . . . 0.0 111.278 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -55.23 -23.63 23.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.668 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.45 -21.16 35.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.955 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.105 HD22 HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -114.06 22.04 14.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -32.41 71.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.55 -18.36 11.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.716 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.466 HD23 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -44.45 140.86 2.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.344 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.645 HG22 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -128.69 179.18 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.118 -179.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.848 HD13 ' HA ' ' A' ' 53' ' ' MET . 9.6 tp -57.3 -33.65 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.482 0.658 . . . . 0.0 109.276 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.75 -47.49 79.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.539 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.1 m-20 -80.18 -27.52 38.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.673 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -55.18 -52.48 63.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.177 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -15.18 62.89 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.324 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -66.06 -40.31 90.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.561 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 47' ' ' ILE . 8.9 mp -47.3 -27.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.347 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 5.9 ttmm 86.66 16.09 0.1 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.633 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.692 HD12 ' CE1' ' A' ' 23' ' ' PHE . 2.8 mt -86.21 137.69 34.83 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.816 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 47' ' ' ILE . 3.0 Cg_endo -45.26 158.87 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.675 2.25 . . . . 0.0 112.023 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.45 57.8 4.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.177 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.47 -58.12 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.58 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.425 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 1.5 m-85 -137.15 33.48 2.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.616 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.1 ttp180 -56.52 -66.66 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.01 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.848 ' HA ' HD13 ' A' ' 39' ' ' ILE . 59.4 mtt -54.84 -34.81 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.68 ' CG2' HD12 ' A' ' 14' ' ' LEU . 55.2 m -58.14 -49.98 75.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.729 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.618 HD13 ' CE2' ' A' ' 23' ' ' PHE . 60.0 mt -66.13 -35.72 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.602 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.645 ' NE1' HG22 ' A' ' 38' ' ' THR . 10.6 t90 -59.48 -55.82 29.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.941 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.433 ' NH1' ' HB3' ' A' ' 53' ' ' MET . 0.0 OUTLIER -53.34 -39.48 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.621 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.809 ' HA3' HD21 ' A' ' 14' ' ' LEU . . . -67.96 -40.98 88.75 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.91 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 34' ' ' LEU . 1.1 tp -64.26 -38.67 91.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.332 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.47 ' NE2' ' CE2' ' A' ' 56' ' ' TRP . 36.7 mt-30 -63.82 -31.15 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.199 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -33.62 66.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.216 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.598 HD11 HD11 ' A' ' 31' ' ' ILE . 11.5 mt -61.93 -42.02 98.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.431 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.15 38.55 1.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.658 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -132.41 -44.47 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.22 -88.07 0.77 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.379 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 -177.02 4.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.807 0.337 . . . . 0.0 110.912 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.71 128.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.963 179.945 . . . . . . . . 0 0 . 1 stop_ save_